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 1 
1 Introduction 
Pathogenic Enterobacteriaceae such as Salmonella spp., E. coli spp., or Yersinia spp. are not 
only found in the gastrointestinal tract but also in soil or water (Fremaux, et al. 2008; Guan 
and Holley 2003; Sherman, et al. 2010). Throughout their infectious lifecycle, they face 
numerous rapidly changing environmental conditions, which include changing temperatures, 
pH, oxygen content, altering nutrients and ion concentrations. Thus, the bacteria need to 
adapt their metabolism immediately according to their new living circumstances. Moreover, 
environmental signals trigger the expression of virulence determinants for optimally survival 
and colonisation of the pathogen within the host organism. 
1.1 The genus Yersinia 
Yersiniae are described as rod-shaped and gram negative bacteria of which some species are 
motile. The bacteria grow at temperatures up to 43°C and at moderate temperature down to 
4°C, which characterizes them as psychrophil. The genus comprises 14 species but only three 
species, i.e. Y. enterocolitica, Y. pseudotuberculosis and Y. pestis, cause diseases in humans 
with a common tropism. The pathogens preferentially colonize the lymphoid tissues of their 
host and form microcolonies and microabscesses. They circumvent the host immune system 
by inhibiting phagocytosis through macrophages or polymorphonuclear leukocytes and impair 
lysis by the complement system. Their infection process, however, differs greatly (Autenrieth, 
et al. 1993; Bergsbaken and Cookson 2009; Heesemann, et al. 2006; Hurst, et al. 2010; Li and 
Yang 2008; Murros-Kontiainen, et al. 2010a; Murros-Kontiainen, et al. 2010b; Sebbane, et al. 
2006).  
Y. pestis, which evolved from Y. pseudotuberculosis 1,500 to 20,000 years ago, represents the 
etiological agent of bubonic, septemic or pneumonic plaque. Y. pestis is found living 
zoonotically in rodents from where it is transmitted to humans by bites of infected fleas. 
Y. pestis still causes outbreaks lately reported from North America, Africa and Asia (Butler 
2009; Perry and Fetherston 1997; WHO 2009).  
Y. enterocolitica and Y. pseudotuberculosis have been isolated from soil, water, plants or 
domestic and wildlife animals, especially pigs. They occur primarily in the temperate zone of 
the northern hemisphere. The species Y. enterocolitica includes a variety of serotypes differing 
in virulence. They comprise serotypes O:3 or O:9 predominantly found in Europe and 
serotypes O:8 or O:13 isolated in North America. In contrast, Y. pseudotuberculosis serotypes 
show comparable infectivity and virulence (Bottone 1997; Bottone 1999; Rosner, et al. 2010). 
Both species cause gut-associated diseases ranging from enteritis and terminal ileitis to 
mesenterial lymphadenitis also known as yersiniosis (Dube 2009; Pepe, et al. 1995; Trulzsch, 
et al. 2007). 
 2 
1.1.1 Route of infection of Y. pseudotuberculosis 
Alike Y. enterocolitica, Y. pseudotuberculosis is taken up by contaminated food or water. The 
bacteria pass the gastrointestinal tract and encounter the ileum which represents the final part 
of the small intestine. During this early infection phase, the pathogen is able to adhere and 
to invade into specialized cells of the host immune system, intercalated within the epithelial 
cell layer, the so-called M-cells (Fig. 1).  
In general, M-cells take up macromolecules as well as pathogenic material by endocytosis or 
phagocytosis. In contrast to neighbouring epithelial cells they lack microvilli at the apical side 
and form a pocket-like structure at their basolateral side containing dendritic cells, 
macrophages and lymphocytes. Thereby, antigenic material is delivered from the lumen 
towards cells of the host immune system (Jang, et al. 2004; Neutra, et al. 1996). 
Y. pseudotuberculosis translocates through the M-cells and reaches the underlying lymphoid 
tissue, the Peyer's patches (Grutzkau, et al. 1990; Hanski, et al. 1989; Sansonetti and 
Phalipon 1999). In the later infection phases, the bacteria are able to proliferate 
extracellularly and cause microabscesses. Within these, yersiniae form microcolonies to sustain 
resistance against phagocytosing neutrophils as well as macrophages (Oellerich, et al. 2007; 
Simonet, et al. 1990). The genus Yersinia has shown to be able to survive in macrophages 
and dendritic cells which might be used as carriers to transfer to the mesenteric lymph nodes. 
Eventually, the bacteria disseminate into deeper lymphatic tissues such as liver, spleen and 
kidney (Marra and Isberg 1996; Pepe and Miller 1993; Pujol and Bliska 2005). Finally, a 
yersiniae infection can result in auto-immune diseases, for example reactive arthritis, in 
particular in hosts carrying the major histocompatibility complex HLA-B27 (Carter and 
Hudson 2009; Girschick, et al. 2008; Toivanen and Toivanen 2004). Few infections in patients 
with underlying disorders such as HIV, diabetes or hepatic cirrhosis have shown that 
enteropathogenic yersiniae may lead to septemic infections (Ljungberg, et al. 1995; Paglia, et 
al. 2005). 
Throughout the infection process, Y. pseudotuberculosis faces different tissues which present 
a variety of different surface molecules and components of the host immune system. The 
pathogen therefore needs to produce specific virulence factors allowing an efficient adaptation 
to these different tissue components. In the early infection phase, Y. pseudotuberculosis 
carries flagella and smooth lipopolysaccharides. To translocate efficiently through the M-cells 
to the lymphoid-follicle tissue yersiniae expose the non-fimbrial protein invasin (Fig. 1). 
For long-term colonisation in the Peyer’s patches and deeper lymphatic tissues yersiniae 
require a set of virulence factors involving the Yersinia adhesin A (YadA), a type III secretion 
system (Yersinia secretion – Ysc) and the thereby transported effector proteins, the Yersinia 
outer protein (Yops) (Fig. 1). 
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Fig. 1. Yersinia infection route. Yersinia (in yellow) enters the human host by contaminated food or water and 
passes the intestinal tract to the small intestine (in red). In the ileum, the bacteria translocate through the gut 
epithelium by invading the M-cells to reach the underlying Peyer’s patches. There, Yersinia proliferates and 
disseminates to the mesenteric lymph nodes and further to liver, spleen or kidney. Early and later infection 
phases are marked on the right, indicating the important virulence factors expressed during these stages 
(according to Sansonetti 2002). 
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1.1.2 Important virulence factors of Y. pseudotuberculosis 
In the beginning of the infection, the enteric pathogens Y. pseudotuberculosis and 
Y. enterocolitica need to penetrate the first epithelial barrier in the distal ileum escaping a 
fast recognition by cells of the innate immune response in the gut lumen. This process is 
mediated by the primary virulence factor invasin. 
Invasin is chromosomally encoded by the inv gene and represents an outer membrane protein 
of the intimin family of adhesins. The 100 kDa molecule comprises a N-terminus anchored to 
the bacterial membrane and five extracellular C-terminal domains D1 to D5. Domains D1 to 
D4 show topological similarities to the Ig superfamily whereas D5 is characterized by a 
C-terminal-lectin-domain (CTLD) (Marra and Isberg 1997; Niemann, et al. 2004). Though 
invasin shows no sequence homology to fibronectin its three dimensional structure is very 
similar to the receptor binding domain of the extracellular matrix component (Stebbins and 
Galan 2001). 
 
Fig. 2. Crystal structure of the Y. pseudotuberculosis invasin. The molecule is located on a bacterial cell with 
a membrane spanning domain in blue. Domains D1 to D4 show homologies to the Ig superfamily. D5 at the 
C-terminus represents a C-type lectin like-domain, which together with D4 forms the adhesion complex of 
invasin (Isberg, et al. 2000). 
Domains D4 and D5 allow invasin a direct high-affinity binding to α5β1 integrins at the luminal 
side of the M-cells. Integrins are receptor molecules on the surface of mammalian cells usually 
involved in cell-cell-interaction. An extracellular domain recognizes the RGD (Arg-Gly-Asp) 
motif within the substrate, which is resembled by two aspartate residues in D4 and D5 
(Fig. 2). An intracellular integrin domain is able to induce a signaling cascade which leads to 
polymerization of actin filaments. Such actin polymerization restructures the cytoskeleton and 
activates pseudopod formation at the bacterial contact site. The invasin protein of 
Y. pseudotuberculosis is able to form multimers mediated by the D2 domain (Fig. 2). This 
clustering induces β1 integrin-clustering and results in the uptake of the bacterium into non-
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phagocytic cells by the zippering mechanism due to an amplification of the intracellular 
signaling events. Y. enterocolitica is missing this D2 domain, so that it internalizes less 
efficiently into human cells (Grassl, et al. 2003; Isberg and Barnes 2001; Isberg, et al. 2000; 
Uliczka, et al. 2009; Wong and Isberg 2005). Y. pestis is unable to express invasin because of 
an IS200 element encoded within the inv gene (Simonet, et al. 1996). Deletion of the inv gene 
in Y. pseudotuberculosis resulted in a reduced colonization of the Peyer’s patches early during 
the infection but did not influence the virulence in the mouse after several days post infection. 
Hence, invasin seems only important for the initial infection stages (Marra and Isberg 1996; 
Pepe and Miller 1993). Indeed, after two to four hours post infection, Y. pseudotuberculosis 
seems to turn off the synthesis of invasin (J. Eitel, unpublished data).  
As mentioned before, Y. pseudotuberculosis synthesizes different virulence factors during the 
ongoing infection phases, which are YadA, a type III secretion system and the Yop effector 
proteins. These are encoded on the 70 kDa Yersinia virulence plasmid pYV. Strains cured 
from pYV proliferate transiently in the mesenterial lymph nodes and spleen but are eventually 
eliminated within granulomas by the host immune system (Pujol and Bliska 2005).  
The outer membrane protein Yersinia adhesin A belongs to the group of trimeric 
autotransporters which have also been found in other organisms such as Escherichia coli, 
Moraxella spp. or Neisseria spp. (Cotter, et al. 2005; Roggenkamp, et al. 2003). The protein 
has a size of 200 to 240 kDa and forms homotrimers. Its lollipop-like structure is assembled of 
a C-terminal membrane anchor of β-barrels, a right handed coiled-coil shaped stalk-neck and a 
surface-exposed head domain (Fig. 3A). The polypeptide interactions of YadA are based on 
the ionic or hydrophobic nature of the molecules (El Tahir and Skurnik 2001; Hoiczyk, et al. 
2000; Koretke, et al. 2006). The head domain of YadA in Y. enterocolitica has been described 
to form nine-coiled left-handed parallel β-roll (Nummelin, et al. 2004). In Y. pestis, YadA 
synthesis is impaired by a frame shift mutation within the gene as well as IS and transposon 
elements located in the yadA promoter region (El Tahir and Skurnik 2001). 
Adhesion of Yersinia to mammalian cells is mediated by binding of the YadA head domain to 
αβ1 integrins using the extracellular matrix proteins fibronectin, collagen or laminin as bridging 
molecules. This binding leads to the activation of signalling pathways in the host cell 
producing proinflammatory cytokines such as interleukin 8 (IL-8) and serum resistance of 
enteric yersiniae (Eitel, et al. 2005; Kirjavainen, et al. 2008; Schmid, et al. 2004; Uliczka, et 
al. 2009). 
The N-terminal part of YadA determines different binding specificities to mammalian cells. 
The YadA head domain of Y. enterocolitica binds to α2β1 or α3β1 integrins via collagen and 
laminin leading to tight adhesion but not cell entry of the pathogen. The head domain of 
Y. pseudotuberculosis contains an additional motif of 30 amino acids which mediates binding 
to fibronectin as a bridging molecule. This leads to α5β1 integrin binding and uptake into the 
host cell (Fig. 3B). In the mouse model, colonization of a Y. enterocolitica yadA mutant in 
the deeper tissues was found to be significantly reduced (Schutz, et al. 2010). 
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The YadA head domain of Y. pseudotuberculosis mediates autoagglutination and 
hemagglutination of the bacteria, which enables them to form microcolonies to sustain 
neutrophil attacks in the lymphatic tissue (Eitel and Dersch 2002; Heise and Dersch 2006; 
Nummelin, et al. 2004).  
The outer membrane protein YadA helps Yersinia to colonize and to proliferate within the 
host tissues. To circumvent the host immune response further virulence determinants need to 
be produced. 
A B 
Fig. 3. YadA from Y. pseudotuberculosis and Y. enterocolitica. A. Domain structures of YadA from 
Y. pseudotuberculosis (Y. pstb.) and Y. enterocolitica (Y. ent.) attached to the bacterial outer membrane. Red 
domains in YadA (Y. pstb.) mediate invasion into host cells. B. Head domain of YadA in Y. pseudotuberculosis. 
binds to fibronectin, whereas YadA from Y. enterocolitica interacts with collagen (according to Heise and 
Dersch 2007).  
A type III secretion system (T3SS) translocates effector proteins of Yersinia from the 
bacterium to extracellular space or into host cells. It represents a protein delivery machinery 
which finds its structural counterparts in the flagellum organelle (Journet, et al. 2005). The 
T3SS is synthesized prior to host cell contact by Yersinia secretion (Ysc) proteins. First, YscC 
polymerizes in the outer membrane (Ramamurthi and Schneewind 2002). YscW (VirG) helps 
to localize YscC at the polymerization site and facilitates oligomerization of YscC (Burghout, 
et al. 2004; Koster, et al. 1997). The inner membrane ring consists of polymerized YscD 
subsequently filled with a 24-subunit ring of the lipoprotein YscJ. The ATPase-C ring 
complex, consisting of YscN, K, L and Q drives the protein pump and shows activity for 
recruitment of proteins (Fig. 4). The export apparatus located within the inner membrane 
pore consists of YscR, S, T, U and V is transcribed in an operon. These integral membrane 
proteins recognize the Yops which are effector proteins exported by the type III secretion 
system. The needle, a hollow tube, is formed by polymerization of the 6 kDa protein YscF 
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(Cornelis 2002a; Cornelis 2002b; Cornelis 2006; Diepold, et al. 2010; Silva-Herzog, et al. 
2008; Spreter, et al. 2009).  
The T3SS senses the contact to the host cell which is facilitated by the binding of outer 
membrane proteins like YadA to integrins. Host cell contact or the penetration of the 
mammalian cell membrane might trigger the translocation of effector proteins. 
 
Fig. 4. Model of the Yersinia injectisome assembly. The different Yersinia secretion (Ysc) components are 
embedded within the inner membrane, through the periplasm and the outer membrane to the extracellular area 
(according to Diepold, et al. 2010). 
Lipopolysaccharides, lipoproteins and lipoteichoic acids exposed on the bacterial cell surface 
stimulate the innate immunity response of the host. Phagocytes internalize intruding bacteria. 
This kills the bacteria and induces the production of proinflammatory cytokines such as 
TNF-α and IL-8 which in turn activate natural killer cells, T-cells and macrophages of the 
innate immune system. Moreover, cytokines promote formation of T helper 1 cell belonging to 
the adaptive immune response. The Yersinia outer proteins, or Yops, counteract this defence 
mechanism (Ruckdeschel, et al. 2008; Viboud and Bliska 2005).  
Some effector molecules assist the translocation of others into the host cell. YopN, TyeA and 
LcrG function as a secretion channel plug that opens the T3SS needle, when it has pierced 
the mammalian cell membrane. YopB and YopD show pore forming activity and together with 
LcrV help to translocate effectors through the needle. In addition, the V-antigen LcrV is 
secreted to the extracellular milieu where it has shown to inhibit inflammation by binding to 
Toll-like receptors (Cornelis 2002b; Viboud and Bliska 2005). 
Yops, transferred to the eukaryotic cell, interfere with numerous signaling pathways and cell 
functions. YopH, a protein tyrosine phosphatase, manipulates the signaling cascade of focal 
adhesion proteins in epithelial cells and macrophages (Aepfelbacher, et al. 2007; Trosky, et al. 
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2008). YopE, T and O (YpkA in Y. enterocolitica) represent members of the bacterial toxin 
family which target Rho GTPases of the host cell (Fig. 5). Thereby, reorganization of the 
cytoskeleton for phagocytosis is impaired (Matsumoto and Young 2009; Trosky, et al. 2008). 
YopJ (YopP in Y. enterocolitica) inhibits MAP (mitogen-activated protein) kinases and the 
NF-κB signaling pathway which leads to a repression of the cytokine production (Ruckdeschel, 
et al. 2008). Furthermore, YopJ is essential for Yersinia initiating apoptosis in naïve 
macrophages. The leucine-rich protein YopM is transported into the nucleus of the host cell 
by a vesicle-associated pathway (Fig. 5). There, the protein seems to affect transcription of 
genes which regulate cell growth and -cycle (Aepfelbacher, et al. 2007). Functions of the Yops 
show that yersiniae have developed various ways to inhibit or reprogram the immune response.  
 
Fig. 5. Targets of the Yersinia type III effectors within the host cell. Three effectors including YopE, YopT, 
and YpkA impair the function of the Rho family small GTPases. YpkA phosphorylates Gaq and stimulates the 
GTPase. YopH influences components of the focal adhesion complex by dephosphorylation, which interferes 
with processes of host phagocytosis. Phosphorylation and activation of MAPK kinases is prevented by 
acetylation of Ser/Thr residues through YopJ. The actin cytoskeleton in the host cell is rearranged and 
transcription of immune response genes is inhibited (Shao 2008). 
To produce early or late phase virulence factors in the target tissues for efficient and long-
term infection of the host, Yersinia needs to tightly regulate their expression in response to 
environmental keys. In vitro, Y. pseudotuberculosis synthesizes early virulence factors only at 
moderate temperature, during stationary growth phase and nutrient rich environment which 
resembles external environment or contaminated food conditions. Production of virulence 
determinants from the late stage is monitored at temperatures above 30°C, during exponential 
growth and minimal medium (Eitel and Dersch 2002; Heroven, et al. 2007; Heroven and 
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Dersch 2010; Nagel, et al. 2001; Pepe, et al. 1994). The bacteria sense these triggering 
signals within the host via a complex regulatory network. 
1.2 Environmental control of virulence determinants of the early 
infection phase 
Invasin expression is regulated by specific environmental signals such as temperature, nutrient 
availability and growth rate. In contrast to inv transcription in Yersinia, an inv-phoA promoter 
fusion was not activated in E. coli under invasin synthesis conditions. Thus, inv gene 
expression seemed to be the result of the induction by a Yersinia specific factor. By 
transposon mutagenesis in Yersinia and a complementation strategy in E. coli, an inv 
regulatory protein, the regulator of virulence A (RovA), was identified (Nagel, et al. 2001; 
Revell and Miller 2000). 
1.2.1 The invasin activator RovA – regulator of virulence A 
The RovA protein is highly homology to proteins like Hor or SlyA which represent global 
transcriptional activators belonging to the MarR family. The crystal structure of the 15 kDa 
protein revealed a central helix-turn-helix motif which is responsible for DNA binding. It is 
followed by two β-sheets (N. Quade, unpublished data, Fig. 6A). The RovA protein forms 
dimers achieved by a dimerization domain consisting of the first N-terminal helix and the last 
two C-terminal helices. For DNA binding in promoter regions, RovA recognizes non-
palindromic target sites with a consensus sequence of A/T ATTAT A/T. Two recognitions sites 
were found within the inv promoter 207 nt upstream of the transcriptional start site (Nagel, 
et al. 2001; Tran, et al. 2005). 
RovA itself is transcribed from two promoters P1 and P2 located 76 nt and 343 nt upstream 
of the transcription start. The protein binds to its own promoter region and autoregulates its 
expression. Autoactivation of rovA gene transcription is achieved by binding of at least two 
RovA dimers upstream of promoter P2. High RovA concentrations within the cell, however, 
induce the binding of the regulator to a low affinity binding site downstream of promoter P1 
and abolishes further induction of rovA gene expression. This autoregulatory feed back loop 
represents a mechanism to control RovA levels within the bacterium.  
RovA synthesis occurs during stationary growth, in complex medium and at moderate 
temperatures similar to invasin expression. An inv promoter missing the RovA binding site was 
deregulated in response to temperature (Heroven, et al. 2004; Nagel, et al. 2001). 
Temperature-regulation of inv transcription through regulation of RovA synthesis is affected 
by the thermosensing characteristics of the RovA protein. The structure of the RovA protein 
was found to be thermally instable revealing altered helix and β-sheet arrangements at higher 
temperatures compared to moderate temperatures. At 37°C, the conformational changes 
impair the DNA binding affinity of RovA and reduce transcription activation of invasin and 
rovA expression (Fig. 6B). Additionally, partially defolded RovA at 37°C is subject to 
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degradation by ClpP/Lon proteases, especially during exponential growth phase, which is most 
probably facilitated by an unknown cofactor (Herbst, et al. 2009). Thus, regulation of RovA 
synthesis mediates invasin expression in response to temperature and growth phase. 
A 
 
B 
Fig. 6. Structure and thermoregulation of RovA. A. Crystal structure of RovA, which forms homodimers (in 
red and blue), each containing several α-helices (labeled at the red monomer). The central helix-turn-helix motif 
is required for binding to the DNA (N. Quade, unpublished data). B. Model of thermo-dependent rovA gene 
expression at 25°C and 37°C during stationary phase and during exponential growth at 37°C (Herbst, et al. 
2009). 
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During mouse infection experiments, a rovA deletion in Yersinia confers lower virulence to the 
bacteria than deletion of the inv gene. rovA mutants were severely attenuated in 
dissemination to deeper tissues. An infection was only established in the Peyer’s patches, 
whereas an inv mutant was also isolated from mesenteric lymph nodes and the spleen 
(Heroven, et al. 2007; Nagel, et al. 2003; Revell and Miller 2000). Further investigations 
revealed that a Y. enterocolitica rovA-deficient strain resulted in an increased inflammation in 
the Peyer’s patches. In addition, IL-1α expression was not induced. These results and recent 
microarray data show that the global transcriptional activator RovA does not only activate inv 
expression. It also influences a variety of other genes including virulence determinants such as 
pH6 antigen and genes involved in metabolism (Tran, Heroven unpublished results; Cathelyn, 
et al. 2006). Virulence of a Y. pestis rovA mutant after subcutaneous infection of mice was 
80fold attenuated whereas it was only slightly reduced after infection of mice intranasanally or 
intraperitoneally. This indicated that RovA in Y. pestis encounters a more important role 
during bubonic plaque than during pneumonic plaque. 
A genetic search for regulators influencing rovA transcription led to the identification of the 
nucleoid-associated protein H-NS, the LysR-type regulator RovM, the Carbon storage 
regulator system (Csr) and the nucleoid-associated protein YmoA. 
1.2.2 The nucleoid-associated protein H-NS 
The nucleoid-associated protein H-NS forms dimers by its N-terminal oligomerization domain, 
which is connected to the C-terminal DNA-binding domain by a flexible linker peptide 
(Fig. 7A) (Arold, et al. 2010; Fang and Rimsky 2008; Stoebel, et al. 2008). In general, H-NS 
is known to organize chromosomal DNA (Dorman 2004). By DNA-protein-DNA bridges, 
H-NS binds simultaneously to independent DNA-binding sites and induces loop formation 
resulting in a higher condensation of chromosomal DNA (Fig. 7B) (Noom, et al. 2007; 
Stoebel, et al. 2008). Further, the nucleoid-associated protein influences transcription activity 
by altering the DNA topology in the promoter regions of target genes. It preferentially binds 
to AT-rich DNA sequences in promoter regions with intrinsic curvature which leads to an 
impaired association of the RNA polymerase. Further studies demonstrated a very weak 
binding of H-NS to unspecific DNA. Binding of H-NS to DNA with high affinity occurs to the 
consensus sequence 5'-TCGATATATT-3'. This sequence acts as a nucleation site from which 
H-NS oligomerizes along the DNA (Dame, et al. 2001; Prosseda, et al. 2004; Tolstorukov, et 
al. 2005). The protein exhibits preference to repress horizontally acquired DNA to protect the 
recepting bacterium from expression of harmful gene products. H-NS recognizes xenogenic 
DNA because of its lower GC-content compared to chromosomal DNA (Blot, et al. 2006; 
Lucchini, et al. 2006; Navarre, et al. 2007; Oshima, et al. 2006). H-NS also revealed the 
ability to bind to RNA molecules and might act as a chaperone (Brescia, et al. 2004).  
Besides homodimer formation, H-NS has been described to form heterodimers with other 
nucleoid-associated proteins such as Hha in E. coli and Salmonella or YmoA in Yersinia 
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(Cordeiro, et al. 2008; Fass and Groisman 2009; Madrid, et al. 2007). H-NS and Hha of 
Salmonella were reported to repress expression of hilD, hilC and rtsA, encoding essential cell 
invasion factors, in response to osmolarity (Olekhnovich and Kadner 2007). In Salmonella, a 
major part of gene transcription was upregulated during a temperature shift from 25°C to 
37°C which was attributed to a putative conformational change in the H-NS structure, thus 
reduced DNA-binding ability (Duong, et al. 2007; Ono, et al. 2005). In contrast, H-NS 
oligomerizes at 37°C to a higher extent than at 25°C (Fang and Rimsky 2008). 
In Yersinia, inv and rovA transcription are repressed by the H-NS protein which binds to 
AT-rich sequences within the inv and rovA promoter regions (Ellison, et al. 2004; Heroven, et 
al. 2007; Heroven and Dersch 2010). To inhibit invasin expression, H-NS interacts with the 
inv promoter from position -31 nt to -207 nt relative to the transcription start. Within the 
rovA promoter H-NS covers a DNA stretch from -429 nt to -547 nt upstream of promoter P2. 
By that, the inv and the rovA promoter are repressed at 37°C (Ellison 2006, Heroven 2007). 
At 25°C, the RovA protein functions as an antagonist of H-NS silencing because of its higher 
binding affinity to the target promoter sequences (Heroven, et al. 2004; Tran, et al. 2005). 
This has also been shown for other proteins such as SlyA in Salmonella or the H-NS-type 
protein Ler from enteropathogenic E. coli strains (Fass and Groisman 2009; Stoebel, et al. 
2008). 
A
 
B
 
Fig. 7. The nucleoid-associated protein H-NS A. H-NS1-82 dimer (cyan and blue) model (Arold, et al. 2010) 
B. Binding of the nucleoid-associated protein H-NS affects the DNA conformation and leads to DNA bridging or 
oligomerization along DNA strands. This sterically prevents binding of the RNA polymerase or covers the 
recognition site of an antagonist (according to Dillon and Dorman 2010). 
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1.2.3 RovM - the modulator of rovA expression 
In addition to H-NS, the LysR-type regulator RovM (PecT, HexA, LrhA) inhibits transcription 
of the rovA regulator gene. During growth in nutrient-deprived media, RovM downregulates 
RovA synthesis (Heroven and Dersch 2006).  
In Y. pseudotuberculosis, the LysR regulator binds to palindromic sequences of 30 nucleotides 
with the central motif T-N11-A upstream of rovA promoter P1. The association of RovM to 
the DNA does not interfere with H-NS binding sites (sec. 1.2.2). Still, RovM downregulates 
rovA expression in cooperation with H-NS. The nucleoid-associated protein might induce 
structural rearrangements of the promoter region, for example curvature, leading to a more 
efficient RovM-DNA complex formation. 
Homologs of RovM have been found in Erwinia chrysanthemi where PecT negatively regulates 
expression of pectate lyases, motility, exopolysaccharides and also virulence of the 
phytopathogens (Castillo, et al. 1998; Condemine, et al. 1999; Nasser, et al. 2005). LrhA in 
E. coli has shown to repress genes responsible for motility, flagella synthesis, chemotaxis and 
biofilm formation (Blumer, et al. 2005; Lehnen, et al. 2002). Higher RovM levels in 
Y. pseudotuberculosis induced flagellar synthesis but showed attenuated dissemination to 
deeper tissues in the mouse model. rovM expression is positively autoregulated and maximal 
under minimal medium conditions. Heroven and Dersch (2006) further demonstrated that 
RovM mediates medium-dependent regulation of rovA transcription.  
1.2.4 The carbon storage regulator system 
In Y. pseudotuberculosis, medium-dependent control of RovM synthesis is controlled by the 
activity of the carbon storage regulator (Csr) system (Heroven and Dersch 2010). The Csr 
system has been identified in other enterobacteria such as E. coli and Salmonella (Babitzke 
and Romeo 2007; Papenfort and Vogel 2010; Vogel 2009). In Pseudomonas and Erwinia the 
homologous system was named Rsm system for regulator of secondary metabolism (Cui, et al. 
1995; Cui, et al. 1999; Lapouge, et al. 2008). In general, the system is composed of the RNA-
binding protein CsrA (RsmA/E), and untranslated regulatory Csr or Rsm RNAs. The CsrA 
protein forms dimers of approx. 18 kDa. A monomer consists of five β-strands β1 to β5 
followed by an α-helix H1. Dimerization of CsrA monomers is mediated by the interaction of 
β-strands β1 and β5 (shown for the crystal structure of RsmE in Fig. 8A) (Gutierrez, et al. 
2005; Schubert, et al. 2007). Mercante et al. (2006) described that these β-strands contain 
important residues for regulation and RNA-binding. CsrA (RsmA/E) proteins are able to bind 
to GGA motifs within target mRNAs, overlapping with ribosomal binding sites. This blocks 
binding of ribosomes and in most cases renders the target mRNAs for RNA degradation, for 
instance the mRNA of the glgCAP operon in E. coli (Baker, et al. 2002) (Fig.8B). However, it 
has been reported that binding of CsrA to the mRNA of flhDC positively influenced RNA 
levels (Wei, et al. 2001).  
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The regulatory Csr (Rsm) RNAs form secondary structures with several hairpin-loops of 
complementary RNA sequences. Single-stranded loop regions within these hairpins contain 
GGA motifs which bind CsrA dimers and thereby sequester the CsrA (RsmA/E) proteins from 
regulating other factors in the cell (Babitzke and Romeo 2007; Majdalani, et al. 2005; Vogel 
2009). Another component of the Csr system, the CsrD protein was found to destabilize CsrB 
and CsrC RNAs in E. coli. The GGDEF and EAL domain containing protein seems to 
facilitate targeting of the RNAs by RNAse E (Suzuki, et al. 2006). 
In other pathogens, the Csr (Rsm) system is implicated in the regulation of virulence factors. 
In S. Typhimurium, the Csr system controls gene expression promoting invasion and gene 
transcription from Salmonella pathogenicity island 1 (SPI-1), which encodes a type III 
secretion system (Altier, et al. 2000; Vogel 2009). The csrA-deficient strains of 
enteropathogenic E. coli were impaired to form actin pedestals on epithelial cells and were not 
able to disrupt transepithelial resistance, which is established across polarized epithelial cells. 
Bhatt and coworkers (2009) demonstrated that the secretion of effectors and translocators 
was strongly reduced. In Erwinia, the RsmA (CsrA) protein is implicated in expression of soft 
rot disease genes (Cui, et al. 1999). RsmA (CsrA) of Pseudomonas regulates exoenzyme 
production and secondary metabolite production (Blumer, et al. 1999; Lapouge, et al. 2008; 
Reimmann, et al. 2005). 
Besides the regulation of virulence, CsrA (RsmA/E) proteins are involved in the control of 
global gene expression. In Salmonella, CsrA affects flagella synthesis and carbon metabolism 
(Lawhon, et al. 2003; Vogel 2009). A csrA deletion in E. coli leads to attenuated growth. The 
CsrA protein is essential for the bacterium to grow on synthetic medium containing glycolytic 
carbon sources (Timmermans and Van Melderen 2009). It activates glycogen biosynthesis and 
glyconeogenesis and represses glycolysis (Majdalani, et al. 2005; Romeo 1998; Timmermans 
and Van Melderen 2010).  
Such a global effect was also observed for a Y. pseudotuberculosis csrA mutant strain 
(Heroven, et al. 2008). Loss of the CsrA protein leads to a strong growth defect in the 
bacteria. Furthermore, transcription of flagella and motility genes is abolished due to reduced 
levels of the flhDC mRNA. CsrA in Y. pseudotuberculosis was found to indirectly upregulate 
RovM synthesis, which in turn inactivates rovA expression. Expression of the CsrA-
antagonizing regulatory RNAs CsrC and CsrB stimulated transcription of the rovA gene by 
repressing RovM production. As in E. coli, CsrC and CsrB RNA levels in Y. pseudotuberculosis 
are counterregulated due to an autoregulatory loop (Heroven, et al. 2008; Weilbacher, et al. 
2003).  
Moreover, the Csr system revealed to be responsible for mediating medium-dependent 
regulation of rovM and therefore rovA transcription (Heroven, et al. 2008). In E. coli, both 
RNAs, CsrC and CsrB, are induced in minimal medium, depending on the addition of  certain 
amino acids (Jonas and Melefors 2009). In contrast, the regulatory RNA CsrC of 
Y. pseudotuberculosis is highly abundant in complex medium in stationary growth, whereas it 
 15 
is absent in minimal medium. This is similar to the expression of the rovA gene in response to 
environmental conditions. RovA levels were only elevated in minimal medium, when csrA was 
deleted and hence the synthesis of RovM was inhibited. CsrB levels in Y. pseudotuberculosis 
were low under all tested conditions. csrB expression was only elevated by overexpression of 
uvrY, which resembles one component of the two-component-system UvrY/BarA (see 1.2.4.1) 
(Heroven, et al. 2008).  
A 
 
B 
 
Fig. 8. Structure of the CsrA-like protein RsmE and the function of CsrA within the Carbon storage 
regulatory system. A. RsmE homodimer interacting with 20 nucleotides of the hcnA RNA (Schubert, et al. 
2007). B. Interplay of the CsrA protein binding either to the CsrB RNA or the Shine-Dalgarno sequence of the 
glgCAP mRNA (Majdalani, et al. 2005).  
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1.2.4.1 Regulators of the Csr system 
The two-component system UvrY/BarA is composed of the sensor kinase BarA and the 
response regulator UvrY, also found in Pseudomonas (GacS/GacA) and Vibrio (VarS/VarA) 
(Lapouge, et al. 2008; Lenz, et al. 2005). BarA belongs to a subclass of tripartite sensor 
kinases, phosphorylating the cognate response regulators via an ATP-His-Asp-His-Asp 
phosphorelay system. UvrY represents a member of the FixJ family. The regulator is 
phosphorylated at the N-terminal regulatory domain which activates the DNA-binding domain 
at the C-terminus (Birck, et al. 1999; Pernestig, et al. 2001).  
The BarA-UvrY system in E. coli upregulates expression of both, the CsrB and CsrC RNAs. 
The sensor kinase was found to be activated by metabolic end products such as formate and 
acetate whereas low pH values represses uvrY transcription. Regulation by the UvrY/BarA 
system is essential for E. coli to trigger the Csr system to switch between glycolytic and 
gluconeogenic metabolic pathways (Mondragon, et al. 2006; Pernestig, et al. 2003). Also the 
induction of Csr or Rsm RNAs in Pseudomonas and Vibrio is mediated by the UvrY/BarA-like 
two-component systems. In this case the system is implicated in quorum sensing via secretion 
and senses an unknown autoinducing signal molecule (Lapouge, et al. 2008).  
Up to date, the environmental activation signal inducing the BarA/UvrY of Yersinia is 
unknown but overexpression of UvrY under the control of an inducible promoter was found to 
activate csrB expression (Heroven, et al. 2008). CsrC synthesis instead is reduced under these 
conditions due to the negative feedback control between the Csr RNAs. 
The ubiquitous RNA-binding protein Hfq is a homolog of the eukaryotic Sm or Sm-like 
proteins, which are involved in splicing and degradation of mRNAs. In general, the chaperone 
binds to regulatory RNAs involved in RNA metabolism. It was first identified as a host factor 
in E. coli which was essential for in vitro replication of RNA phage Qβ (Aiba 2007; Brennan 
and Link 2007; Chao and Vogel 2010). Hfq is a hexameric protein of 11 kDa subunits which 
binds to AU rich and polyA sequences (Brennan and Link 2007; Link, et al. 2009). Hfq is 
involved in several RNA-related regulation mechanisms. It facilitates base-pairing of regulatory 
RNAs to mRNAs. For example it promotes base pairing of the SgrS RNA with the ptsG 
mRNA at its ribosomal binding site, resulting in silencing of ptsG translation. In this case, 
presence of Hfq leads to rapid duplex formation of the RNAs, whereas it is decelerated under 
Hfq depletion conditions (Kawamoto, et al. 2006; Rasmussen, et al. 2005). 
The binding of Hfq to the sodB mRNA in E. coli and the subsequent binding of the small 
iron-responsive regulatory RNA RyhB showed that base-pairing occurs because Hfq-annealing 
changed RNA structure. The RNA chaperone thereby promotes interaction of the two 
accessible complementary RNAs sodB and RyhB (Geissmann and Touati 2004).  
Hfq controls a large number of regulatory RNAs. As a consequence, deletion of hfq often 
results in a strong growth reduction and attenuation of virulence in gram-negative pathogens 
such E. coli, S. typhimurium, V. cholerae or Y. pestis (Chao and Vogel 2010). Also Csr/Rsm 
 17 
RNAs are often controlled by the RNA-binding protein Hfq. For instance, Hfq and RsmA bind 
concurrently to the Csr-type RNA P. aeruginosa. The chaperone binding site overlaps with the 
RNAse E recognition sequence. As a result, Hfq prevents degradation of the regulatory RNA 
(Sorger-Domenigg, et al. 2007).  
In Y. pseudotuberculosis, loss of Hfq had a major negative effect on the bacterial growth and 
abolished rovA expression during stationary growth at 25°C (Heroven, Böhme, unpublished 
results). This indicates that Hfq might also be important for the Csr-type RNAs in 
Y. pseudotuberculosis. 
1.2.5 The nucleoid-associated protein YmoA 
Genetic screening for rovA transcription regulators in Y. pseudotuberculosis revealed ymoA as 
a regulator. An ymoA-deficient strain was less invasive into HEp-2 cells in gentamycin 
protection assays (Böhme, unpublished results). Thus, YmoA seems to play a crucial role in 
Y. pseudotuberculosis virulence factor regulation. 
The 8 kDa “Yersinia modulator A” (YmoA) belongs to the Hha/YmoA family, which is part 
of the nucleoid-associated proteins super family. Members of the Hha/YmoA have pleiotropic 
effects on the bacterial physiology and virulence and are encoded in one or more copies in 
bacterial genomes. They influence the regulation of gene expression, plasmid supercoiling and 
frequency of insertion element transposition (Madrid, et al. 2007; Madrid, et al. 2002).  
The homolog of YmoA in E. coli and Salmonella, the regulator of “High hemolysin activity” 
(Hha), shares 82% sequence identity with the Yersinia protein. Both are able to complement 
each other. Hha induces transposition events in a Y. enterocolitica ymoA mutant. YmoA 
restores regulation of hemolysin activity in a hha mutant in E. coli (Balsalobre, et al. 1996; de 
la Cruz, et al. 1992; Mikulskis and Cornelis 1994).  
Structures of the E. coli Hha and the Yersinia YmoA protein have been elucidated (Fig. 9). 
Both form four helices, of which three comprise a helical bundle core structure. Helix four 
represents the shortest helix and is positioned against the outer face of helix three. Hha and 
YmoA show a conserved structure with only small difference according to their high sequence 
identity. Further, their N-termini show a significant similarity to the N-terminal 
oligomerization domain of the H-NS protein family. This indicated that the members of the 
YmoA/Hha family interact with H-NS-type proteins. In fact, interaction of YmoA and H-NS 
as well as Hha and H-NS has been described recently (Nieto, et al. 2002). Purification of 
H-NS by affinity chromatography from E. coli cell extracts led to the co-purification of Hha. 
H-NS-Hha complexes showed stronger binding to DNA than Hha homomers itself. 
Conformational analysis of YmoA suggests, that YmoA might substitute for an H-NS dimer in 
a higher order structuring which could lead to altered scaffolding and DNA suprastructuring 
(McFeeters, et al. 2007). Microarray analysis revealed several genes, which are controlled by 
Hha and H-NS (Madrid, et al. 2002). Rodriguez et al. (2005) demonstrated that replacement 
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of the N-terminal domain of H-NS by Hha complements some of the hns-mediated 
phenotypes in E. coli.  
 
Fig. 9. Protein structures of YmoA and Hha. N and C represent the N and the C terminus. α-helices are 
indicated by numbers (McFeeters, et al. 2007). 
In contrast to Yersinia, other Enterobacteriaceae genomes encode two or multiple homologs 
of the Hha/YmoA family. For example, besides Hha, S. enterica serovar Typhimurium 
encodes the Hha-type protein YdgT which regulates effector gene expression of Salmonella 
pathogenicity island 2. Synthesis of YdgT allows survival of Salmonella in host cell vacuoles 
(Coombes, et al. 2005; Paytubi, et al. 2004; Silphaduang, et al. 2007). The Hha-like protein 
oriC-binding nucleoid-associated protein (Cnu) in E. coli interacts with 26 nucleotide sequence 
called cnb within the origin of replication. Elimination of cnu and hha resulted in reduced 
origin content (Bae, et al. 2008; Kim, et al. 2005). No redundant members of the YmoA/Hha 
family seem to be expressed in Yersinia. That might explain that deletion of the ymoA gene in 
Y. pseudotuberculosis causes a severe reduction in bacterial growth. Furthermore, ymoA 
mutant strains exhibit a significantly lower stress resistance against temperature, osmotic, 
ionophoric and pH stress (K. Böhme, unpublished data). Loss of ymoA in Y. enterocolitica 
has been observed to be lethal (Ellison, et al. 2003). 
In enteropathogenic bacteria, proteins of the YmoA/Hha family are often implicated in 
virulence gene expression. Hha, the regulator of, was named after the regulation of virulence 
factor synthesis such as pore-forming toxin hemolysin in E. coli. There it binds to the 
promoter region of the hlyCABD operon. Moreover, Hha shows impact on the expression of 
virulence factors from the Vir plasmid. Repression of these virulence factors occurs in response 
to environmental signals, i.e. low temperature and high osmolarity (Balsalobre, et al. 1999; 
Mourino, et al. 1996; Sharma and Zuerner 2004).  
In S. enterica serovar Typhimurium, Hha downregulates the transcription of two crucial 
virulence regulator genes, invF and hilA, that stimulate the expression of virulence genes 
located in the Salmonella pathogenicity island 1. In comparison to Hha in E. coli, Hha in 
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Salmonella inhibits gene expression at low temperature and low osmolarities, which prevents 
the synthesis of a type III secretion apparatus and production of secreted effector proteins 
under these conditions (Eichelberg and Galan 1999; Fahlen, et al. 2001; Jones 2005). 
In Y. enterocolitica, a transposon insertion in the ymoA gene led to an induced expression of 
the yadA and yopE gene at moderate temperatures, which are usually repressed under these 
conditions. In addition, synthesis of the effector proteins YopB and YopD was further 
stimulated at 37°C in a ymoA-deficient strain compared to the wild type (Cornelis, et al. 
1991). Mikulskis et. al. (1994) demonstrated that YmoA is responsible for temperature and 
growth phase control of the Yersinia-enterotoxin encoding yst gene. In a ymoA-deficient 
strain, yst was transcribed during the exponential growth phase at 25°C, whereas in the wild 
type strain yst expression occurs mainly at 37°C during stationary growth. Further, Cornelis 
(1993) described an increased fragility of chromosomal DNA in a ymoA mutant in 
Y. enterocolitica. Ellison and Miller (2003) found that YmoA in Y. enterocolitica also 
downregulates transcription of the primary invasion factor invasin. It is proposed that the 
YmoA protein interacts with H-NS to establish a repression complex binding to the inv 
promoter at moderate temperatures as well as 37°C (Ellison and Miller 2006).  
Taken together, YmoA and Hha influence expression of their target genes depending on 
environmental signal such as temperature or osmolarity. This regulation is due to the 
environmental control of the YmoA or Hha protein synthesis itself. Hha in E. coli is maximally 
expressed at high osmolarities (Mourino, et al. 1998). In contrast to YmoA levels in 
Y. enterocolitica, YmoA protein in Y. pestis was found to be degraded at 37°C by ATP-
dependent ClpP and Lon proteases (Ellison, et al. 2003; Jackson, et al. 2004). Deletion of 
clpP and lon repressed expression of the yop genes at elevated temperatures. Such 
degradation might also occur in Y. pseudotuberculosis where the YmoA protein levels are 
similarily increased at 25°C compared to higher temperatures (K. Böhme, unpublished data).  
Considering the activating effect on rovA expression in Y. pseudotuberculosis and its negative 
impact on the expression of genes essential during the ongoing infection, such as yadA and 
the yop genes, YmoA might represent an important trigger in Yersinia virulence. 
1.3 Model of virulence factor regulation in Y. pseudotuberculosis 
The following model comprises data on the regulatory components affecting important 
virulence factors during early infection stage of Y. pseudotuberculosis in the host (Fig. 10). 
Synthesis of the primary invasion factor invasin in the initial phases of the infection is 
activated by RovA in response to conditions such as 25°C, complex medium and stationary 
growth. RovA is able to displace H-NS from the inv and the rovA promoter, where the RovM 
protein can repress rovA expression in concert with the nucleoid-associated protein under 
minimal medium conditions. Synthesis of RovA in complex medium is activated by the 
presence of the CsrC RNA, which binds and thereby titrates the CsrA protein from inducing 
RovM synthesis. The CsrB RNA can activate rovA expression in the same manner when its 
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expression is strongly upregulated by the two component system UvrY/BarA. Additionally, 
Hfq and YmoA induce rovA expression and so invasin which leads to adhesion and invasion 
into the M-cells and translocation to the Peyer’s patches.  
On the other side, YmoA represses yadA and yop gene expression as well as the transcription 
of type III secretion system genes at lower temperatures by preventing the synthesis of the 
AraC-like regulator LcrF. 
 
Fig. 10. Working model of virulence factor expression in Y. pseudotuberculosis. Arrows display direct 
activation of the gene expression or protein synthesis, whereas dashed arrows label indirect regulation. Dotted 
arrows indicate unkown regulation mechanisms. T represents repression or inactivation. Virulence factors 
expressed during early (blue) and late (red) virulence phases are indicated on the bottom. 
1.4 Environmental control of virulence determinants during the 
later infection phases 
When Y. pseudotuberculosis enters the later stages of the infection the bacterium is exposed 
to higher temperatures over a longer period of time. Moreover the pathogen faces dramatic 
changes in the nutrient availability during the transition from the gut lumen to the 
environment in the deeper tissues. Especially, temperature and Ca2+ concentration are known 
to trigger production of a whole set of virulence factors encoded by the virulence plasmid 
pYV. Transcription of yadA, the type III secretion system and the yop genes is upregulated at 
elevated temperature above 30°C and under low Ca2+ level conditions. In vitro, yersiniae show 
a strong growth restriction in Ca2+-deprived nutrient-rich medium at 37°C, which is caused by 
a massive secretion of Yop effector proteins (Ramamurthi and Schneewind 2002). This is 
referred to as the low calcium response (Lcr).  
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Activation of the yop genes occurs in the presence of the transcriptional activator LcrF 
(VirF in Y. enterocolitica) also encoded on pYV. The 30 kDa protein is highly homologous to 
transcriptional activators of the AraC-like protein family. This group of regulators is 
characterized by a highly conserved C-terminal domain with two helix-turn-helix DNA-binding 
motifs. The poorly conserved N-terminal domain containing regions for oligomerization is 
connected to the C-terminus by a flexible linker (Cornelis, et al. 1989; Gallegos, et al. 1997; 
Martin and Rosner 2001). 
In Y. enterocolitica, VirF (LcrF) was found to induce transcription of yopE, yopH, the virC 
operon, the lcrGVH-yopBD operon and yadA (Hoe, et al. 1992; Lambert de Rouvroit, et al. 
1992; Skurnik and Toivanen 1992). Alignments of the promoter regions controlled by the 
AraC-type regulator revealed that VirF dimers bind to isolated sequences or inverted repeats 
covering a region with a length of about 60 nt. The promoter sequences of VirF-regulated 
genes yopE, lcrG, virC and yopH share a TTTTaGYcTtTat motif (Wattiau and Cornelis 
1994). AraC-like transcriptional regulators which influence the expression of type III secretion 
systems, have also been analyzed in other pathogens (Francis, et al. 2002). For example, a 
homolog of LcrF (VirF) in Pseudomonas aeruginosa, ExsA, regulates ten genes of the type III 
secretion system in response to Ca2+ concentrations (Brutinel, et al. 2008; Vakulskas, et al. 
2009; Yahr and Wolfgang 2006).  
Production of LcrF (VirF) is controlled by environmental signals and regulatory components. 
LcrF (VirF) synthesis is strongly dependent on the growth temperature. Higher protein levels 
of the regulator are only produced at 37°C but not at moderate temperatures. Hoe and 
Goguen (Hoe and Goguen 1993) hypothesized post-transcriptional regulatory mechanism 
based on RNA structure rearrangements that induce LcrF translation at higher temperatures 
in Y. pestis. Waldminghaus et al. (2007) performed a database screen for RNA thermometers. 
The search was based on the ability of 5' untranslated regions of protein-coding RNAs to 
form a secondary structure with imperfect base pairing at the Shine-Dalgarno sequence. The 
5' untranslated region of the Y. pestis LcrF RNA was predicted to encounter a FourU RNA 
thermometer (Fig. 11A). These FourU thermometers are characterized by a consecutive 
stretch of four uracils interacting with the AGGA motif of the Shine-Dalgarno sequence. In 
their model they propose that, at low temperatures, this base pairing sequesters the ribosomal 
binding site of the target RNA and inhibits translation into the protein. Elevated temperatures 
may unfold the RNA secondary structure and thereby permit recognition of the Shine-
Dalgarno site by ribosomal subunits, initiating protein synthesis (Fig. 11B) (Narberhaus 
2010). 
Temperature regulation of LcrF (VirF) synthesis was further found to depend on the presence 
of the nucleoid-associated protein YmoA. In Y. enterocolitica, loss of ymoA induced the 
expression of a virF (lcrF) reporter gene fusion already at moderate temperature, whereas it is 
repressed in a wild type strain (Cornelis, et al. 1991). The lcrF promoter region, which is 
affected by YmoA, remains to be analyzed.  
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Fig. 11. The FourU RNA thermometer within the 5' untranslated region of LcrF in Y. pestis. A. Model of the 
predicted secondary structure of the FourU RNA thermometer within the 5' untranslated region of lcrF in 
Y. pestis. The FourU motif is marked by a rectangle (Waldminghaus, et al. 2007). B. Function of a RNA 
thermometer. Secondary structures form at low temperatures (left) which leads to base pairing of the ribosomal 
binding site. Increasing temperatures unfold the RNA conformation which liberates the Shine-Dalgarno site (right). 
Ribosomal subunits bind to the AGGA motif and start translation of the coding RNA (According to Narberhaus 
2010). 
1.5 Aim of this work 
In this study, environmental control of the two major virulence factors invasin and YadA by 
the nucleoid-associated protein YmoA and regulatory elements should be analyzed. 
Preliminary experiments revealed that the activator RovA of the primary invasion factor 
invasin is not synthesized in the absence of YmoA (Heroven, et al. 2007). Previous studies 
demonstrated that rovA expression is controlled by the Csr system involving the RNA-binding 
protein CsrA and two regulatory RNAs CsrC and CsrB. These regulate rovA expression 
through the LysR-type regulator RovM depending on the nutrient-availability and 
temperature. A major goal of this study was to determine how YmoA exerts its influence on 
rovA expression and what components of the RNA regulatory network contribute or are 
implicated in the YmoA-mediated control of rovA. As nucleoid-associated proteins such as 
YmoA have been found to form heteromers with H-NS (Nieto, et al. 2002) the role of 
YmoA/H-NS interaction in the control of rovA expression in Y. pseudotuberculosis should be 
addressed. In addition, it was studied how the RNA chaperone Hfq is involved in the control 
of rovA expression mediated by the regulatory RNAs CsrC and CsrB. 
YmoA represses YadA production and the expression of genes encoding for Yop effector and 
type III secretion proteins at moderate temperatures. The transcription of these genes is 
induced by the activity of the LcrF protein which itself underlies YmoA-dependent 
thermoregulation. The aim in this work was to elucidate the complex control of LcrF synthesis 
including transcriptional regulation by YmoA or other regulatory components and 
posttranscriptional mechanisms such as the predicted RNA FourU thermometer. 
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2 Material and Methods 
2.1 Material 
2.1.1 Equipment 
Equipment used in this study is listed in Table 1. 
Table 1. Equipment and material. 
equipment manufacturer 
bunsen burner Fireboy Plus IBS Integra 
centrifuge 3-18 K Sigma
centrifuge RC5C Sorvall
chromatography columns Poly-Prep Biorad
Cuvettes Sarstedt 
developing machine, Optimax Typ TR MS Laborgeräte 
electroporation cuvettes Peqlab
electroporator GenePulser II Biorad
elisa reader iMark Microplate BioRad
falcon tubes (15 ml; 50 ml) Greiner
filter units (0,075 mm) Nalgene 
french press Aminco
gel documentation system Biorad
gel system minigel Peqlab
gel system PerfectBlue Gelsystem Mini L Revolution Peqlab
glass funnels, bottles, beakers and flasks Schott
glass pipets Hirschmann 
hybridisation oven OV-2 Biometra 
magnetic stirrer MR3001 Heidolph 
microcentrifuge 5415 R Eppendorf 
microcentrifuge Mini-Spin Eppendorf 
microtiter plates Greiner
microwave Panasonic 
petri dishes Sarstedt 
pH meter 827 pH lab Metrohm 
pipet tips Sarstedt 
pipettes Eppendorf 
pipettor Accu-Jet Brand
power supply high power voltage Biorad
Power Supply Power Pac Universal Biorad
precision balance Sartorius 
protein blotting system Mini Trans-Blot cell Biorad
protein electrophoresis system Mini Protean Tetra cell Biorad
reaction tubes (1,5 ml; 2 ml) Sarstedt 
shaker Multitron 2 Infors HAT 
spectrophotometer UV/VIS Ultrospec 2100 pro Amersham Biosciences 
sterile filters 0,2 µm Schleicher/Schüll 
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equipment manufacturer 
sterile plastic pipettes Greiner
thermocycler T3000 Biometra
thermocycler Mastercycler personal Eppendorf
Thermomixer comfort Eppendorf
vacuum pump VWR
vertical electrophoresis PerfectBlue™ Twin Peqlab
vortexer Scientific industries 
whatman paper Schleicher/Schüll 
2.1.2 Chemicals 
Chemicals used in this study are listed in Table 2. 
Table 2. Chemicals. 
chemicals manufacturer 
5-bromo-4-chloro-3-indolyl phosphate (BCIP) Roth
5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-gal) Roth
acrylamid/bisacrylamid mix (30) Roth
acrylamid/bisacrylamid mix (40) Roth
agar for E. coli Gerbu
agar, noble for Yersinia Difco
agarose Peqlab
ammoniumpersulfate (APS) T. H. Geyer
anhydrotetracycline IBA BioTagnology 
Bacto tryptone Difco
Bacto yeast extract Difco
blocking reagent Roche
bromophenol blue Roth
calcium chloride Roth
carbenicillin Merck
chloramphenicol Merck
chloroform J. T. Baker
Coomassie Brilliant Blue G250 Roth
D-desthiobiotin IBA BioTagnology 
dimethylformamide (DMF) Roth
di-potassium hydrogen phosphate (K2HPO4) Roth
dithiothreitol (DTT) Roth
ECL Western blotting substrate Thermo Scientific (Pierce) 
ethanol absolut Sigma
ethidium bromide Roth
formamide Applichem
glucose Roth
glycerol Applichem
glycine Roth
isopropanol J. T. Baker
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chemicals manufacturer 
isopropyl β-D-1-thiogalactopyranoside (IPTG) Roth
kanamycin Merck
L(+)-arabinose Roth
magnesium chloride Roth
magnesium sulfate Merck
methanol J. T. Baker 
Ni-NTA agarose Qiagen
o-nitrophenyl-β-galactoside (ONPG) Fluka
p-nitrophenyl phosphate (PNPP) Sigma
potassium dihydrogen phosphate (KH2PO4) Roth
sodium carbonate Roth
sodium chloride Roth
sodium dodecyl sulfate (SDS) Applichem 
sodium hydroxide Merck
Strep-Tactin® Superflow® high capacity IBA BioTagnology 
Unless noted otherwise, chemicals, which are not shown, were purchased from Roche Germany GmbH, 
Difco, Merck, Roth and Sigma. 
2.1.3 Enzymes, antibodies and kits 
Enzymes used in different experiments of this study are listed in Table 3. 
Table 3. Enzyme. 
enzyme manufacturer 
benzonase Merck
Mango Taq polymerase Bioline
Phusion polymerase Finnzymes 
Taq polymerase NEB
antarctic phosphatase NEB
T4 DNA ligase Promega 
RNase A Qiagen
RNase V1 Ambion
RNase T Ambion
calf intestine phosphatase (CIP) NEB
T4 polynucleotide kinase (PNK) Fermentas 
Moloney Murine Leukemia Virus (M-MLV) reverse transcriptase USB
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Antibodies used in this study are listed in Table 4. Primary antibodies are polyclonal 
antibodies produced in rabbits.  
Table 4. Used antibodies. 
antibody manufacturer/source dilution 
primary antibodies   
Anti-RovA Davids Biotechnology 1:3,000 
Anti-RovM Davids Biotechnology 1:5,000 
Anti-H-NS Davids Biotechnology 1:10,000 
Anti-YmoA Davids Biotechnology 1:2,500 
Anti-CsrA Davids Biotechnology 1:10,000 
Anti-Hfq Davids Biotechnology 1:5,000 
Anti-LcrF H. Wolf-Waatz 1:20,000 
secondary antibodies  
Anti-rabbit immunoglobulin alkaline phosphatase Sigma 1:8,000 
Anti-rabbit immunoglobulin horse radish peroxidase NEB 1:6,000 
 
Commercial kits were used for detection or purification of nucleic acids and are listed in Table 5. 
Table 5. Kits used in this study. 
Kit Use of kit manufacturer 
Dig luminescent detection detection of dig-labeled RNA Roche 
QIAquickTMPCR Purification purification of DNA Qiagen 
QIAquickTMPlasmid Midiprep preparation of plasmids Qiagen 
QIAquickTMPlasmid Miniprep preparation of plasmids Qiagen 
SVTotal RNA Isolation preparation of total RNA Promega 
TranscriptAidTM T7 High Yield 
Transcription Kit 
in vitro transcription of template DNA Fermentas 
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2.1.4 Media and supplements 
LB medium (Luria-Bertani medium): (Sambrook J. 1989)
 5 g Bacto yeast extract
 10 g Bacto tryptone
 5 g NaCl
 filled up to 1 L with aqua bidest
 
DYT medium (Double Yeast Trytone medium): (Miller 1992) 
 10 g Bacto yeast extract
 16 g Bacto tryptone
 5 g NaCl
 filled up to 1 L with aqua bidest
 
BHI medium (Brain heart infusion medium): 
 37 g BHI (BD Biosciences, USA)
 filled up to 1 L with aqua bidest
 
SOC medium (Super optimal broth): 
 5 g Bacto yeast extract
 20 g Bacto tryptone
 0.5 g NaCl
 2.5 ml 1 M KCl
 10 ml 1 M MgCl2
 10 ml 1 M MgSO4 
 filled up to 1 L with aqua bidest
 
1x minimal medium A: (Sambrook J. 1989) 
 10.5 g K2HPO4
 4.5 g KH2PO4
 1 g (NH4)2SO4
 0.5 g sodiumcitrate·2H2O
 filled up to 1 L with aqua bidest
 
After autoclaving other sterile supplements of the following end 
concentrations were added to minimal medium A: 
 1 mM MgSO4
 0.1 mM CaCl2
 0.2 % casamino acids
 0.2 % glucose
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For solid media 15 g of agar were added to 1 L of liquid media. Selective medium was 
prepared by addition of appropriate sterile filtrated antibiotics after autoclaving which are 
listed in Table 6. 
Table 6. Antibiotics and applied concentrations. 
antibiotic concentration of stock solution final concentration in media 
carbenicillin 100 mg/ml H2O 100 μg/ml
chloramphenicol 30 mg/ml Ethanol 30 μg/ml
kanamycin 50 mg/ml 50 μg/ml
tetracycline 5 mg/ml Ethanol 10 μg/ml
2.1.5 Oligonucleotides 
The following oligonucleotides in Table 7 were used for cloning and mutagenesis purposes. 
Table 7. Oligonucleotides. 
name sequence restriction site 
primers for plasmid construction  
1 5'- GCG GCG GTC GAC CTC TTG GCG ACA GCC ATC -3' SalI 
2 5'- GGG CGC GGA TCC GCT AAG CAG ACT ATT TCA C -3' BamHI 
3 5'- TTT GCT AGC GTG ATT TAT TAT ATT GGT TTT G -3' NheI 
4 5'- GTT ATA CTG TCC TAA AAA TCT AAT GAG GTG TAT TGA 
G -3' 
5 5'- CTC AAT ACA CCT CAT TAG ATT TTT AGG ACA GTA TAA 
C -3' 
6 5'- TTT GAA TTC GCC ATC TTG TGA ATG CTC AAC -3' EcoRI 
7 5'- GCG GCG GCT AGC CTC AAT ACA CCT CAT TAG -3' NheI 
8 5'- GGG CCG GTC GAC CCA TTA CGT TCC TTA AAC ATA 
AG -3' 
SalI 
9 5'- GCG GCG GAA TTC CCT TCA TCC CGT GGT AGG -3' EcoRI 
10 5'- GGG CCG GTC GAC CTT GTA TAT CCA TTA CGT TCC TTC 
CTT GCA TGG TGT ATC CGT ACC -3' 
SalI 
11 5'- GCG GCT GCA GCC ATC TTG TGA ATG CTC AAC AAC C -3' PstI 
12 5'- GCG GCC TGC AGG GCT GCA ATG TAA CTA GGA ATA 
TGG -3' 
PstI 
13 5'- GCG GCC TGC AGG CTA TAA TAC GAC TCA CGC -3' PstI 
14 5'- GCG CGC TGC AGG ACT GGC GTG AGT CGT ATT ATA 
GC -3' 
PstI 
15 5'- GCG GCC TGC AGG GGG TGA TTA ACA CCG GC -3' PstI 
16 5'- GCG GCC TGC AGC AGT ATG GTA ATT GTA TTT CTC C -3' PstI 
17 5’- GCG GCC TGC AGC AGT ATT GTC ATT ACT ATT ACA 
TG -3' 
PstI 
18 5'- GCG GCC TGC AGG CGC AAG GTG TGA TAT TGC -3' PstI 
19 5'- GCG GCC TGC AGC CAC ATA TTG CGC GAA CTC G -3' PstI 
20 5'- GCG GCG CTG CAG CCT TCA TCC CGT GGT AGG -3' PstI 
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21 5'- GCG GCG CTG CAG CCA ATA ACA AAT TGA CTA GC -3' PstI 
22 5'- GCG GCG CTG CAG CTT GTA TATCCA TTA CGT TCC -3' PstI 
23 5'- GCG CGG GTC GAC TCC CTA TCA GTG ATA GAG ATT GAC 
ATC CCT ATC AGT GAT AGA GAT ACT GAG CAC TTG GTA 
CGG ATA CAC CAT -3' a 
SalI 
24 5'- CGG CGC GGA TCC GAA AGA AGA GAA AGA AAA AAG -3' BamHI 
25 5' CTT GTA TAT CCA TTA CGT TCC TTC CTT GCA TGG TGT 
ATC CGT ACC -3' 
 
26 5'- GGT ACG GAT ACA CCA TGC AAG GAA GGA ACG TAA TGG 
ATA TAC AAG -3' 
 
27 5'- GCG GCG GTC GAC CCT TCA TCC CGT GGT AGG -3' SalI 
28 5'- GGG CGC GGA TCC GAT TGG GCC GGA ATC TAG C -3' BamHI 
29 5'- CGG CGC GGA TCC GGA CAA TGG TCG ATG AC -3' BamHI 
30 5'- GGG GGC GTC GAC GTT ACA CGA GAC GCT GC -3' SalI 
31 5'- GGG CGC CTG CAG GCA ATG AAG CCG GAA CAA ATC -3'  PstI 
32 5'- GGG GCC CTG CAG CGA GTC AGA ATA AGC ATT CTT 
TG -3' 
PstI 
 
primers for mutagenesis  
33 5'- C TAC GCG ACG AAA TAC TTT TTT TGT TTT GGC GTT 
AAA AGG TTT TCT TTA TTG TGT AGG CTG GAG CTG CTT 
C -3' b 
 
34 5'- CGA GCT TGA GAA GCG ACG CCG GAC GCG CCC TAG CAG 
CGA CAT CCG GCC TCA GCA TAT GAA TAT CCT CCT TAG 
T -3' b 
 
35 5'- GCT CTA TTA TTA CCT CAA CAA ACC ACC CCA ATA TAA 
GTT TGA GAT TAC TAC GTG TAG GCT GGA GCT GCT TC -3' b 
 
36 5'- CAA TAA AAA ATC CCG CCG CTG GCG GGA TTT TAA GCA 
AGT GCA ATC TAC AAA AGC ATA TGA ATA TCC TCC TTA 
GT -3' b 
 
37 5'- CCT GCG AGT TTA TCT TGT TAG AAT TAT TAC AAC CAT 
AGG TAG AAG GTG TAG GCT GGA GCT GCT TC -3' b 
 
38 5'- GGG TAT GTC TTC ATG GCG AAA AAG TAT AAA ATT CTT 
AAT AAA CAG CCG GTT ATA GCT CCG AAA GCG CAT ATG 
AAT ATC CTC CTT AGT -3' b 
 
39 5'- GCA AAG CAA AAG TTC AAA ATC ACC -3'  
40 5'- GGT TAA TTG GTT GTA ACA CTG G -3'  
41 5'- CGA TAG ACA GCT GTA TTT ATA TG -3'  
42 5'- GCA AAG CAA AAG TTC AAA ATC ACC GGT TTT TCT TCT 
CGA TAT ACA AAT TAA TAT TGG TGG AAC TAT CCC -3' c
 
43 5'- GGT TAA TTG GTT GTA ACA CTG GCT GCT TAG CGC TGG 
TTA AGA CAC ACA ACG TTG AGC CGA TAA TCT CTA TCG -3' c 
 
44 5'- CCT GTA TTA TCA CTT TCC TGC -3'  
45 5'- CTT TCA GTG AGC TGA TGA ATC -3'  
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name sequence restriction site 
46 5'- GCA AAG CAA AAG TTC AAA ATC ACC CCG TCT CCT AAT 
AGA ATT TAC TTT GGC GCC ATT CAT AAC CGA TTC TAC 
TTG -3' c 
47 5'- GGT TAA TTG GTT GTA ACA CTG GGA CTT ATT TCT GCG 
AGC CGA TAT ACT ATA GTG TAT GTA AAT  AGA AC -3' c 
48 5'- GAC GCT TGT AGT GGT TAT AC -3' 
underlined ... restriction sites; a italic ... tetracycline promoter sequence; b italic ... homologous to pKD4 
kanamycin cassette; c italic ... homologous to kanamycin cassette from pACYC177 
2.1.6 Strains and plasmids 
E. coli and Yersinia strains which were used in this study are listed in Table 8. Plasmids, 
which are referred to in this study are listed in Table 9. 
Table 8. E. coli and Yersinia strains. 
strains description reference/source 
E. coli  
CC118 λpir F - ∆(ara-leu)7697 ∆(lacZ)74 ∆(phoA)20 araD139 
galE galK thi rpsE rpoB arfE am recA1, λpir 
(Manoil and Beckwith 1986) 
BL21 λ DE3 F - ompT gal dcm lon hsdSB(rB - mB -) λDE3 (Studier, et al. 1990) 
KB1 BL21λDE3 (∆stpA) this study
KB2 BL21λDE3 (∆hns) this study
KB3 KB1 (∆hns) this study 
KB4 KB3 (∆hha) this study
Y. pseudotuberculosis  
YPIII pIB1, wild type (Bolin, et al. 1982) 
YP3 pIB1, rovA::Tn10(60)a; CmR (Nagel, et al. 2001) 
YP41 pIB1, ∆rovM; KnR (Heroven and Dersch 2006) 
YP48 pIB1, ∆csrC; KnR (Heroven, et al. 2008) 
YP50 pIB1, ∆ymoA; KnR A. K. Heroven 
YP51 pIB1, ∆csrB; ApR (Heroven, et al. 2008) 
YP52 pIB1, ∆csrB, ∆csrC; ApR, KnR (Heroven, et al. 2008) 
YP53 pIB1, ∆csrA; KnR (Heroven, et al. 2008) 
YP63 pIB1, ∆clpP; KnR (Herbst, et al. 2009) 
YP67 pIB1, ∆lon, ApR (Herbst, et al. 2009) 
YP68 pIB1, ∆clpP, ∆lon, KnR, ApR (Herbst, et al. 2009) 
YP69 pIB1, ∆csrB (Heroven, et al. 2008) 
YP72 pIB1, ∆rovM A. K. Heroven 
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YP73 pIB1, ∆rovM; ∆ymoA, KnR this study 
YP75 pIB1, ∆csrB, ∆ymoA; KnR Julia Schaake 
YP78 pIB1, ∆lon A. K. Heroven 
YP80 pIB1, ∆hfq A. K. Heroven 
YP81 pIB1, ∆lon ∆clpP, KnR this study 
R ... antibiotic resistance 
Table 9. Plasmids. 
plasmid description reference 
pACYC177 cloning vector, p15A, ApR, KnR (Chang and Cohen 1978)
pACYC184 cloning vector, TetR, CmR, ori p15A (Chang and Cohen 1978)
pAKH11 pET28a, hns +, KnR (Heroven, et al. 2004) 
pAKH31 pK18, hns '; TetR A. K. Heroven 
pAKH32 pK18, TetR A. K. Heroven 
pAKH42 pACYC184, rovM +, CmR (Heroven and Dersch 2006)
pAKH47 pGP20, rovA'-'lacZ (17)a, TetR (Heroven and Dersch 2006)
pAKH56 pACYC184, csrA +, CmR  (Heroven, et al. 2008) 
pAKH59 pACYC184, csrC +, CmR (Heroven, et al. 2008) 
pAKH63 pGP20, rovM'-'lacZ (41)a, TetR (Heroven and Dersch 2006)
pAKH71 pACYC184, ymoA +, CmR A. K. Heroven 
pAKH73 pGP20, hns'-'lacZ (24)a, TetR A. K. Heroven 
pAKH74 pACYC184, hns +, CmR (Heroven and Dersch 2006)
pAKH76 pHT124, csrC'-lacZ (-355 to +81)b, ApR (Heroven, et al. 2008) 
pAKH77 pASK-IBA5plus, ymoA +, ApR A. K. Heroven 
pAKH88 pHT124, csrB '-lacZ (-431 to +45)b, ApR A. K. Heroven 
pAKH97 pHT124, csrC '-lacZ (-500 to +4)b, ApR (Heroven, et al. 2008) 
pAKH103 pHT124, csrC '-lacZ (-355 to +4)b, ApR A. K. Heroven 
pAKH104 pHT124, csrC '-lacZ (-355 to +257)b, ApR A. K. Heroven 
pAKH106 pHT124, csrC '-lacZ (-355 to +31)b, ApR A. K. Heroven 
pAKH107 pHT124, csrC '-lacZ (-355 to +61)b, ApR A. K. Heroven 
pAKH115 pACYC184, hfq +, CmR A. K. Heroven 
pAKH119 pHSG575, hfq +, CmR A. K. Heroven 
pAKH125 pHT124, csrC '-lacZ (-310 to +4)b, ApR A. K. Heroven 
pAKH126 pHT124, csrC '-lacZ (-283 to +4)b, ApR A. K. Heroven 
pAKH127 pHT124, csrC '-lacZ (-204 to +4)b, ApR A. K. Heroven 
pAKH128 pHT124, csrC '-lacZ (-106 to +4)b, ApR A. K. Heroven 
pBAD18-
lacZ(481) 
translational lacZ fusion vector, ApR, ori pBR, 
ori M13 
(Waldminghaus, et al. 2005)
pBO1817 pUC18, T7-lcrF '(-123 to 10)c,
for structure probing, ApR 
J. Kortmann 
pBO1818 pUC18, T7-lcrF '(-123 to 63)c,
for toeprint analysis, ApR 
J. Kortmann 
pBO1819 pUC18, T7-lcrF '(-51 to 10)c,
for structure probing, ApR 
J. Kortmann 
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pBO1822 pUC18, T7-lcrF '(-51 to 63)c, for toeprint analysis, 
ApR 
J. Kortmann
pBO1823 pUC18, T7-lcrF '(-123 to 10)c, for structure 
probing, ApR, (UU-28/-27CC)c 
J. Kortmann
pBO1824 pUC18, T7-lcrF '(-123 to 63)c, for toeprint 
analysis, ApR, (GUU -30 to -28 AAA)c 
J. Kortmann
pBO1825 pUC18, T7-lcrF '(-51 to 10)c, for structure 
probing, ApR, (UU-28/-27CC)c 
J. Kortmann
pBO1832 pUC18, T7-lcrF '(-51 to 10)c, for structure 
probing, ApR, (GUU -30 to -28 AAA)c 
J. Kortmann
pBO1833 pUC18, T7-lcrF '(-123 to 63)c, for toeprint 
analysis, ApR, 
(UU-28/-27CC)c 
J. Kortmann
pBO1855 pUC18, T7-lcrF '(-123 to 10)c, for structure 
probing, ApR, 
(GUU -30 to -28AAA)c 
J. Kortmann
pCP20 FLP recombinase expression vector, ApR, CmR (Datsenko and Wanner 2000) 
pED05 pBAD18-lacZ(481), PBAD::gnd'-'lacZ, ApR E. Dornbusch 
pED06 pBAD18-lacZ(481), PBAD::lcrF(-123; AG -46/-45 
CC)c'-'lacZ (25)a, ApR 
E. Dornbusch 
pED07 pBAD18-lacZ(481), PBAD::lcrF(-123; GUU -30 
to -28 AAA)c'-'lacZ (25)a, ApR 
E. Dornbusch 
pED08 pBAD18-lacZ(481), PBAD::lcrF(-123; UU -28/-27 
CC)c'-'lacZ (25)a, ApR 
E. Dornbusch 
pED10 pBAD18-lacZ(481), PBAD::yscW(+5)lcrF '-'lacZ 
(25)a, ApR 
E. Dornbusch 
pED13 pBAD18-lacZ(481), PBAD::lcrF(-123; AUA -36 
to -34 CCC)c'-'lacZ (25)a, ApR 
E. Dornbusch 
pET28a T7 overexpression vector, KnR Novagen
pGP20 protein fusion vector, 'lacZ, TetR, ori pSC101 P.Gerlach
pHT124 promoter-probe vector, lacZ +, ApR, ori ColE1 H. Tran-Winkler 
pK18 cloning vector, KnR, ori pUC18 (Pridmore 1987) 
pKB01 pBR322, ymoA +, ApR, TetR K. Böhme
pKB02 pGP20, ymoA'-'lacZ (6)a, TetR K. Böhme
pKB03 pZA31-luc, Ptet::csrB, CmR (Heroven, et al. 2008) 
pKB04 pHSG575, ymoA +, CmR this study
pKB06 pGP20, barA'-'lacZ (2)a, TetR (Heroven, et al. 2008) 
pKB07 pGP20, uvrY'-'lacZ (3)a, TetR (Heroven, et al. 2008) 
pKB13 pBAD18-lacZ(481), lcrF '(-127 to 74; ∆-41 
to -30)c, ApR  
this study
pKB14 pBAD18-lacZ(481), lcrF '(-127 to 74), ApR this study
pKB17 pHT124, csrC '-lacZ (81; ∆24 to 57)b, ApR this study
pKB18 pBAD18-lacZ(481), lcrF '(-63 to 74), ApR this study 
pKB20 pHT124, csrC '-lacZ (71)b, ApR this study
pKB34 pTS02, yscW(-573)clcrF '-'lacZ (25)a, ApR this study
pKB35 pTS02, yscW(-573)c'-'lacZ (5)a, ApR this study
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pKB38 pTS02, yscW(-8)clcrF '-'lacZ (25)a, ApR this study 
pKB39 pTS02, yscW(-466)clcrF '-'lacZ (25)a, ApR this study 
pKB40 pTS02, yscW(-368)clcrF '-'lacZ (25)a, ApR this study 
pKB41 pTS02, yscW(-267)clcrF '-'lacZ (25)a, ApR this study 
pKB42 pTS02, yscW(-171)clcrF '-'lacZ (25)a, ApR this study 
pKB43 pTS02, yscW(-73)clcrF '-'lacZ (25)a, ApR this study 
pKB45 pTS03, csrC '-lacZ (-355 to +4)b, ApR this study 
pKB46 pTS03, csrC '-lacZ (-355 to +81)b, ApR this study 
pKB47 pHSG575, Ptet::csrC, CmR this study 
pKB49 pHSG576, PcsrC::csrC (∆+24 to +57)b, CmR this study 
pKB59 pHSG576, PcsrC::csrC, CmR this study 
pKB60 pHSG576, csrA+, CmR this study 
pKB63 pTS02, csrA'-'lacZ (5)a, ApR this study 
pKD4 kanamycin cassette template, KnR (Datsenko and Wanner 2000)
pKD46 recombination vector, λred +, ApR (Datsenko and Wanner 2000)
pKOBEG-sacB recombination vector, sacB +, CmR, ori pBAD (Derbise, et al. 2003) 
pPD264 pACYC184, inv::TnphoA(60), CmR, KnR (Nagel, et al. 2001) 
pSF3 pGP20, lcrF(-526)c'-'lacZ (25)a, TetR S. Fehse 
pSF4 pGP20, yscW(-573)clcrF '-'lacZ (25)a, TetR S. Fehse 
pTS02 pGP20, ApR T. Stolz 
pTS03 promoter-probe vector, lacZ +, ApR, ori pSC101 T. Stolz 
pTT01 pTS03, Ptet -lacZ, ApR T. Thiermann 
pUC18 cloning vector, ApR, ori pBR322 (Norrander, et al. 1983)
a ... amino acids, b ... nucleotides relative to transcription start, c ... nucleotides relative to start codon 
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2.2 Methods 
2.2.1 General microbiological methods 
2.2.1.1 Cultivation conditions 
E. coli strains used in this study were grown under aerobic conditions at 37°C on solid or in 
liquid media. All cultures were shaken in a desk shaker. The cultivation of 
Y. pseudotuberculosis strains was mainly carried out at 25°C, for special experiments at 37°C. 
2.2.1.2 Sterilisation 
All autoclaveable solutions were sterilized for 20 min at 121°C and 1 to 2 bar overpressure in 
an autoclave. Non-autoclaveable solutions such as antibiotic solutions were sterile filtered 
(sterile filter, pore diameter 0.2 μm). Pipettes and glass ware were sterilized in a dry heat 
sterilizer at 180°C. 
2.2.1.3 Measurement of cell density 
The cell density of a bacterial strain was determined photometrically by measuring the optical 
density OD578 with a spectrophotometer. An OD578 of 1 corresponds to about 1·109 cells/ml 
(Sambrook, et al. 1989) containing 150 μl of protein (Miller 1992). For reference the identical 
growth medium was used. 
2.2.1.4 Characterization of the bacterial growth 
To monitor the growth curve of a bacterial culture an overnight culture was diluted 1:1000 in 
the appropriate medium. The culture was grown at different conditions and OD578 was 
measured isochronously. The growth rate was calculated by 
growth rate [h -1] = OD600/time 
2.2.2 General genetic and molecular biological methods for DNA 
2.2.2.1 DNA marker 
To measure the size of DNA fragments after agarose gel electrophoresis GeneRuler™ DNA 
Ladder Mix (Fermentas, Germany) was used for each run containing the following fragment 
lengths: 10000, 8000, 6000, 5000, 4000, 3500, 3000, 2500, 2000, 1500, 1200, 1031, 900, 800, 
700, 600, 500, 400, 300, 200 and 100 base pairs. A gel pocket was filled with 0.1 to 0.5 μg of 
the marker. 
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2.2.2.2 Measurement of DNA concentration and purity 
To determine the DNA concentration and the purity of DNA samples, their optical density 
was measured at 260 nm and 280 nm with the NanoDrop (PEQLAB Biotechnologie GmbH, 
Germany). DNA absorbs light maximally at a wavelength of 260 nm. One unit OD260 
corresponds to a concentration of 50 μg/ml for double-stranded DNA. The DNA 
concentration is the product of the OD260 of the sample multiplied with its dilution factor and 
50 μg/ml. In contrast to DNA, protein absorbs light optimally at 280 nm. The purity of a 
DNA sample is calculated by the ratio OD260/OD280. Ratios between 1.7 and 1.9 represent 
pure DNA. 
2.2.2.3 Polymerase chain reaction (PCR) 
Polymerase chain reaction was carried out to amplify DNA fragments. For this reaction, a 
heat stable DNA polymerase (Taq polymerase) elongates two oligonucleotides (see sec. 2.1.5) 
hybridized to the beginning and the end of the target DNA region. 
The Phusion High-Fidelity DNA Polymerase (Finnzymes, USA) with a proof reading activity 
to reduce the error rate was used for amplification of DNA fragments for cloning. A typical 
Phusion PCR reaction with a volume of 100 μl contained the following ingredients: 
HF buffer (5 x) 20 μl
dNTPs (10 mM) 2 μl
template 1 μl
primer A (10 mM) 3 μl
primer B (10 mM) 3 μl
Phusion polymerase (2 U/µl) 1 μl
H2O 70 μl
 
For test-PCR purposes, e.g. to check for positive cloning results, the MangoTaq polymerase 
was used with the following PCR reaction mixture: 
Mango buffer (5 x) 20 μl
dNTPs (100 mM) 1 μl
MgCl2 (50 mM) 3 μl
template 1 μl
primer A (10 mM) 3 μl
primer B (10 mM) 3 μl
Mango Taq polymerase (1 U/µl) 1 μl
H2O 69 μl
 
A PCR cycle begins with the denaturating of the DNA double strand at 95 °C. The next step 
is performed at temperatures from 50°C to 65°C (depending on the primer sequence) and 
leads to the annealing of the primers to complementary single strands. The synthesis of the 
corresponding complementary strand starting at each primer occurs at 72°C (elongation). 
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The variable parameters during the PCR were calculated as the following: 
1. The time of the first elongation step depends on the size of the DNA segment to be 
amplified and the elongation rate of the Taq polymerase. The MangoTaq polymerase 
as well as the Phusion polymerase synthesizes 1,000 bp per 30 sec. 
2. The annealing temperature is determined by the length and the composition of the 
primers used in the reaction. It is calculated after Suggs et al. (1981). 
One cycle is repeated 30 to 40 times. A typical program is carried out with the following 
procedure: 
1. Denaturating 5 min at 95°C
2. Denaturating 30 sec at 95°C
30-40 cycles 3. Annealing 30 sec at variable temperature
4. Elongation variable at 72°C
5. Elongation 5 min at 72°C 
 
The first denaturating step ensures complete denaturation of all DNA double strands and the 
second elongation step completes synthesis of all PCR products. If necessary, primer 
sequences included restriction sites for cloning purposes (sec. 2.1.5). PCR products were 
cleaned from 100 μl reaction volume as described by the manufacturer instructions using the 
“QIAquick PCR Purification Kit” and were eluted in 30 μl aqua bidest. 
2.2.2.4 Isolation of DNA 
2.2.2.4.1 Plasmid preparation 
To isolate plasmid DNA a culture with bacteria harboring the plasmid to be isolated was 
grown overnight in LB medium supplemented with the appropriate antibiotic. Preparation of 
the plasmid was carried out according to the alkaline extraction procedure described by 
Birnboim and Doly (1979) using the “QIAGEN Plasmid Mini Kit” (QIAGEN, Germany). 
Plasmid-DNA was generally eluted from the columns with 50 μl H2O. 
For large-scale preparation of plasmid DNA “QIAGEN Plasmid Midi Kit” (QIAGEN, 
Germany) was performed according to the manufacturer's instructions. The DNA was eluted 
in 50 μl aqua bidest. 
2.2.2.4.2 DNA agarose gel electrophoresis 
Separation of double-stranded DNA fragments according to their size was achieved by agarose 
gel electrophoresis. This method makes use of the ability of negatively charged DNA to move 
towards the anode when an electrical field is applied. The DNA moving velocity is determined 
by the length and the conformation of the DNA as well as the agarose concentration within 
the gel and the applied voltage. In this study an agarose concentration of 0.8% was usually 
used for DNA separation. Small DNA fragments were separated in 2% agarose gels. The gel 
electrophoresis was performed at a voltage of 90 to 120 V in TAE buffer. To facilitate the 
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application of DNA samples to the gel, loading buffer (1 x) was added. As the reaction buffer 
of the Mango Taq polymerase already contained loading buffer substances, these PCR 
reaction samples were directly applied to the gel. To measure the size of the DNA fragments 
5 μl marker were used. 
For visualization of the DNA the gel was stained in ethidium bromide (1 μg/ml in water), 
which intercalates within nucleic acids and are fluorescent under UV light. Gels were exposed 
to UV light at 226 nm and photographed with a CCD (charge-coupled device) camera of the 
gel documentation system. 
TAE buffer (1 x): 40 mM TRIS acetate; 1 mM EDTA pH 8.0 
loading buffer (1 x): 50% glycerol; 0.01% bromophenol blue; 0.01% xylene cyanol 
2.2.2.4.3 DNA isolation from agarose gels 
DNA fragments of interest with a specific size were separated from other fragments via gel 
electrophoresis, stained and isolated under UV light at a wavelength of 315 nm. The DNA 
fragment was separated from the agarose using the “QIAquick Gel Extraction Kit” (QIAGEN, 
Germany) as described by the manufacturer. The DNA was eluted from the column with 30 μl 
aqua bidest. 
2.2.2.4.4 DNA extraction with phenol 
To remove contaminating proteins from a DNA solution, phenol extraction was used with 
subsequent precipitation of the DNA with sodium acetate and ethanol. Therefore, one volume 
of DNA solution was mixed thoroughly with one volume of phenol. The mixture was 
centrifuged at 13,000 rpm for 3 min in a 5415 R microcentrifuge (Eppendorf, Germany) and 
the aqueous phase was transferred to a new tube. In the following, one volume of chloroform 
was added, mixed and centrifuged. After transfer of the aqueous phase to a new tube, the 
chloroform extraction was repeated. For precipitation of the DNA, 1/10 volume sodium 
acetate and two volumes ethanol (100%) were added, mixed intensively and incubated for 
10 min at -20°C. After centrifugation for 10 min at 4°C, the supernatant was discarded. The 
DNA pellet was dried and resolved in aqua bidest. 
2.2.2.4.5 DNA sequencing 
The DNA sequencing was performed by GATC (Constance, Germany) or at the Department 
of Genome Analysis (HZI, Germany). 
2.2.2.5 Cloning techniques 
2.2.2.5.1 Restriction digests 
Restriction analysis was used to insert DNA fragments into vectors during the cloning process 
or to determine the size of a certain DNA fragment. Therefore, type II restriction enzymes 
were used which recognize specific palindromic nucleotide sequences of four to eight base 
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pairs. Within these sequences these enzymes produce overhanging (“sticky”) ends or blunt 
ends. Restrictions enzymes cut optimally at a specific temperature and buffer, which are 
provided by the manufacturer. 
Enzymes and buffers (10 x concentrated) used in this study were purchased by New England 
Biolabs (USA). Each restriction experiment was carried out for 30 min to four hours at the 
optimum reaction temperature described by the manufacturer. Inactivation was achieved by 
heat inactivation for 20 min at 80°C. If the enzymes could not be inactivated by heat, they 
were removed by purification with the “QIAquick PCR Purification Kit” (QIAGEN, Germany) 
or by phenol extraction with subsequent sodium acetate and ethanol precipitation (sec. 
2.2.2.4.4). 
2.2.2.5.2 Preparative digest 
To achieve appropriate amounts of a certain DNA fragment for cloning experiments, 
preparative restriction digests were performed. Therefore, one to two μg of plasmid DNA were 
digested for 30 min at 37°C. A standard reaction volume of 100 μl consisted of: 
aqua bidest 82 μl
plasmid DNA (midi prep.) 5 μl
buffer (10 x) 10 μl
restriction enzyme 1 1.5 μl
restriction enzyme 2 1.5 μl .
2.2.2.5.3 Analytical digest 
Analytical digests were used to check the result of a cloning experiment. Prepared plasmid 
DNA was digested with appropriate restriction enzymes. A 20 μl standard reaction mix 
contained the following ingredients: 
aqua bidest 7.5 μl
plasmid DNA (mini prep.) 10 μl
buffer (10 x) 2 μl
restriction enzyme 0.5 μl
 
The reaction mixture was incubated generally at 37°C for one hour. DNA fragments were 
separated by gel electrophoresis to analyze the size of the digested fragments. 
 39 
2.2.2.5.4 Dephosphorylation of plasmid DNA 
To reduce the religation rate of a vector, which was linearized with one restriction enzyme, 
the digested plasmid was treated with “Antarctic Phosphatase” (NEB, USA). The enzyme 
catalyzes the removal of phosphate groups at 5'-position from the cleavage site. A standard 
reaction volume contained: 
restriction reaction 100 μl
Antarctic Phosphatase 2 μl
10 x reaction buffer 11 μl
This reaction was carried out for 15 min at 37°C and was inactivated for 5 min at 65°C. 
2.2.2.5.5 Ligation 
For the construction of plasmids, ligation reactions were carried out. The T4 DNA ligase 
(Promega) helps to form new phosphodiester bondages between an insert, generated by PCR 
or by preparative digests, and the linearized vector. 
A ligation reaction was generally incubated overnight at 8°C and was composed of: 
ligation buffer (10 x) 1.0 μl
vector (0.5-1.0 μg/μl) 0.5 μl
DNA fragment (ca. 0.5-1.0 μg/μl) 8.0 μl
T4 DNA-Ligase (4 U/μl) 0.5 μl
10 x Reaction Buffer: 300 mM TRIS-HCl (pH 7.8 at 25°C), 100 mM MgCl2, 100 mM DTT and 10 mM ATP 
Plasmid constructions are described in the supplementary material. 
2.2.2.6 Transformation 
2.2.2.6.1 Electrocompetent E. coli cells 
To prepare electrocompetent E. coli cells bacteria of a single colony were incubated overnight 
at 37°C in 5 ml LB medium supplemented with the appropriate antibiotic. This preculture was 
used to inoculate 200 ml LB or DYT medium 1:100, incubated at 37 °C. At an OD600 of 0.5 
to 0.8 the culture was cooled on ice for 15 to 30 min. Cells were harvested at 4°C by 
centrifugation in a Sigma 3-18 K centrifuge using 19776-H rotor at 6,000 rpm for 5 min. The 
bacterial pellets were washed with 30 ml cold aqua bidest and centrifugation was repeated at 
6,000 rpm for 8 min and 4°C. In the following, the bacterial pellets were washed with 30 ml 
10% glycerol. After the last centrifugation step the pellet was resuspended in 1/1000 volume 
of 10% glycerol and divided into 40 μl aliquots. These aliquots were used immediately for 
transformation or stored at -20°C. 
Electrocompetent E. coli pKD46 cells were cultivated as described for E. coli above. At an 
OD600 of 0.2 the culture was induced by arabinose at a final concentration of 0.2% and 
cultivation was continued. When the culture reached an OD600 of 0.8, cells were harvested and 
washed as described for E. coli. 
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2.2.2.6.2 Electrocompetent Yersinia cells 
Electrocompetent Yersinia cells were produced by inoculation of 200 ml BHI medium 1:50 
with a fresh overnight culture. This culture was incubated at 25°C until an OD600nm of approx. 
0.8 was reached. The bacteria were prepared and washed as described above for E. coli but 
the last washing step was carried out using 30 ml transformation buffer instead of 10% 
glycerol. Subsequent to the centrifugation, the pellet was resuspended in 1/500 volume 
transformation buffer. 40 μl aliquots were directly used for transformation. 
For production of electrocompetent Yersinia pKD46, 200 ml of LB medium supplemented 
with carbenicillin were inoculated 1:50 by an overnight culture and incubated at 25°C. At an 
OD600nm of 0.2 the culture was induced by arabinose at a final concentration of 0.2%. Cells 
were harvested at an OD600nm of 0.5 to 0.8 by centrifugation as described above. Washing 
steps were performed as described for E. coli using 10% glycerol. The washed pellet was 
resuspended 1:500 in 10% glycerol. 40 μl aliquots were prepared and immediately used for 
transformation. 
Transformation buffer for Yersinia spp.: 272 mM sucrose; 15% glycerol 
2.2.2.6.3 Electroporation 
For the efficient transformation of plasmids into electroporation into E. coli and 
Y. pseudotuberculosis strains electroporation was performed. Therefore, 1 μl of desalted DNA 
or 4 μl of a dialyzed ligation reaction were added to a 40 μl aliquot of electrocompetent cells. 
This mixture was filled into a chilled cuvette harboring an electrode gap of 0.2 mm (Peqlab, 
Germany). A voltage of 2.2 kV with a capacity of 25 μF and a resistance of 200 Ωwas 
applied. 
For RED-recombinase-mediated mutagenesis 6 to 16 μl of the PCR fragment encoding the 
insertion fragment were transformed into Yersinia pKD46 strains. Electroporation was 
performed as described for Yersinia except that cells were incubated in SOC medium for 
phenotypical expression. 
After electroporation E. coli cells were resuspended immediately in 1 ml LB, Yersinia cells 
were suspended in DYT medium. For phenotypical expression of the resistance genes, E. coli 
was incubated for one hour at 37°C, whereas Yersinia cells were incubated for two hours at 
25°C. E. coli pKD46 cells were incubated at 25°C since pKD46 carries a temperature-sensitive 
ori. In the following, cells were plated on the appropriate selective solid medium and incubated 
overnight at 37°C. Solid media with Y. pseudotuberculosis were incubated for two days at 
25°C. 
2.2.2.7 Mutagenesis of E. coli and Yersinia 
Gene knock-outs in E. coli and Yersinia were generated using the RED recombinase system as 
described previously (Datsenko and Wanner 2000; Derbise, et al. 2003).  
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E. coli strain KB1 was generated by introducing a fragment carrying a stpA deletion amplified 
with primers 33 and 34 in strain BL21λDE3. E. coli KB1 was used to mutate the hns gene 
with a fragment amplified with primers 35 and 36 leading to strain KB3. E. coli strain 
BL21λDE3 stpA -hns -hha -, described as KB4, was derived from KB3 by transformation of a 
fragment amplified with primers 37 and 38 encoding a hha mutation. These strains were 
derived by amplifying a kanamycin cassette by PCR. The used primers were homologous to 
the resistance gene encoded on pKD4 followed by homologous sequences of adjacent regions 
of the target gene. The PCR fragment was transformed into E. coli BL21 pKD46 
(sec. 2.2.2.6.1). Chromosomal integration of the fragment was selected by plating on LB 
supplemented with kanamycin. Subsequently, mutant derivatives were cured of the 
temperature-sensitive plasmid pKD46 by cultivation at 37°C. To remove the resistance gene 
at its FLP recognition sites the mutants were transformed with the helper plasmid pCP20 
encoding the FLP recombinase. For thermal induction of FLP synthesis and subsequent 
removal of the temperature-sensitive plasmid pCP20, mutants were incubated at 37°C. 
Y. pseudotuberculosis strains YP73 was derived from YP72 (YPIII rovM  -) by deleting ymoA. 
Further, the clpP gene was mutated in YP78 (YPIII lon  -) generating YP81. To do so, the 
kanamycin resistance gene was amplified using primer pair 39/40. Next, the Yersinia genomic 
DNA was used as a template to amplify 500-bp regions flanking the target gene. The 
upstream fragment was amplified with a primer pair of which the reverse primer contained 
additional 20 nt at the 5'-end which were homologous to the start of the kanamycin 
resistance gene. The downstream fragment was amplified with a primer pair of which the 
forward primer contained additional 20 nt at the 5'-end which were homologous to the end of 
the kanamycin resistance gene. In the next step, a PCR reaction was performed with the 
forward primer of the upstream fragment and the reverse primer of the downstream fragment 
using the upstream and downstream PCR products of the target gene and the kan PCR 
fragments as templates. For the deletion of ymoA, the upstream fragment was synthesized by 
using primers 41 and 42. The downstream fragment was amplified with primers 43 and 44. 
The last PCR step was carried out with primer pair 41/44. To delete the clpP gene, an 
upstream and downstream fragment were generated using primer pairs 45/46 and 47/48. 
Using primers 45 and 48 the kanamycin cassette was amplified with flanking clpP regions. 
The PCR fragments were transformed into Y. pseudotuberculosis YPIII pKOBEG-sacB and 
chromosomal integration of the fragment was selected by plating on LB supplemented with 
kanamycin. Mutants were subsequently grown on LB agar plates without NaCl plus 10% 
sucrose, and faster growing colonies without pKOBEG-sacB were selected and proven by PCR 
and DNA sequencing. 
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2.2.3 Molecular biological methods for RNA 
2.2.3.1 RNA isolation 
To study influences of gene regulation on RNA levels of the virulence factors in 
Y. pseudotuberculosis, total RNA of the bacteria was isolated. Two to four ml of bacterial 
culture were withdrawn and mixed with 0.4 volume stop solution. Subsequently, the 
suspension was snap-frozen in liquid nitrogen. Bacterial cells were pelleted by centrifugation at 
13,000 rpm for 5 min at 4°C in a microcentrifuge 5415 R (Eppendorf, Germany) and lysed by 
resuspension in a lysozyme solution for 5 min at room temperature. RNA isolation was 
performed using the SV Total RNA purification kit (Promega, USA) according to the 
manufacturer’s description. RNA was eluted with 100 μl RNase-free H2O (Gibco,USA) and the 
RNA concentration was determined. 
stop solution: 95% ethanol, 5% Aqua phenol 
lysozyme solution: 50 mg/ml lysozyme in TE buffer (pH 7.5) 
TE buffer (pH 7.5): 100 mM TRIS-HCl pH 7.5, 1 mM EDTA pH 8.0 
2.2.3.2 Measurement of RNA concentration 
RNA concentration of a RNA isolation experiment was determined with a NanoDrop (Peqlab, 
Germany). RNA absorbs light at a wavelength of 260 nm. One unit of absorbance at 260 nm 
corresponds to 40 μg RNA per ml water. RNA purity is measured by the ratio of absorbance 
at 260 nm to 280 nm. 
2.2.3.3 RNA agarose gel electrophoresis 
To separate RNAs by size, RNA samples were applied to gel electrophoresis. In an electrical 
field, negatively charged RNA molecules move towards the anode. RNA size and conformation 
determine the velocity of the RNA migration through a polymeric agarose matrix. Since RNA 
forms secondary structures, RNAs samples were denatured prior to gel electrophoresis by the 
addition of a loading buffer containing formaldehyde and formamide and heating for 10 min 
at 70°C. To determine the quality of an RNA sample, ethidium bromide was added to the 
loading buffer. 
In general, 10 μg of total RNA were applied to a 1.2% MOPS-agarose gel. Gel electrophoresis 
was carried out for 90 min at a voltage of 120 V. After gel electrophoresis, the RNA was 
visualized by exposure to UV light at a wave length of 226 nm and documented by a gel 
documentation system.  
RNA loading buffer (5 x): 0.03% bromophenol blue, 4 mM EDTA, 0.1 mg/ml EtBr, 2.7% formaldehyde, 31% 
formamide, 20% glycerol in 4 x MOPS buffer 
MOPS (20 x): 200 mM MOPS, 50 mM sodium acetate, 10 mM EDTA 
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2.2.3.4 Northern blot analysis 
Northern blotting was used to detect specific RNAs within a RNA population with a 
hybridization probe complementary to the target RNA. After gel electrophoresis the RNA is 
transferred onto a positively charged nylon membrane by capillary forces. Therefore, the 
agarose gel was equilibrated by incubation in 20 x SSC solution for 30 min and then placed 
upside down onto whatman papers saturated with 2 x SSC, covering whatman paper 
saturated with 20 x SSC solution. The gel was covered with a nylon membrane Nytran™ N 
(Whatman, USA), overlayed with dry whatman paper. The blotting was performed for 
4.5 hours. Subsequently, the RNA was crosslinked twice to the membrane with a stratalinker 
UV (Stratagene, USA). 
Prehybridization, hybridization to Dig-labeled DNA-probes and membrane washing was carried 
out using the DIG luminescent Detection kit (Roche, Germany) according to the 
manufacturer’s instructions. Probes were synthesized by PCR (for primers see Table 10) using 
the Taq polymerase (NEB) as followed: 
ThermoPol buffer (10 x) 10 μl
DIG DNA labelling Mix (10 x) 10 μl
MgSO4 (25 mM) 10 μl
template 1 μl
primer A (10 μM) 3 μl
primer B (10 μM) 3 μl
Taq polymerase (1 U/μl) 1 μl
H2O 62 μl
 
The following primers were used to synthesize Dig-labeled DNA probes from chromosomal 
DNA of Y. pseudotuberculosis strain YPIII. 
Table 10. Primer for DNA probes. 
name sequence  
51 5'- GCA ATC AGC TAG TCA ATT TG -3' csrC forward 
52 5'- GGG CGC GGA TCC GAT TGG GCC GGA ATC TAG C -3' csrC reverse 
53 5'- CGG CGC GGA TCC CTC TCA CAC CAG CTG TG -3' csrB forward 
54 5'- GGG GGC GTC GAC GGC AAA CTC AAT ATC CTG -3' csrB reverse 
 
Dig-labeled DNA-RNA hybrids were visualized by chemiluminescence detection using CDP-
Star (Roche, Germany). After incubation with the chemiluminescent substrate the membrane 
was exposed to X-ray films CL-Xposure (Thermo Scientific, USA) and developed by a 
developing machine Optimax Type TR (MS Laborgeräte, Germany). 
20 x SSC: 3 M NaCl, 0.3 M Natriumcitrat, pH 7 
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2.2.3.5 RNA stability assay 
RNA stability assay was used to determine the degradation of the CsrC RNA in different 
Yersinia mutant backgrounds. A Y. pseudotuberculosis overnight culture was mixed with 
Rifampicin at a final concentration of 500 μg/ml to inhibit transcription initiation. Samples 
were taken simultaneously and centrifuged at 13,000 rpm for 2 min in a 5415 R 
microcentrifuge. A 0.4 volume stop solution was added. Total RNA was isolated and Northern 
blotting was performed as described above (sec. 2.2.3.1 to sec. 2.2.3.4). 
rifampicin solution: 10 mg/ml rifampicin in methanol 
2.2.3.6 In vitro transcription  
To monitor RNA stability of regulatory RNAs or to analyze the secondary structure and its 
influences on translational events, RNA needed to be transcribed in vitro using PCR product 
or linearised plasmids as templates.  
2.2.3.6.1 In vitro transcription with PCR templates 
For synthesis of RNA in vitro, the template of the target gene was amplified by using a 
forward primer, carrying a T7 recognition site fused to the 5' end of the gene sequence, and a 
reverse primer binding to the 3' end. The PCR product was purified by “QIAquick PCR 
Purification Kit” (Qiagen, Germany) 
Primers used to synthesize the template for the reverse transcriptase reaction from 
chromosomal DNA of Y. pseudotuberculosis strain YPIII are listed below (Table 11). 
Table 11. Primer for Reverse transcription template. 
name sequence   
55 5'- GGG CGC GTA ATA CGA CTC ACT ATA GTT GGT ACG 
GAT ACA CCA TGC- 3' 
 Ptet::csrC forward 
56 5'- CCA GTG TCC TAA CAT CCC T- 3'  csrC reverse 
57 5'- GGG CGC GTA ATA CGA CTC ACT ATA GGC CTG GCG 
GCC ATA GCG- 3' 
 Ptet::5S rRNA 
forward 
58 5'- GCCTGGCAGTGTCCTACTC- 3'  5S rRNA reverse 
underlined ... recognition site for T7 polymerase 
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In vitro transcription was performed using the TranscriptAidTM T7 High Yield Transcription 
Kit as described by Fermentas (Germany). A typical in vitro transcription reaction was 
prepared as the following: 
5 x TranscriptAidTM reaction buffer 4 μl
ATP/CTP/GTP/UTP mix (equal volumes) 8 μl
template DNA 2 μl
DEPC-treated water 4 μl
TranscriptAidTM enzyme mix 2 μl
 
The reaction mixture was incubated overnight at 37°C.  
2.2.3.6.2 Run-off in vitro transcription  
RNAs synthesized in vitro by run-off transcription were used for RNA structure probing and 
toeprint analysis. Therefore, an insert which carried the T7 polymerase recognition site fused 
to the 5' end of the DNA sequence encoding the target RNA region was ligated into the 
vector pUC18 (plasmids see Table 9). Plasmids were linearized by digestion with MlsI, 
extracted by phenol method and precipitated with sodium acetate and ethanol 
(sec. 2.2.2.4.4). 
The purified DNA was used in a reaction mix as described in the following: 
5 x transcription buffer 40 μl
dNTP Mix (20 mM) 20 μl
linearized template DNA 4 μg
RiboLock™ RNase inhibitor 5 μl
T7 RNA polymerase 6 μl
triton 2 μl
 
RNA synthesis was carried out overnight at 37°C. The RNA was purified by phenol extraction 
and ethanol precipitation as described in sec. 2.2.3.7 and 2.2.3.8. 
2.2.3.7 RNA phenol extraction 
To remove contaminating proteins from a RNA sample RNA was extracted with phenol. For 
that, a 200 μl RNA solution was mixed thoroughly with 150 μl Roti-Aqua phenol (Roth, 
Germany) and centrifuged at 13,000 rpm for 3 min in a 5415 R microcentrifuge. The aqueous 
phase was transferred to a new tube and mixed with 150 μl chloroform. After mixing, 
centrifugation was performed as described before. This step was repeated and the aqueous 
phase transferred to a new vial for precipitation. 
2.2.3.8 RNA precipitation 
To precipitate RNA, three volumes of ethanol were added to one volume of RNA solution 
supplemented with 1/10 volume of Na acetate and glycogen. The mixture was incubated 
at -20 °C for 15 min. In the following, the precipitate was centrifuged at 13,000 rpm for 
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15 min at 4°C in a 5415 R microcentrifuge. The pellet was washed with 100 μl 70% ethanol 
and centrifuged again at 13,000 rpm for 5 min at 4°C. The RNA was diluted in RNase-free 
water.  
2.2.3.9 RNA isolation from polyacryamide gels 
For purification of RNA after run-off in vitro transcription and radioactive-labeling, RNA was 
separated in 6% polyacrylamide/urea gels with a thickness of 1 mm in TBE buffer. After 
preparation of the gel at 20 mA, 1,000 V for 30 min, gel run was performed in a gel system 
S2001 (Life technologies, USA) at 25 mA (ca. 1,200 V) depending on the size of the RNA. 
The RNA was visualized under UV-light, the RNA band was cut out and transferred to a 
clean tube filled with 400 μl RNA elution buffer. The sample was incubated for 1 h at 30°C in 
a shaking thermomixer (Eppendorf, Germany). 400 μl RNA elution buffer were transferred to 
a new vial and elution was repeated with additional 400 μl RNA elution buffer. Subsequently, 
the RNA was precipitated with sodium acetate and ethanol (sec. 2.2.3.8). 
TBE buffer (1 x): 89 mM TRIS; 89 mM boric acid; 2 mM EDTA 
6% polyacrylamide/urea solution: 6% acrylamide/bisacrylamide (40%, 19:1 stock), 7 M urea in TBE 
RNA elution buffer: 10 mM EDTA, 0.5 % SDS, 0.1 M sodium acetate pH 5.6 
2.2.3.10 RNA structure probing 
To determine the secondary structure of the 5' untranslated region of LcrF, the radioactively 
labeled RNA was digested with specific RNases and the fragments were separated by 
polyacrylamide gel electrophoresis. 
2.2.3.10.1 Dephosphorylation of RNA 
RNA needs to be dephosphorylated at its 5' end to allow radioactive labeling of the molecule. 
Calf intestine phosphatase (CIP, NEB, USA) catalyses the removal of two phosphate groups 
at the 5' end, leaving one monophosphate group for the labeling reaction. A typical 
dephosphorylation reaction contained the following: 
in vitro transcribed RNA 3 pmol
10 x CIP buffer 5 μl
CIP 1 μl
 
The reaction was incubated for 45 at 37°C. Subsequently, 150 μl of RNase-free water were 
added and the RNA was extracted using phenol (sec. 2.2.3.7). After precipitation with ethanol 
and sodium acetate (sec. 2.2.3.8) the RNA pellet was dissolved in 7 μl.  
2.2.3.10.2 Radioactive labeling of RNA 
For radioactive labeling, RNA, desphosphorylated at the 5' end, was phosphorylated with 
radioactive γ-ATP32 (Hartmann, Germany) using T4 polynucleotide kinase (PNK, Fermentas, 
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Germany) as described by Brantl and Wagner (1994). The enzyme transfers the γ-phosphate 
from ATP to 5' hydroxyl group of RNA.  
The reaction consisted of: 
dephosphorylated RNA 15 pmol
PNK buffer 1 μl
PNK 1 μl
Ribolock RNase inhibitor 0.5 μl
γ-ATP32 4 μl
 
and was incubated for 5 min at 37°C. The reaction was inactivated by the addition of 10 μl 
formamide stop solution and incubated for 5 min at 95°C. In the following, the reaction was 
applied to a 6% polyacrylamide/urea gel and the RNA bands were isolated from the gel 
(sec. 2.2.3.9). After precipitation of the RNA, the pellet was dissolved in 15 μl RNase-free 
water and radioactive labeling efficiency was measured by a scintillation counter (liquid 
scintillation analyzer Tri-Carb 2800 TR, Perkin Elmer, USA). 
formamide stop solution: 17 mM EDTA, 0.05% bromophenol blue/xylene cyanol in formamide 
2.2.3.10.3 Digestion and separation of RNA 
The RNA formation of the LcrF untranslated 5' region was analyzed at 25°C and 37°C. 
Partial digestion of RNA molecules with ribonucleases T1 and V (Ambion, USA) was 
conducted as described by Waldminghaus et al. (2008). Ribonuclease T1 cleaves RNA 3' of 
single-stranded G residues, whereas RNase V recognizes base-paired nucleotides. A reaction 
mixture of 4 μl, the RNA (30,000 counts) was first incubated with 1 μl TMN buffer (5 x), 
0.4 μl tRNA (Invitrogen, Germany) and RNase-free water for five minutes at 25°C or 37°C. 
Then, a volume of 1 μl RNase T1 (0.001 U/μl), RNase V (0.0002 U/μl) or RNase-free water 
(control) were added. After 5 min of incubation at the appropriate temperature, the reaction 
was stopped by addition of 5 μl formamide stop solution. The samples were incubated on ice 
for a few minutes and subsequently heated to 95°C for 5 min for denaturation of secondary 
structures. Alkaline ladders were generated as described previously (Brantl and Wagner 1994). 
60,000 counts of LcrF RNA were supplemented with 4 μl tRNA, 1 μl RNA ladder buffer and 
RNase-free water to a total volume of 10 μl. The ladder reactions were heated for 2 min at 
90°C. 10 μl of formamide stop solution were added. After 5 min of incubation on ice, samples 
were applied to a denaturing 8% polyacrylamide/urea gel to separate RNA fragments. 
Electrophoresis was carried out in TBE buffer at 2,100 V for 1.5 h. Subsequently, the gel was 
dried (gel dryer 583, Biorad, USA), RNA fragments were visualized by overnight exposure to 
an X-ray film and documented by Bioimager FLA-3,000 (Fujifilm, Japan).  
TMN buffer (5 x): 100 mM TRIS acetate pH 7.5; 10 mM MgCl2; 500 mM NaCl 
RNA ladder buffer (10 x): 1 M Na2CO3; 1 M NaHCO3 
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2.2.3.11 RNA toeprint analysis 
RNA toeprinting experiments (Hartz, et al. 1989), also known as primer extension inhibition 
experiments, were used to analyze whether ribosomal binding to the recognition site in the 
5’ untranslated region of LcrF was impaired by secondary structure formation of the RNA at 
low temperatures. In general, in vitro translated RNA of LcrF, consisting of the 
5' untranslated region and the first 63 nucleotides of the coding sequence, was mixed with 
radioactively labeled primer. After the primer had annealed to the 3' end in the coding region 
of LcrF, the RNA was incubated with or without 30S ribosomal subunits at 25°C and 37°C 
and the reverse transcriptase was added. Moloney Murine Leukemia Virus reverse 
transcriptase (M-MLV, USB, USA) synthesizes cDNA starting at the labeled primer towards 
the 5' end of the RNA (Roth, et al. 1988). In case the RNA forms secondary structures or 
stable ribosome-RNA complexes, the M-MLV reverse transcriptase stops transcription in this 
region and falls off the RNA generating small cDNA fragments (toeprint). Full length 
transcripts are synthesized when the secondary structure of the RNA thermometer is resolved 
at higher temperatures or ribosomes are not present.  
 
Fig. 12. The principle of primer extension inhibition (toeprint analysis).M-MLV reverse transcriptase 
synthesizes cDNA from the radioactively-labeled primer at the 3' end of the RNA in 5' direction. Full length 
transcripts are produced when M-MLV is incubated with linear RNA. Toeprint transcripts are generated when 
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RNA and 30S ribosomal subunits or secondary RNA structures are formed, since the M-MLV transcription is 
stopped and the enzyme falls of the RNA template. 
2.2.3.11.1 Radioactive labeling of primers 
To visualize cDNA fragments of the toeprint experiment, the primer, which anneals to the 
3' end of the RNA template, was labeled with γ-ATP32 at its 5' end. The reaction mixture 
was composed of: 
primer (10 pmol/μl) 1 pmol
10 x PNK buffer 2 μl
PNK (10 U/μl) 1 μl
γ-ATP32 2 μl
H2O 14 μl
 
This mixture was incubated for 60 min at 37°C and inactivated by heating to 65°C for 
10 min. Subsequently, the labeled DNA was precipitated as described above (sec. 2.2.3.8). 
The pellet was resuspended in 20 μl RNase-free water. 
2.2.3.11.2 Annealing of primers 
Radioactively labeled primers were annealed to the target mRNA for three hours at 80°C in 
the following reaction: 
primer (0.5 pmol/μl) 4 pmol
1 x VD buffer-Mg2+ 17 μl
mRNA 0.25 pmol/μl
total 25 μl
 
Subsequently, the mixture was snap-frozen in liquid nitrogen and thawed on ice for at least 
30 min. 
5 x VD buffer-Mg2+: 0.05 M TRIS-HCl pH 7.4, 0.3 M NH4Cl, 30 mM β-mercaptoethanol, 0.05 M MgO acetate 
2.2.3.11.3 Extension reaction 
For the toeprinting experiment, the 5' untranslated region of LcrF with the annealed primer 
(annealing mix, sec. 2.2.3.11.2) was incubated with or without 30S ribosomal subunits at two 
different temperatures, 25°C and 37°C. 30S ribosomal subunits were isolated from E. coli as 
described previously (Hartz, et al. 1989). Uncharged tRNAtMet (Sigma-Aldrich, USA) was 
added to stabilize the ribosomal binding complex. A typical reaction was prepared as described 
in the following: 
Watanabe buffer I 4 μl
tRNAtMet (8 pmol/μl) 17 μl
annealing mix 4 μl
 
The mixture was incubated for 10 min at 25°C or 37°C. Subsequently, 6 μl 30S ribosomal 
subunits or TICO buffer were added and incubation was continued for additional 10 min at 
the appropriate temperatures. To initiate the primer extension, 2 μl M-MLV reaction mix was 
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added, containing the reverse transcriptase, and the reaction was carried on for 10 min at 
25°C.  
The MMLV reaction mix was composed of: 
5 x VD buffer-Mg2+ 0.16 μl
MMLV (200 U/μl) 0.33 μl
BSA (1 mg/ml) 0.50 μl
dNTPs solution 0.50 μl
H2O 0.50 μl
Watanabe buffer I: 60 mM HEPES-KOH pH 7.5 (0°C), 10.5 mM Mg(COO)2, 690 mM NH4COO, 
12 mM β-mercaptoethanol, 10 mM spermidine, 0.25 mM spermine 
dNTPs solution: 4.3 mM 4 x dNTPs, 23% 5 x VD buffer-Mg2+ in RNase-free H2O 
Tico buffer: 60 mM HEPES pH 7.4, 10.5 mM Mg(COO)2, 690 mM NH4COO, 12 mM β-mercaptoethanol 
The reaction was stopped by the addition of 20 μl formamide stop solution and heating for 5 min 
at 95°C to resolve secondary structures. For separation of the cDNA fragments, 6 μl of the samples 
were applied to an 8% polyacrylamide/urea gel. 4 μl sequencing reaction (sec. 2.2.3.11.4) 
were applied to obtain a sequence ladder. The gel run was performed for 1.5 hours at 2 kV. In 
the following the gel was dried and exposed to an X-ray film overnight. The cDNA was 
visualized by the Bioimager FLA-3,000 (Fujifilm, Japan).  
2.2.3.11.4 Sequencing reaction 
To synthesize a sequence ladder for toe printing analysis, a sequence reaction was carried out 
using the Thermo Sequenase cycle Sequencing Kit (USB, USA) according to the 
manufacturer’s instructions. Therefore, a mastermix containing the labeled primer was 
prepared as the following: 
template plasmid (100 ng/μl) 1 μl
ɣ-P32-primer 6 μl
buffer (1 mg/ml) 2 μl
Sequenase 7 μl
H2O 2 μl
 
Four times 4 μl mastermix were added to 4 μl nucleotide termination mix each containing one 
kind of dideoxy-NTPs. The reaction was performed in a thermocycler (Biometra, Germany) 
programmed as described below: 
denaturating 96°C 60 s
denaturating 96°C 30 s
annealing 50°C 30 s 40 cycles
elongation 72°C 2 min
 
The reaction was stopped by the addition of 4 μl formamide stop solution and applied to an 
8% polyacrylamide/urea gel. 
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2.2.4 Biochemical methods 
2.2.4.1 β-Galactosidase activity assays 
To monitor expression activities of genes, the specific β-galactosidase activity of a culture 
containing the gene’s promoter fused to a lacZ gene was determined by a modified assay 
described by Miller (1992). 
The OD600 of an overnight culture was measured. Directly from the cuvette 200 μl cells were 
filled into two separate glass tubes for duplicates. Lysis was performed by the addition of one 
drop 0.1% SDS and two drops chloroform, mixing and incubation for 10 min at room 
temperature. In the following 1.8 ml Z-buffer were added. The reaction was started with 
400 μl ONPG and stopped at an appropriate yellow coloration by 1 ml Na2CO3. The reaction 
samples were centrifuged for 2 min and the supernatant was measured by a microtiter plate 
reader at an OD of 405 nm. 
specific activity = OD405·6.75·(OD600·∆t·V)-1 
 
specific activity ... [µmol cleaved substrate/(min·mg protein)] or [U·mg protein] 
OD405 ... optical density of stopped reaction
6.75 ... extinction coefficient of cleaved ONPG [μmol/(min·mg)] 
OD600 ... optical density of bacterial culture
V ... used culture volume [ml]
∆t ... period from start (addition of ONPG) to end (addition of Na2CO3) of enzyme 
reaction 
Z-buffer (1 x): 100 mM sodium phosphate buffer pH 7.0; 10 mM KCl; 1 mM MgSO4 
2.2.4.2 Preparation of whole cell extracts 
The optical density of overnight cultures was adjusted and a 300 μl aliquot was withdrawn 
from each culture. The cells were harvested by centrifugation and resuspended in 150 μl 
1 x sample buffer. The samples were incubated for 5 min at 95°C (Sambrook, et al. 1989). In 
case the cell extract showed viscosity, 1.5 μl benzonase (Merck, Germany) were added and 
the sample was incubated for 1 h at 37°C. Generally, three to five μl whole cell extract were 
applied on SDS polyacrylamide gels. When the target protein was present in lower amounts, 
the volume of the loaded sample was increased. 
1 x sample buffer: 60 mM TRIS-HCL pH 6.8, 2% SDS; 10% glycerol; 3% DTT; 0.02% bromophenol blue 
2.2.4.3 SDS-PAGE analysis 
SDS polyacrylamide gel electrophoresis (Laemmli 1970) allows the separation of proteins 
according to their size in a polyacrylamide gel matrix. The addition of the anionic detergent 
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SDS denatures proteins and charges them negatively, which allows electrophoretic separation 
without the influence of protein charge or conformation. 
In this study, SDS gel electrophoresis was carried out with vertical electrophoresis chambers 
Mini-Protean II (BioRad, USA). Gels were composed of a stacking and separating gel, 
prepared with different polyacrylamide concentrations. 
These different concentrations as well as the different pH values of the stacking and the 
separating gel help to focus the proteins of the samples at the border of the two gels. This 
allows more efficient protein separation. 
A 15% SDS separating gel contained (Sambrook, et al. 1989): 
separating gel buffer pH 8.8 2.5 ml
acryl/bisacrylamide (30%) 5.0 ml
aqua bidest 2.5 ml
TEMED 50 μl
APS (10%) 50 μl 
separating gel buffer (4 x): 1.5 M TRIS-HCl pH 8.8; 4% SDS 
After polymerization of the separating gel, the stacking gel was prepared of the following 
solutions: 
stacking gel buffer (4 x) 2.5 ml
acryl/bisacrylamide (30%) 1.1 ml
aqua bidest 6.5 ml
TEMED 40 μl
APS (10%) 80 μl 
stacking gel buffer (4 x): 0.5 M TRIS-HCl pH 6.8; 4% SDS 
Samples were incubated in 1 x SDS sample buffer for 5 min at 95°C for denaturation and 
loaded onto the gel. SDS-PAGE was performed at a constant current of 25 mA per gel and 
maximum voltage. 
Subsequently, the gels were either stained in CoomassieTM Brilliant Blue G250 for one hour or 
prepared for Western blot analysis (sec. 2.2.4.6). Gels stained with CoomassieTM Brilliant Blue 
were destained by shaking in destaining solution for at least two hours. 
To determine the molecular weight of proteins, 5 μl of markers were used as described above 
(sec. 2.2.4.5). 
SDS running buffer: 33 mM TRIS-HCl pH 8.3; 192 mM glycine; 0.1% SDS 
destaining solution: 30% methanol; 10% acetic acid 
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2.2.4.4 TRICINE-PAGE for low molecular weight proteins 
To separate proteins of low molecular weight, samples were applied to TRICINE-PAGE as 
described previously (Schagger 2006). A typical 20% separating gel was prepared as the 
following: 
3 x gel buffer 3.0 ml
glycerol (100%) 1.0 ml
acryl/bisacrylamide (40%) 4.5 ml
aqua bidest 0.5 ml
TEMED 6.0 μl
APS (10%) 60.0 μl 
 
A typical stacking gel was composed of: 
3 x gel buffer 1.6 ml
acryl/bisacrylamide (30%) 0.8 ml
aqua bidest 3.8 ml
TEMED 7.5 μl
APS (10%) 75.0 μl 
 
Electrophoresis was carried out using cathode buffer for the cathode chamber and anode 
buffer filled in the anode chamber. A voltage of 30 mA was applied per gel. 
3 x gel buffer: 0.3 M TRIS base, 1 M HCl, 0.3% SDS 
cathode buffer: 0.1 M TRIS base, 0.1 M TRICINE, 0.1% SDS 
anode buffer: 0.1 M TRIS base, 0.0225 M HCl 
2.2.4.5 Molecular weight marker for SDS polyacrylamide gel 
electrophoresis (SDS-PAGE) 
To measure the molecular weights of proteins separated by SDS-PAGE, “Protein Ladder 
10-200 kDa“ (Fermentas) marker with the following molecular weights (in kDa) was used: 
116, 66.2, 45, 35, 25, 18.4 and 14.4. 
If SDS-PAGE was followed by a Western blotting, “PageRuler Prestained Protein Ladder” by 
Fermentas was applied with molecular weights in kDa as followed: 170, 130, 100, 72, 55, 40, 
33, 24, 17 and 11. 
2.2.4.6 Western blot analysis 
Proteins, which have been separated by SDS-PAGE, can be detected by antibodies and are 
therefore transferred onto a nitrocellulose membrane (Towbin, et al. 1979). Blotting was 
performed using the “Mini-protean II” Western blot cell (BioRad, USA). The membrane, 
activated with methanol, was placed face-to-face to the gel. These were then enclosed by 
whatman paper and fiber pads soaked in transblot buffer in the blotting gasket. The blot cell 
was placed into the tank filled with transblot buffer, with the membrane facing the anode. 
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Proteins were transferred for one hour at 100 V while cooling and maximum current was 
allowed. Subsequently, the membrane was incubated in 5% TBSTM buffer for 2 hours at 
room temperature or overnight at 4°C to saturate non-specific protein interactions. After 
removal of TBSTM, the membrane was incubated with the primary polyclonal antibody 
diluted in 10 ml TBSTM which was performed for one hour at room temperature. Thereafter, 
the membrane was washed three times with TBST for 10 min and incubated with the 
secondary antibody for one hour. When using anti-rabbit or anti-mouse alkaline phosphatase 
(AP) conjugate was used, the blot membrane was washed with TBST and AP buffer, for 
10 min after each incubation step. To develop the blot a staining solution based on AP buffer 
was applied which contained NBT and BCIP. The reaction was stopped by aqua bidest and 
the stained proteins on the membrane was documented by digital photography. The 
membrane was stored protected from light. 
If the membrane was incubated with anti-rabbit horse radish peroxidase (HRP) conjugate, the 
blot was washed three times with TBST for 10 min. Thereafter, the membrane was incubated 
with Pierce ECL Western blotting substrate (Thermo Scientific, USA) for 5 min. The 
substrate was removed and the blot was exposed to X-ray film for 1 to 15 min. The film was 
developed using a developing machine. 
transblot buffer: 25 mM TRIS, 192 mM glycine; 20% methanol (v/v) 
TBST: 20 mM TRIS pH 7.5; 150 mM NaCl; 0.05% TWEEN-20 
TBSTM: TBST; 5% non-fat dry milk. 
AP buffer: 100 mM TRIS pH 9.5; 100 mM NaCl; 5 mM MgCl2 
AP staining solution: 10 ml AP buffer; 33 µl NBT (100 mg/ml in 70% DTT); 33 µl BCIP (50 mg/ml in DMF) 
2.2.4.7 Protein overexpression and purification 
To study the interaction of YmoA, H-NS and the YmoA-H-NS heteromer with DNA or RNA 
molecules, these proteins were overexpressed and purified. 
2.2.4.7.1 Overexpression of YmoA 
For overexpression of YmoA, the E. coli strain KB4 (BL21 ∆hns∆stpA∆hha) was transformed 
with pAKH77 encoding an N-terminal Strep-tagged YmoA protein. The deletion of hns, stpA 
and hha in KB4 prevents the heteromerization of YmoA with E. coli homologs (Nieto, et al. 
2002) and allows purification of the homologous Yersinia protein. Overexpression was 
performed as described by the manufacturer (IBA GmbH, Germany) 
500 ml LB supplemented with carbenicillin were inoculated 1:50 with an overnight culture of 
KB4 pAKH77 and incubated at 37°C. To induce Ptet::ymoA expression, 50 μl of an AHT 
solution were added at an OD578nm of 0.6. Cultivation was continued for additional four hours. 
Thereafter, cells were harvested at 6,000 rpm for 5 min in an SLA-3000 rotor using a Sorvall 
centrifuge.  
AHT solution: 2 mg AHT dissolved in 1 ml DMF 
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2.2.4.7.2 Overexpression of H-NS 
To overexpress H-NS, the C-terminal H-NS-His6 producing strain KB4 pAKH11 was cultivated 
overnight at 37°C in LB supplied with kanamycin. The next day, 500 ml LB containing 
kanamycin was inoculated 1:100 with the preculture and incubated at 37°C. At an OD578nm 
between 0.4 and 0.6, 2 mM IPTG were added to induce protein production. Cells were 
harvested after an additional cultivation for three hours by centrifugation at 6,000 rpm for 
5 min with a SLA-3000 rotor in a Sorvall centrifuge. 
2.2.4.7.3 Preparation of cell extracts 
For cell disruption, the frozen pellets were thawed and resuspended in the appropriate buffer. 
To purify Strep-YmoA, pelleted cells of the 500 ml overexpression culture of KB4 pAKH77 
were resuspended in 5 ml buffer W. Cells of a 500 ml H-NS-His6 overexpression culture 
KB4 pAKH11 were dissolved in 5 ml lysis buffer.  
Protein extraction of the cell suspension was performed by mechanical cell lysis using a French 
press (Aminco, USA) as described by the manufacturer. Cell debris was removed by 
centrifugation of the cell lysate at 14,000 rpm for 30 min at 4°C in a Sigma 3-18 K 
(Germany). The centrifugation was repeated with the supernatant. 
buffer W (washing buffer): 100 mM TRIS-HCl, 150 mM NaCl, 1 mM EDTA, pH 8 
lysis buffer: 50 mM TRIS-HCL pH 8; 300 mM NaCl 
2.2.4.7.4 Purification of YmoA protein 
Purification of Strep-YmoA was carried out using a PolyPrep column (Biorad, USA) filled 
with a column volume (CV) of 2 ml Strep-Tactin® Superflow® high capacity (IBA GmbH, 
Germany). The purification was performed according to the manufacturer’s instructions.  
After equilibration of the column with 2 CV’s buffer W, the supernatant (sec. 2.2.4.7.3) was 
applied. To remove unspecifically bound protein from the column, it was washed five times 
with 1 CV buffer W. Elution of Strep-YmoA was performed by applying six times of 0.5 CV 
elution buffer. Washing and elution fractions were collected in clean tubes and samples were 
taken for SDS-PAGE analysis. 
buffer E: 100 mM TRIS-HCl, 150 mM NaCl; 1 mM EDTA; 2.5 mM desthiobiotin; pH 8 
2.2.4.7.5 Purification of the H-NS protein 
His-tagged H-NS was purified by applying the supernatant (sec. 2.2.4.7.3) to a PolyPrep 
column (Biorad, USA), which was filled with a column volume of 2 ml Ni-NTA agarose 
(Qiagen, Germany) and equilibrated with 5 ml lysis buffer.  
Unspecifically bound protein was eluted in two steps. The column was washed twice with 5 ml 
washing buffer 1 containing 40 mM imidazole. In the following the column was washed three 
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times with 5 ml washing buffer 2 with an imidazole concentration of 60 mM to achieve more 
intensive removal of contaminating protein.  
His-tagged H-NS was eluted from the column by applying one CV elution buffer for five 
times. All fractions were collected in clean tubes and samples were taken to analyze the 
protein content via SDS-PAGE. 
washing buffer 1:  50 mM TRIS-HCl pH 8, 300 mM NaCl, 40 mM imidazole 
washing buffer 2:  50 mM TRIS-HCl pH 8, 300 mM NaCl, 60 mM imidazole 
elution buffer:  50 mM TRIS-HCl pH 8, 300 mM NaCl, 250 mM imidazole 
2.2.4.8 Measurement of the protein concentration 
The protein concentration of purified proteins was determined using the Protein Assay Kit II 
(BioRad) or CoomassieTM Protein Assay Reagent (Bradford 1976). The procedure was 
followed according to the manufacturer's instructions. 
2.2.4.9 RNA-Protein electrophoretic mobility shift assay (EMSA) 
The interaction of YmoA and H-NS homomers with the CsrC RNA was studied by incubation 
of in-vitro transcribed CsrC RNA with increasing protein amounts. Therefore, the reaction was 
composed of the following: 
ivT CsrC 13.5 pmol
5S RNA (control) 13.5 pmol
10 x RNA binding buffer 0.4 μl
protein 6.0 μl
Ribolock RNase inhibitor 0.1 μl
filled to 10 μl with H2O
 
 
The mixture was incubated for 30 min at 25°C and subsequently applied to an 8% 
polyacrylamide gel in PerfectBlueTM Twin chambers (Peqlab, Germany). RNA and RNA-
protein complexes were separated for 2.5 hours at 70 V. The gel was stained with SYBR® 
Green II (Invitrogen, USA) and photographed by a gel documentation system (BioRad, USA).  
RNA binding buffer (10 x): 0.1 M TRIS-HCl pH 7.5, 0.1 M MgCl2, 1 M KCl, 75% glycerol, 0.03 M DTT 
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3 Results 
3.1 YmoA activates early infection virulence factor invasin 
through a complex regulatory network 
During the early infection phase, Yersinia pseudotuberculosis expresses the outer membrane 
protein invasin which most efficiently helps the bacterium to invade into M-cells. Production 
of invasin in response to environmental signals is mediated by the MarR-type regulator RovA. 
The synthesis of RovA itself is the result of a complex regulatory network comprising the 
global regulator H-NS, the LysR regulatory protein RovM, the Carbon storage regulator (Csr) 
system and the two-component system UvrY-BarA. The nucleoid-associated protein YmoA 
was identified during a gene bank screen to induce expression of a chromosomal rovA-lacZ 
fusion in Y. pseudotuberculosis strain YP38. This work analyzes, how YmoA affects RovA 
production by regulating components of the regulatory cascade of rovA transcription, in 
particular the Csr system. 
3.1.1 YmoA activates rovA expression by downregulating RovM 
Previously, Nieto et al. (2002) demonstrated, that the nucleoid-associated proteins YmoA and 
H-NS are able to form heterodimers. Furthermore, transcription of the rovA gene was shown 
to be regulated by H-NS which binds to an AT-rich stretch upstream of both rovA promoters 
(Heroven, et al. 2004). To analyze whether YmoA controls rovA expression through YmoA-
H-NS complex formation which interferes with H-NS oligomerization, the RovA synthesis was 
monitored in the presence or absence of functional H-NS in Y. pseudotuberculosis wild type 
strain YPIII and a ymoA mutant strain YP50.  Since H-NS mutations have been shown to be 
lethal in Y. pseudotuberculosis, a dominant-negative N-terminal H-NS fragment (H-NS') 
encoded on a plasmid (pAKH31) was overexpressed in the Y. pseudotuberculosis wild type 
strain YPIII and ymoA-deficient strain YP50. The N-terminal H-NS fragment (H-NS'), missing 
the DNA-binding domain of H-NS, dimerizes with functional H-NS monomers. This leads to 
non-functional H-NS'/H-NS dimers with impaired DNA-binding function that are unable to 
silence rovA expression (Heroven, et al. 2004).  
Whole cell extracts of the ymoA mutant strain YP50 contained lower amounts of the RovA 
protein compared to samples of wild type strain YPIII. Inactivation of the H-NS-DNA-binding 
activity by introducing phns' into the wild type strain YPIII resulted in elevated levels of 
RovA. RovA levels of a Y. pseudotuberculosis strain expressing non-functional H-NS' in the 
absence of ymoA (YP50 phns') were significantly reduced in comparison to the parent strain 
producing inactive H-NS' (YPIII phns') and the Y. pseudotuberculosis wild type strain YPIII 
(Fig. 13).  
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Fig. 13. YmoA and H-NS independently regulate RovA synthesis. Whole cell extracts were prepared from 
overnight culture samples at 25°C of Y. pseudotuberculosis wild type strain YPIII and ymoA mutant strain YP50 
containing the empty vector pV (pAKH32) or phns' (pAKH31). Proteins were separated by 15% SDS gel 
electrophoresis and immunoblotted using a polyclonal anti-RovA antibody. For control of unspecific antibody 
detection whole cell extract of the rovA mutant strain YP3 was analyzed. A protein molecular weight marker 
was loaded on the left. The RovA protein is marked by an arrow. 
Deletion of ymoA in Y. pseudotuberculosis repressed RovA synthesis whereas non-functional 
H-NS'-dimers induced RovA production. H-NS inactivation in a Y. pseudotuberculosis ymoA 
mutant did not restore wild type levels of RovA protein. This indicates that YmoA regulation 
of RovA synthesis does not occur through inactivation of H-NS-mediated silencing of rovA 
transcription.   
Despite H-NS, also the LysR regulator RovM represses rovA transcription. RovM interacts 
with a short site upstream of the rovA promoter P1 (Heroven and Dersch 2006; Lawrenz and 
Miller 2007). To analyze whether YmoA affects rovA gene transcription through RovM, 
expression of a plasmid-encoded rovA-lacZ fusion (pAKH47) was determined in 
Y. pseudotuberculosis wild type (YPIII), ymoA mutant (YP50), a rovM mutant (YP72) and a 
ymoA/rovM-deficient strain (YP73). β-galactosidase activity was monitored from overnight 
cultures and whole cell extracts were prepared to examine RovA protein levels. β-galactosidase 
activity of rovA-lacZ fusion in a ymoA mutant was reduced to about 50% of the wild type 
expression. In a rovM mutant strain, rovA expression was about twofold increased compared 
to the wild type independent whether YmoA was present or not (Fig. 14A). 
Immunoblotting with an anti-RovA antibody confirmed this result and showed that RovA 
protein levels are downregulated in a ymoA mutant strain, whereas an increase of RovA 
production was observed in whole cell extracts of a rovM and a rovM/ymoA mutant strain 
compared to the wild type strain. (Fig. 14B). 
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Fig. 14. YmoA activates rovA expression indirectly through RovM. A. To monitor rovA promoter activity, 
plasmid pAKH47 encoding a rovA-lacZ fusion was introduced into Y. pseudotuberculosis wild type strain YPIII, 
the ymoA mutant strain YP50, the rovM mutant strain YP72 and the ymoA/rovM double mutant strain YP73. 
β-galactosidase activity was measured from overnight cultures in LB medium at 25°C. The enzyme activity is 
given in µmol/(min·mg). Data show mean values ± standard deviation of three independent experiments, each 
performed in duplicate. B.  Cultures of Y. pseudotuberculosis YPIII, YP50 (ymoA-), YP72 (rovM -) and YP73 
(ymoA -/rovM -) were grown overnight at 25°C. Samples were withdrawn, the OD600nm was adjusted and whole 
cell extracts were prepared. Using 15% SDS gel electrophoresis proteins were separated, transferred onto an 
Immobilon membrane and RovA was detected by immunoblotting with a polyclonal anti-RovA antibody. The 
molecular weight marker is loaded on the left and the RovA protein marked by an arrow.  
The previous experiments demonstrated that YmoA induces RovA production at the 
transcriptional level. Absence of RovM derepressed rovA transcription in the presence and 
absence of YmoA indicating that YmoA regulates rovA expression upstream of RovM 
(Fig. 13). In addition, YmoA might affect RovA on the post-transcriptional level, since slightly 
lower amounts of the RovA protein were detectable in the ymoA/rovM double mutant 
compared to a rovM mutant although rovA transcription remained unaffected. 
To determine whether YmoA regulates rovA expression by controlling RovM synthesis, the 
YmoA influence on a rovM '-'lacZ fusion (pAKH63) and on RovM protein levels was tested. 
To do so, the rovM '-'lacZ fusion plasmid was transformed in Y. pseudotuberculosis wild type 
(YPIII) and the ymoA mutant strain (YP50). To determine the effect of ymoA overexpression 
and complementation of the ymoA mutant, the ymoA expression plasmid (pAKH71) was also 
introduced into the wild type and the ymoA-deficient strain. β-galactosidase activity was 
measured from overnight cultures and samples for whole cell extracts were prepared to 
monitor the RovM protein amount within the cells. Expression of the rovM '-'lacZ fusion was 
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highly induced in a ymoA mutant strain in contrast to wild type whereas addition of the 
ymoA+ plasmid fully complemented the ymoA deletion (Fig. 15A). 
Analysis of RovM protein levels in the wild type and the ymoA mutant strain confirmed these 
data. Significantly higher levels of RovM were observed in the ymoA mutant strain and 
introduction of a ymoA+ plasmid reduced RovM to levels found in the wild strain (Fig. 15B).  
A 
 
B 
Fig. 15. YmoA represses rovM. A. The impact of YmoA on rovM gene expression was determined by 
measuring the β-galactosidase activity of a plasmid-encoded rovM-lacZ fusion (pAKH63) in 
Y. pseudotuberculosis YPIII and YP50 (ymoA -) transformed with the empty vector pV (pAKH85) or pymoA+ 
(pAKH71). β-galactosidase activity was examined in overnight cultures in LB medium at 25°C and is given in 
µmol/(min·mg). The data represents the mean ± standard deviation of three independent experiments, each 
performed in duplicate. B. To monitor RovM protein levels whole cell extract were prepared from overnight 
culture samples of strains as described above. Proteins were separated by 12% SDS gel electrophoresis, 
transferred onto an Immobilon membrane by Western blotting and RovM was detected with polyclonal anti-
RovM antibody. A molecular weight marker was loaded on the left and RovM is marked by an arrow.  
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These results suggest that YmoA negatively controls rovM expression in 
Y. pseudotuberculosis. Absence of YmoA results in a strong activation of RovM protein 
synthesis which in turn represses rovA transcription together with H-NS. 
3.1.2 YmoA represses rovM expression through the Csr system 
Synthesis of the LysR regulator RovM of Y. pseudotuberculosis is controlled by the Csr 
system in response to nutrient availability. The RNA-binding protein CsrA stimulates RovM 
protein production indirectly. This function is inhibited by two untranslated regulatory RNAs, 
CsrC and CsrB. Synthesis of these RNAs is strongly induced in complex medium but repressed 
in minimal medium (Heroven, et al. 2008). 
To determine whether YmoA controls RovM synthesis by controlling csrA expression, a 
csrA'-'lacZ fusion (pKB63) was introduced into Y. pseudotuberculosis YPIII (wild type) and 
YP50 (ymoA -). Complementation of the ymoA deletion and overexpression of ymoA was 
tested by introduction of the ymoA+ plasmid pAKH71 into the ymoA mutant and the wild 
type strain, respectively. To measure csrA promoter activity, β-galactosidase activity of the 
promoter fusion was monitored and whole cell extracts were prepared to compare protein 
levels with an anti-CsrA antibody. Expression of the csrA'-'lacZ fusion was similar in the wild 
type and the ymoA mutant strain in the absence or presence of the ymoA+ plasmid 
(Fig. 16A). Furthermore, CsrA levels in a ymoA mutant were similar or only slightly reduced 
relative to the Y. pseudotuberculosis wild type strain, and no significant changes were 
observed in the both strains in the presence of the ymoA+ plasmid. (Fig. 16B). As a loss of 
ymoA in Y. pseudotuberculosis causes only mild effects on CsrA synthesis, YmoA seems to 
use a different mechanism to control RovM levels.  
A 
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Fig. 16. CsrA synthesis is not influenced by YmoA. A. csrA gene expression was monitored by expression of a 
plasmid-encoded csrA-lacZ fusion (pKB63) in Y. pseudotuberculosis YPIII and YP50 (ymoA -) harboring an 
empty vector pV (pAKH85) or pymoA+ (pAKH71). β-galactosidase activity was measured from overnight 
cultures, grown in LB medium at 25°C. The enzyme activity is given in µmol/(min·mg). The data shows the 
mean ± standard deviation of three independent experiments, each performed in duplicate. B. Cultures of 
Y. pseudotuberculosis YPIII and YP50 (ymoA -) harboring the empty vector pV (pAKH85) or pymoA+ 
(pAKH71) were grown overnight. The OD600nm of the samples withdrawn was adjusted and whole cell extracts 
were prepared. Using 18% TRICINE gel electrophoresis proteins were separated, transferred onto an Immobilon 
membrane and CsrA protein was detected by immunoblotting with a polyclonal anti-CsrA antibody. The 
molecular weight marker is loaded on the left and the CsrA protein is marked by an arrow. 
The Csr RNAs CsrC and CsrB downregulate RovM synthesis in Y. pseudotuberculosis by 
binding multiple (9–18) copies of the CsrA protein to their AGGA motifs in the loop 
structures of the regulated RNAs. Thereby, they sequester CsrA from interacting with their 
target mRNAs and inhibit CsrA mediated activation of RovM production (Dubey, et al. 2005; 
Heroven, et al. 2008). For that reason, it was evaluated whether YmoA influences expression 
of csrC and csrB. Expression of transcriptional csrC-lacZ (pAKH97) and csrB-lacZ (pAKH88) 
fusions was analyzed in Y. pseudotuberculosis YPIII (wild type) and YP50 (ymoA-). To 
complement the loss of ymoA in YP50, a plasmid carrying the ymoA gene (pAKH71) was 
introduced. The promoter activity was measured by determining the β-galactosidase activity 
of the reporter gene fusions in overnight cultures. Additionally, RNA samples were prepared 
and Northern blotting was performed with anti-CsrC and anti-CsrB probes to visualize the 
two Csr RNAs in the wild type and the ymoA mutant strain. Expression of the csrC-lacZ 
fusion was not significantly altered in the absence of the ymoA gene (Fig. 17A). Introduction 
of a ymoA+ plasmid to the ymoA mutant had only a small effect (30% reduction) on csrC 
transcription. However, CsrC RNA concentrations were significantly reduced in a ymoA 
mutant strain in contrast to CsrC levels in the wild type strain. Complementation of the ymoA 
deletion led to an increase of CsrC levels, but did not fully restore CsrC concentrations to wild 
type levels (Fig. 17A). 
In contrast, csrB transcription was 1.5fold induced in the ymoA-deficient strain relative to the 
wild type strain and ymoA was able to complement csrB expression although CsrB RNA levels 
were not fully restored (Fig. 17B). 
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Fig. 17. YmoA activates CsrC synthesis and represses csrB expression. A plasmid-encoded csrC-lacZ fusion 
(pAKH97) or csrB-lacZ fusion (pAKH88) was used to determine the expression of (A) the csrC or (B) csrB 
gene in Y. pseudotuberculosis YPIII and YP50 (ymoA -) carrying an empty vector pV (pAKH85). For 
complementation plasmid pymoA+ (pAKH71) was introduced into the ymoA mutant. β-galactosidase activity 
was examined in overnight cultures grown in LB medium at 25°C and is given in µmol/(min·mg). The data 
represent the mean ± standard deviation of three independent experiments, each performed in duplicate. 
Furthermore, overnight cultures of YPIII, YP50 (ymoA-), YP48 (csrC -) and YP51 (csrB -) were grown in LB 
medium at 25°C. Total RNA was prepared and used for Northern blot analysis. CsrC (A) and CsrB (B) RNAs 
were detected by hybridization using Dig-labeled specific DNA-probes. 23S and 16S rRNAs were used as loading 
controls. 
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Whereas csrC-lacZ transcription was independent of ymoA, CsrC RNA levels were strongly 
reduced in the absence of YmoA (Fig. 17A). This suggested that YmoA influences CsrC 
synthesis on the post-transcriptional level. Furthermore, YmoA affects CsrC and CsrB 
synthesis in an opposite manner. Most likely, YmoA controls expression of one RNA which in 
turn leads to counterregulation due to the negative autoregulatory control mechanism of CsrB 
and CsrC. 
3.1.3 YmoA regulates CsrC synthesis independently of CsrB  
Heroven et al. (2008) found, that CsrB in Y. pseudotuberculosis is activated by the 
UvrY/BarA two-component system in response to an unknown signal. For this reason it was 
analyzed whether YmoA regulates the expression of uvrY and barA. A barA'-'lacZ (pKB06) 
and a uvrY '-'lacZ (pKB07) fusion were introduced into Y. pseudotuberculosis YPIII (wild 
type) and YP50 (ymoA -) and β-galactosidase activity was measured from overnight cultures. 
To test the influence of overexpression and complementation of ymoA on uvrY and barA 
expression, the plasmid pymoA+ (pAKH71) was also introduced into wild type and ymoA 
mutant. As shown in Fig. 18A, barA-lacZ expression was not influenced by loss or 
overexpression of ymoA. In contrast, uvrY-lacZ expression was stimulated to about 1.5fold of 
the wild type promoter activity in a ymoA mutant strain and expression of ymoA reduced 
uvrY transcription to about 60% (Fig. 18B). In summary, YmoA seems to activate 
transcription of uvrY, independently of barA expression (Fig. 18).  
  
A 
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Fig. 18. YmoA represses uvrY expression. The  β-galactosidase activity of a (A) barA-lacZ fusion (pKB06) or 
(B) uvrY-lacZ fusion (pKB07) in Y. pseudotuberculosis YPIII and YP50 (ymoA -) harboring an empty vector pV 
(pAKH85) or pymoA+ (pAKH71) was measured from cultures grown overnight in LB medium at 25°C. The 
β-galactosidase activity is given in µmol/(min·mg). The data represent the mean ± standard deviation of three 
independent experiments, each performed in duplicate. 
Next, it was important to determine whether YmoA-dependent CsrC synthesis occurs through 
upregulation of CsrB RNA levels, which is compensated by downregulation of csrC expression 
through an unknown negative control mechanism (Heroven, et al. 2008). RNA was prepared 
from Y. pseudotuberculosis YPIII (wild type) and YP50 (ymoA -), YP69 (csrB -) and YP75 
(ymoA-/csrB -). To measure the outcome of the Csr control system the activity of a CsrA-
dependent translational rovM '-'lacZ fusion (pAKH63) was determined in overnight cultures of 
these strains, and Western blot analysis was performed to detect RovM by immunoblotting. 
CsrC RNA levels were reduced significantly in the ymoA-deficient strain compared to the wild 
type. Loss of the csrB gene leads to slightly higher CsrC RNA levels whereas CsrC synthesis in 
a ymoA/csrB double mutant strain is drastically repressed similar to a ymoA mutant strain 
(Fig. 19A). 
In agreement with previous results, rovM expression and RovM synthesis are regulated in the 
opposite manner. Deletion of ymoA induces rovM transcription, whereas a loss of csrB had no 
effect. Expression of rovM in a ymoA/csrB double mutant was still strongly increased and 
significantly higher amounts of the RovM protein were detectable, similar to the ymoA-
deficient strain (Fig. 19B). 
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Fig. 19. YmoA regulates CsrC independently of CsrB. A. Total RNA was prepared from overnight cultures of 
Y. pseudotuberculosis YPIII, YP50 (ymoA -), YP69 (csrB -) and YP75 (ymoA -/csrB -) grown in LB medium at 
25°C. The RNA was separated and transferred onto a membrane by Northern blotting. CsrC RNA was detected 
by a specific Dig-labeled probe. 16S rRNA was visualized as a loading control. B. rovM-lacZ expression was 
measured in YPIII, YP50, YP69 and YP75 harboring pAKH63. β-galactosidase activity was determined from 
overnight cultures in LB medium at 25°C and is given in µmol/(min·mg). The data represent the mean ± 
standard deviation of three independent experiments, each performed in duplicate. 
Taken together, absence of YmoA led to a strong reduction of CsrC levels in a csrB + and 
csrB-deficient strain. This demonstrated that YmoA activates CsrC production independently 
of csrB expression. 
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3.1.4 YmoA influences CsrC RNA stability 
Previous experiments of this study (Fig. 17A) demonstrated that loss of ymoA does affect 
CsrC levels but not expression of a csrC-lacZ fusion. To analyze how YmoA influences CsrC 
RNA post-transcriptionally, a set of transcriptional csrC-lacZ fusions was constructed, 
harboring csrC fragments with varying portions of the csrC gene, i.e. up to position +4, +39, 
+61, +71, +81, +254 relative to the transcriptional start point. Y. pseudotuberculosis YPIII 
(wild type) and YP50 (ymoA-) were transformed with pcsrC(+4)-lacZ (pAKH103), 
pcsrC(+39)-lacZ (pAKH106), pcsrC(+61)-lacZ (pAKH107), pcsrC(+71)-lacZ (pKB20), 
pcsrC(+81)-lacZ (pAKH76) or pcsrC(+254)-lacZ (pAKH104) and β-galactosidase activity 
was measured from overnight cultures (Fig. 20A). Transcription activity of csrC fused to the 
lacZ gene at positions +39, +61, +71, +81 and +254 in the wild type strain YPIII was 
reduced to circa 60-70% of csrC(+4)-lacZ with only the first 4 nucleotides of the csrC gene. 
Expression of csrC fused to lacZ at position +4, +39 and +61 was identical in the wild type 
and the ymoA mutant strain. In contrast, csrC expression of csrC(+71)-lacZ, csrC(+81)-lacZ, 
csrC(+254)-lacZ expression was about 50% lower in the absence of YmoA. (Fig. 20B). 
  
A
B
Fig. 20. YmoA activates expression of csrC 5' transcripts harboring the first 71 nt of the csrC gene. 
A. Constructed csrC-lacZ fusions with varying 3' ends of csrC. B. Transcription activity of pcsrC(+4)-lacZ 
(pAKH103), pcsrC(+39)-lacZ (pAKH106), pcsrC(+61)-lacZ (pAKH107), pcsrC(+71)-lacZ (pKB20), 
pcsrC(+81)-lacZ (pAKH76) or pcsrC(+254)-lacZ (pAKH104) in Y. pseudotuberculosis YPIII and YP50 (ymoA-) 
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was determined by measuring β-galactosidase activity of overnight cultures grown in LB medium at 25°C. 
β-galactosidase activity is given in µmol/(min·mg). The data represent the mean ± standard deviation of three 
independent experiments, each performed in duplicate. 
Extending 3' portions of the csrC gene lead to reduced expression of the csrC-lacZ fusions. 
This indicates that an increasing length of the CsrC transcripts might interfere with the 
translation of the lacZ gene. Transcription of at least 71 nucleotides of the csrC gene was 
required for YmoA-mediated activation of csrC expression whereas expression of csrC-lacZ 
fusion with shorter csrC portions was independent of YmoA. 
Computational analysis of the CsrC RNA structure by Mfold (http://mfold.bioinfo.rpi.edu/cgi-
bin/rna-form1.) revealed that the first 61 nucleotides of CsrC form a stem-loop structure 
(Fig. 21A). To test, whether this loop influences csrC-lacZ expression, a sequence from 
position +24 to +57 (Fig. 20A) relative to the transcription start was deleted from a 
csrC(+81)-lacZ fusion (pKB17) and introduced into Y. pseudotuberculosis YPIII (wild type) 
and YP50 (ymoA -). Expression of csrC(+81)-lacZ fusion in a ymoA mutant was reduced to 
about 50% of the wild type level. The deletion of the +24 to +57 region also downregulated 
csrC-lacZ expression to circa 50% regardless of the presence or absence of the ymoA gene 
(Fig. 21B).  
To confirm these results and to analyze whether the csrC fragment from position +24 to +57 
is important for YmoA regulation and CsrC stability, CsrC and CsrC (∆+24 to +57) RNA 
levels were monitored in the wild type and the ymoA mutant strain. To monitor CsrC RNA 
levels, plasmids carrying the wild type csrC gene (pKB59) or csrC with a deletion from 
positions +24 to +57 (pKB49) were introduced into Y. pseudotuberculosis YPIII (wild type) 
and YP50 (ymoA -). In agreement to the csrC-lacZ expression data, significantly lower levels 
of CsrC RNA were found when nucleotides +24 to +57 relative to the transcription start were 
deleted. In the ymoA mutant, the overall concentration of the CsrC and the CsrC (∆+24 to 
+57) RNA was significantly reduced, whereby amounts of the CsrC RNA were slightly higher 
than that of the deletion variant (Fig. 21C). 
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Fig. 21. Deletion of the first secondary loop formation in the CsrC RNA destabilizes CsrC synthesis. 
A. Secondary structure prediction of CsrC from nucleotide +1 to +102 generated by Mfold 
(http://mfold.bioinfo.rpi.edu/cgi-bin/rna-form1.cgi). The transcription start (+1) and positions 24 and 57, 
which represent the 5' and 3' end of the deletion, are indicated. B. β-galactosidase activity was measured in 
overnight cultures at 25°C of Y. pseudotuberculosis YPIII and YP50 (ymoA-) carrying a csrC(+81)-lacZ 
(pAKH76) or csrC(+81; ∆ +24 - +57)-lacZ (pKB17) fusion. Enzyme activity is given in µmol/(min·mg). The 
data represent mean values ± standard deviation of three independent experiments, each performed in 
duplicate. C. For Northern blot analysis, total RNA was prepared from overnight cultures of 
Y. pseudotuberculosis YPIII and YP50 (ymoA-) harboring csrC+ (pKB59) and csrC(∆+24 - +57) (pKB49) 
plasmids. Total RNA was separated and transferred onto a Nytran membrane. CsrC was detected with specific 
Dig-labeled DNA probe. 
This demonstrated that formation of the first stem loop of CsrC RNA enhance RNA synthesis, 
most likely by promoting a stable RNA structure. Although expression of the CsrC 
(∆+24 to +57) RNA is identical in the wild type and the ymoA mutant, intracellular RNA 
concentrations are still somewhat reduced in the absence of YmoA. This implies that in 
addition to the 5' hairpin structure also other portions of the CsrC RNA are stabilized by 
YmoA. 
To further proof that YmoA regulates CsrC on the post-transcriptional level, the csrC 
promoter was exchanged by an inducible promoter, to exclude YmoA influence on csrC 
transcription. First, a Ptet -lacZ (pTT01) fusion was transformed into wild type strain and the 
ymoA mutant to determine, whether YmoA affects transcription of the Ptet promoter. No 
difference of the Ptet -lacZ expression was detectable between the wild type and the ymoA 
mutant demonstrating that Ptet expression is independent of ymoA (Fig. 22A). 
In the following, a plasmid encoding csrC transcribed from the Ptet promoter (pKB47) was 
introduced into wild type strain YPIII and the ymoA mutant YP50. The strains were 
cultivated in minimal medium overnight to prevent expression of the chromosomal csrC gene, 
which was previously shown to be repressed under these conditions (Heroven, et al. 2008).  
In fact, synthesis of CsrC from the chromosome in the wild type and the ymoA mutant strain 
was abolished under these cultivation conditions. Strikingly, high CsrC levels were found in the 
wild type strain expressing csrC from the Ptet promoter, whereas the amount of CsrC was 
strongly reduced in the ymoA mutant (Fig. 22B). These results support the hypothesis, that 
YmoA is responsible for post-transcriptional activation of CsrC synthesis, most likely by 
regulation of the CsrC RNA stability. 
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Fig. 22. YmoA-mediated act ivat ion of CsrC synthesis occurs on the post-transcr ipt ional level .  
A. Y. pseudotuberculosis YPIII and YP50 (ymoA-) harboring the Ptet -lacZ plasmid (pTT01) were grown overnight 
in MMA medium at 25°C. β-galactosidase activity is given in in µmol/(min·mg). The data represent mean values 
± standard deviation of three independent experiments, each performed in duplicate. B. Total RNA was prepared 
from samples of Y. pseudotuberculosis YPIII and YP50 (ymoA-) carrying an empty vector pV (pHSG575) or 
Ptet::csrC (pKB47). Strains were cultivated overnight in minimal medium at 25°C. Total RNA was prepared for 
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Nothern blot analysis and CsrC was detected by a specific Dig-labeled probe. The 16S and 23S rRNAs served as 
loading controls.  
3.1.5 CsrC RNA stability in Y. pseudotuberculosis is affected by YmoA in 
a CsrA-independent manner 
In Y. pseudotuberculosis, the CsrC RNA is not detectable, when CsrA is absent (Heroven, et 
al. 2008). In order to test, whether CsrA affects synthesis of CsrC on the post-transcriptional 
level, csrC-lacZ fusions with varying csrC gene lengths to position +4 (pAKH103), +39 
(pAKH106), +61 (pAKH107), +71 (pKB20), +81 (pAKH76) and +254 (pAKH104) were 
expressed in Y. pseudotuberculosis YPIII and the isogenic csrA mutant strain YP53. 
β-galactosidase activity was measured from overnight cultures. 
In contrast to the ymoA mutant background, expression analysis of the different csrC-lacZ 
fusions revealed similar or only slightly different expression levels in the wild type and the csrA 
mutant. This indicates that CsrA influence on CsrC might be independent of YmoA and vice 
versa (Fig. 23). 
 
Fig. 23. CsrA has no influence on csrC-lacZ expression. Transcription activity of pcsrC(+4)-lacZ (pAKH103), 
pcsrC(+39)-lacZ (pAKH106), pcsrC(+61)-lacZ (pAKH107), pcsrC(+71)-lacZ (pKB20), pcsrC(+81)-lacZ 
(pAKH76) or pcsrC(+254)-lacZ (pAKH104) transformed into Y. pseudotuberculosis YPIII and YP53 (csrA-) was 
determined by measuring the β-galactosidase activity in overnight cultures in LB medium at 25°C. β-galactosidase 
activity is given in µmol/(min·mg). The data represent mean values ± standard deviation of three independent 
experiments, each performed in duplicate. 
Fortune et al. (2006) found, that the Csr-type RNAs in Salmonella were stabilized by the 
presence of CsrA. To address whether CsrA is also required for CsrC stability, csrC was 
expressed under the control of the tet promoter (Ptet) and CsrC levels were monitored in 
Y. pseudotuberculosis YPIII (wild type) and YP53 (csrA-) grown overnight in minimal medium 
at 25°C. Although activity of Ptet was per se not reduced in a csrA mutant (Fig. 24A), CsrC 
RNA transcribed from Ptet was only detectable in the wild type and not in the csrA-deficient 
strain (Fig. 24B). This indicates that CsrA influences CsrC on the post-transcriptional level. 
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Fig. 24. CsrA is required for the presence of CsrC. The β-galactosidase activity of a Ptet -lacZ fusion encoded 
on pTT01 introduced into Y. pseudotuberculosis YPIII and YP53 (csrA-) was measured from overnight cultures 
in MMA medium at 25°C. The enzyme activity is given in µmol/(min·mg). The data represent mean values ± 
standard deviation of three independent experiments, each performed in duplicate. B. CsrC was detected by 
Northern blot analysis with specific Dig-labeled probes using total RNA prepared from samples of YPIII and 
YP53 (csrA-) harboring an empty control vector pV (pHSG575) or pPtet::csrC (pKB47). Strains were cultivated 
in MMA medium overnight at 25°C. The 16S and 23S rRNAs served as loading controls. 
Previous experiments demonstrated that YmoA and CsrA have a positive influence on the 
CsrC RNA and exert their influence on the post-transcriptional level. Most likely, they affect 
the decay of the CsrC RNA. In order to analyze the impact of YmoA and CsrA on CsrC 
stability in Y. pseudotuberculosis, RNA stability assays were performed. CsrC was not 
detectable in a csrA mutant when expressed from its own promoter or Ptet under non-inducing 
conditions (Heroven, et al. 2008; Fig. 24B). To allow higher CsrC expression in the absence of 
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csrA, the csrA mutant strain YP53 carrying pPtet::csrC (pKB47) was grown in the presence of 
0.1, 0.25, 0.5 and 1 nM anhydrotetracycline to induce the Ptet promoter. As shown in Fig. 25, 
increasing CsrC RNA levels were detected at AHT concentration from 0.1 to 1 nM, but the 
overall concentration was still very low in comparison to CsrC production in the wild type 
strain. 
 
Fig. 25. Ptet::csrC induction analysis in a csrA mutant. A plasmid encoding the csrC gene under the control of 
the tet promoter was introduced into Y. pseudotuberculosis YPIII and YP53 (csrA-) and cultivated overnight in 
MMA medium at 25°C. Subsequently, 0.1, 0.25, 0.5 and 1 nM AHT were added to the csrA-deficient strain and 
1 nM to the wild type culture. Total RNA was isolated from samples withdrawn after growth for two hours, 
separated and CsrC was detected by Northern blotting using a specific Dig-labeled probe. 
To further analyze the influence of CsrA on CsrC stability, Y. pseudotuberculosis YPIII (wild 
type), YP50 (ymoA-) and YP53 (csrA-) expressing Ptet::csrC from plasmid pKB47 were 
cultivated in minimal medium to early stationary phase. To allow CsrC production in the csrA 
mutant background 0.5 nM of the inducer AHT was added. Subsequently, transcription was 
inhibited by the addition of rifampicin to a final concentration of 500 μg/ml. Samples were 
withdrawn at indicated time points and CsrC was detected by Northern blot analysis using 
CsrC-specific probes. The intensities were calculated relative to CsrC amount at the starting 
point (Fig. 26A/B “0 min.”) of the experiment. 
CsrC was only slowly degraded with a half-life of about 116 min in Y. pseudotuberculosis wild 
type. In contrast, a significantly faster degradation of CsrC was observed in ymoA- and csrA- 
mutants. In the csrA mutant, the CsrC RNA was rapidly degraded with a half-life of circa 
11 min (Fig. 26A). CsrC RNA concentrations in a ymoA mutant decreased steadily with a 
half-life of approx. 46 min (Fig. 26B).  
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Fig. 26. YmoA and CsrA stabilize the CsrC RNA. CsrC RNA stability was determined in Y. pseudotuberculosis 
YPIII in comparison to YP53 (csrA-) (A) and YP50 (ymoA-) (B). All strains harboring pPtet::csrC (pKB47) were 
cultivated in MMA medium overnight at 25°C. csrC expression in csrA mutant was induced by addition of 
0.5 nM AHT and cultured for two additional hours at 25°C. Transcription was inhibited by the addition of 
rifampicin at a final concentration of 500 μg/ml. Samples were taken every 10 minutes to investigate stability in 
the csrA mutant (red line) (A) or 20 minutes to study CsrC stability in the ymoA mutant (green line) (B). The 
total RNA was prepared, separated and CsrC was detected by Northern blotting using a CsrC-specific DNA-probe. 
16S and 23S rRNAs served as loading controls. Northern blots were documented by a gel doc system (Biorad) and 
analyzed by Biorad Image LabTM Software. Data are presented in relative CsrC RNA concentration units plotted 
against the time (min). Dotted lines mark time points when half of the RNA amount was degraded. Dashed lines 
represent the line of best fit. 
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Taken together, CsrC is less stable in both, a csrA and ymoA mutant. RNA amounts decline 
much faster in a Y. pseudotuberculosis csrA mutant than in a ymoA-deficient strain, which 
suggests that binding of CsrA to CsrC might stabilize RNA and prevent degradation by 
RNases. YmoA affects the RNA stability to a smaller extent. Taking into account, that YmoA 
does not influence CsrA synthesis, the nucleoid-associated protein might promote proper 
folding of the CsrC RNA, which facilitates CsrA binding and might thus have an indirect 
influence on CsrC RNA stability. 
Furthermore, it was tested whether overexpression of ymoA can complement the loss of csrA 
and vice versa. Therefore, low copy plasmids carrying ymoA (pKB4) or csrA (pKB60) were 
introduced into Y. pseudotuberculosis YPIII (wild type), YP50 (ymoA-) and YP53 (csrA-). 
Total RNA was prepared from overnight cultures and CsrC was detected by Northern blotting 
using a CsrC-specific probe. In comparison to Y. pseudotuberculosis wild type CsrC synthesis, 
no RNA was detected in the ymoA and the csrA mutants. Overexpression of ymoA or csrA 
led to higher CsrC amounts in the wild type strain. Furthermore, CsrC synthesis in the csrA- 
and ymoA-deficient strains was fully restored by addition of the csrA+ plasmid. Strikingly, no 
CsrC RNA was detectable in a csrA mutant expressing ymoA, whereas wild type levels of 
CsrC were observed in a ymoA mutant in the presence of the ymoA+ plasmid (Fig. 27).   
This clearly showed that loss of CsrC in a ymoA mutant strain can be complemented by csrA 
overexpression. In contrast, the YmoA protein is not able to restore the function of the CsrA 
protein on CsrC stability. 
 
 
Fig. 27. YmoA and CsrA do not fully complement CsrC synthesis.To monitor CsrC synthesis by Northern blot 
analysis, Y. pseudotuberculosis YPIII and YP53 (csrA-) and YP50 (ymoA-) were transformed with an empty vector 
pV (pHSG576), pymoA+ (pKB4) or pcsrA+ (pKB60) and cultivated in LB medium overnight at 25°C. Total RNA 
was prepared, separated and the CsrC RNA was visualized after transfer to a Nytran membrane by hybridization 
with a specific Dig-labeled DNA probe. 
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These results suggest that influence of CsrA and YmoA on CsrC RNA stability is different. 
CsrA seems to be far more essential for CsrC stability than the nucleoid-associated protein 
YmoA. It is possible, that YmoA supports CsrA-mediated stabilization of the CsrC transcript. 
In fact, another nucleoid-associated protein, StpA of the H-NS family, has been demonstrated 
to bind RNA and act as a chaperone facilitating RNA folding and base pairing (Mayer, et al. 
2007). For this reason, it should be determined whether YmoA is also able to bind to the 
CsrC RNA and thereby enhances CsrA-mediated CsrC stability. To do so, N-terminal Strep-
tagged YmoA protein (pAKH77) was purified from an E. coli strain (KB4) which is deficient 
in hns, stpA and hha, e.g. all E. coli homologs of the YmoA and H-NS families. Subsequently, 
RNA-bandshift experiments were performed with CsrC and the 5S rRNA as a negative control 
using increasing amounts of YmoA protein. 
 
Fig. 28. YmoA does not interact with the CsrC RNA. In vitro transcribed CsrC RNA and 5S rRNA were 
incubated for 30 min at room temperature with purified 9.3, 18.5, 37 and 74 μM of N-terminal Strep-tagged 
YmoA (lane 2 to 5, respectively). As a control CsrC and 5S rRNA were incubated with 1 x RNA-bandshift buffer 
(lane 1). Samples were separated in an 8% non-denaturing polyacrylamide gel and visualized by SybrGreen staining 
under UV light. 
As shown in Fig. 27, Strep-tagged YmoA did not interact with CsrC RNA even at higher 
protein concentrations, indicating that the influence of the nucleoid-associated protein on 
CsrC stability in Y. pseudotuberculosis is indirect and occurs via another regulatory factor. 
3.1.6 Control of YmoA and CsrA synthesis influences CsrC levels in 
response to environmental signals 
Production of RovA and RovA-dependent invasin synthesis are regulated by specific 
environmental conditions. Their expression is induced in complex medium, during stationary 
growth and at moderate temperatures. Furthermore, CsrA has been shown to be responsible 
for medium-dependent activation of RovM production, which abolished rovA expression 
(Heroven, et al. 2008). To further characterize how the regulatory network of rovA reponses 
to environmental signals, YmoA and CsrA synthesis conditions were addressed in detail. Since 
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CsrC of Y. pseudotuberculosis has been reported to be synthesized only in nutrient-rich, but 
not under minimal medium conditions, CsrA and YmoA protein levels of Y. pseudotuberculosis 
wild type strain YPIII were monitored in minimal medium MMA and complex medium LB at 
25°C and 37°C in exponential and stationary phase (Fig. 29). Expression of the csrA gene was 
subjected to growth phase control. Significantly higher amounts where found during the 
stationary phase. In contrast, temperature and growth media had no considerable effect on 
CsrA synthesis (Fig. 29A). In contrast, YmoA protein levels were observed to be strongly 
dependent on media, temperature and growth phase. Maximal expression was observed at 
moderate temperature, in complex medium and during exponential growth whereas lowest 
expression was seen at 37°C in minimal medium during stationary phase (Fig. 29B). 
A 
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Fig. 29. CsrA and YmoA protein synthesis is regulated by environmental parameters. To monitor CsrA and 
YmoA levels during stationary growth, Y. pseudotuberculosis wild type strain YPIII was cultivated overnight in LB 
and minimal medium MMA at 25°C and 37°C. For exponential growth, overnight culture were diluted 1:50 in LB 
or minimal medium MMA and cultivated at 25°C and 37°C until cultures reached an OD600nm of about 0.8. 
Samples were withdrawn, the OD600nm was adjusted and whole cell extracts were prepared. Proteins were separated 
by 18%-20%TRICINE-PAGE and transferred onto an Immobilon membrane. A. CsrA was detected with a 
polyclonal anti-CsrA antibody. Cell extract from a csrA mutant strain YP53 culture was used as a control. 
B. YmoA protein was detected with a polyclonal anti-YmoA antibody. Cell extract from a ymoA mutant strain 
YP50 culture was used as a control. Molecular weight ladder was applied on the left. CsrA and YmoA protein 
bands were marked by arrows. 
Absence of YmoA and the reduced levels of CsrA protein at 37°C in minimal medium during 
exponential growth could explain the reduced stability of CsrC under these conditions. 
Otherwise, both proteins are present at 25°C. This could lead to higher CsrC levels, in 
particular during exponential phase. 
To analyze temperature and growth phase regulation and its influence on CsrC synthesis, in 
more detail, CsrA and YmoA protein levels as well as CsrC RNA amounts were detected along 
the growth curve of Y. pseudotuberculosis wild type strain YPIII grown in LB medium at 25°C 
and 37°C. Whole cell extracts and total RNA were prepared from samples withdrawn every 
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two hours from an over-day culture. At 25°C, CsrC levels were found to be low during early 
exponential phases but increased significantly during the transition from exponential to 
stationary growth with maximal amounts of CsrC during stationary phase (OD600nm=4.0). At 
37°C, CsrC amounts were found to be highest at an OD600nm of about 2.7, when 
Y. pseudotuberculosis entered early stationary growth phase, but CsrC levels decreased again 
during stationary phase (Fig. 30). Different CsrC concentration patterns seem to be the result 
of different CsrA and YmoA levels. Whereas the concentration of the CsrA protein increased 
during stationary growth phase at 25°C as well as 37°C, overall CsrA levels were significantly 
higher at moderate temperatures. In contrast, high levels of YmoA were only detectable 
during exponential growth (OD600nm=3.0), but the amounts of YmoA decreased strongly 
during stationary growth. Overall, significantly higher YmoA concentrations were detectable in 
Y. pseudotuberculosis at moderate temperature, e.g. no protein was observed during 
stationary growth at 37°C (Fig. 30).  
In summary, highest CsrC levels were detected in Y. pseudotuberculosis when CsrA reached 
intermediate levels and YmoA is still present. This indicates that CsrC stability is the result of 
balanced YmoA and CsrA levels under specific environmental conditions, especially at low 
temperatures, high cell density and in nutrient-rich medium. 
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Fig. 30. CsrC, YmoA and CsrA levels are regulated by growth phase and temperature in 
Y. pseudotuberculosis. Y. pseudotuberculosis wild type strain YPIII was diluted 1:100 from an overnight culture 
and grown in LB medium at 25°C (blue) and 37°C (red). Samples were taken simultaneously every two hours and 
the OD600nm to monitor growth. For CsrC detection, total RNA was prepared from the samples, separated and CsrC 
was detected by Northern blot analysis using a CsrC-specific Dig-labeled DNA probe. To detect YmoA and CsrA 
by specific polyclonal antibodies, the cell density of the samples was adjusted and whole cell extracts were 
prepared. Proteins were separated on 18% (CsrA) and 20% (YmoA) TRICINE gels and visualized by 
immunoblotting. 
YmoA levels seem to be strongly dependent on temperature. Jackson et al. (2004) observed 
that YmoA in Y. pestis is rapidly degraded at 37°C by ATP-dependent ClpXP and Lon 
proteases. To study whether also YmoA of Y. pseudotuberculosis was subjected to 
temperature-regulated proteolysis, YmoA protein levels were analyzed in overnight cultures of 
Y. pseudotuberculosis wild type (YPIII), and isogenic clpP (YP63), lon (YP67) and clpP/lon 
double (YP68) mutant strains.  
Whereas YmoA protein was present in Y. pseudotuberculosis wild type at 25°C, it was not 
detectable at 37°C. Absence of clpP resulted in elevated YmoA amounts at both temperatures 
compared to the wild type, although significantly lower protein levels were observed at 37°C. 
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In a lon mutant, YmoA degradation was significantly reduced at 37°C and no temperature-
dependent proteolysis of YmoA was observed in the clpP/lon double mutant (Fig. 31). These 
results suggest that YmoA in Y. pseudotuberculosis is degraded by the ATP-dependent ClpP 
and the Lon protease in a temperature-dependent manner, i.e. degradation at 37°C. 
 
Fig. 31. YmoA is degraded by ATP-dependent Clp/Lon proteases in response to temperature. Whole cell 
extracts were prepared from overnight culture samples of Y. pseudotuberculosis YPIII, YP63 (clpP -), YP64 (lon -) 
and YP67 (clpP/lon -) grown at 25°C and 37°C. Whole cell extract of YP50 (ymoA-) was used as negative control. 
Proteins were separated by 20% TRICINE-PAGE, followed by immunoblotting. YmoA was visualized by a 
polyclonal anti-YmoA antibody. A molecular weight ladder is loaded on the left. YmoA protein is marked by an 
arrow. 
3.1.7 The chaperone Hfq induces CsrC and CsrB synthesis and activates 
rovA expression 
The RNA chaperone Hfq has previously been shown to increase the stability of Rsm (Csr) 
RNAs whereby it enhances the sequestration of the CsrA-like protein RsmA in P. aeruginosa 
(Sorger-Domenigg, et al. 2007). As Hfq has also been found to influence rovA expression in 
Y. pseudotuberculosis (A. K. Heroven, unpublished data), the influence of Hfq on the 
regulatory cascade (e.g. RovM and the Csr-system) was analyzed.  
Western blot analysis were performed using whole cell extracts of YPIII and the isogenic hfq 
mutant strain YP80 with or without the hfq+ plasmid pAKH115 to visualize RovA and RovM 
regulator proteins (Fig. 32). In an hfq mutant, RovA levels were significantly reduced 
compared to the wild type. Overexpression of hfq restored RovA levels in an hfq mutant and 
resulted in slightly higher amounts of RovA in the wild type strain. Opposite expression levels 
were observed for the RovM protein. Significantly higher RovM levels were detected in the 
hfq-deficient strain whereas slightly lower amounts of RovM were detected in the presence of 
the hfq+ plasmid in both, the wild type and the hfq mutant. Hence, Hfq activates rovA 
expression by downregulation of RovM synthesis.  
Because RovM synthesis is controlled by the Csr system, influence of the RNA chaperone Hfq 
on the presence of the CsrC and CsrB RNA was evaluated. To do so, total RNA was prepared 
from YPIII (wild type) and YP80 (hfq -) with the empty vector or the hfq+ plasmid. CsrB and 
CsrC were visualized by Northern blotting using CsrB- and CsrC-specific probes. In addition, 
whole cell extracts were prepared of these strains. CsrA was detected by immunoblotting. 
CsrA levels remained identical in all strains, demonstrating that CsrA production is 
independent of hfq. In contrast, the CsrC RNA was observed in Y. pseudotuberculosis wild 
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type but not in an hfq mutant and overexpression of hfq resulted in significantly higher 
amounts in the wild type and the hfq mutant strain 
CsrB levels were very low in the wild type and could not be detected in the hfq-deficient 
strain. In contrast, hfq overexpression from a plasmid resulted in slightly higher amounts of 
CsrB in the wild type or the hfq mutant (Fig. 32B). 
A
B
Fig. 32. Hfq activates RovA synthesis by downregulation of RovM synthesis through upregulation of the Csr 
RNAs. Y. pseudotuberculosis YPIII and YP80 (hfq -) carrying an empty vector pV (pAKH85) or hfq+ plasmid 
(pAKH115) were cultivated overnight in LB medium at 25°C. A. For detection of RovA and RovM protein, whole 
cell extracts were prepared, separated by 15% (RovA) or 12% (RovM) SDS-PAGE and transferred onto an 
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Immobilon membrane. RovM and RovA were visualized by specific polyclonal antibodies. A molecular weight ladder 
is loaded on the left and RovM or RovA are marked by arrows. B. CsrA protein levels were determined by Western 
blotting. Whole cell extracts from strains described above were prepared, separated by 18% TRICINE-PAGE and 
CsrA was detected after immunoblotting with an anti-CsrA polyclonal antibody. A molecular weight marker is 
loaded on the left. CsrA is indicated by an arrow. Additionally, total RNA was prepared from samples of overnight 
cultures and analyzed via Northern blotting using specific anti-CsrC and anti-CsrB Dig-labeled DNA probes. 16S 
and 23S rRNA was visualized as loading controls. 
These results indicate that Hfq is essential for the synthesis of the Csr RNAs in 
Y. pseudotuberculosis. In the presence of Hfq, CsrB and CsrC production is upregulated. This 
allows the sequestration of CsrA which results in the reduction of RovM levels under these 
conditions.  
As Hfq acts as a chaperone, it was assumed that Hfq might be implicated in YmoA-dependent 
stabilization of CsrC. To prove this hypothesis, influence of Hfq on CsrC stability was tested. 
For this purpose, csrC was expressed under the control of the tet promoter to exclude 
influence on transcription. Expression analysis of Ptet-lacZ fusion (pTT01) in YPIII (wild type) 
and YP80 (hfq -) demonstrated that loss of hfq has no effect (Fig. 33A). This allowed us to 
compare CsrC stability in YPIII (wild type) and YP80 (hfq -) harboring a plasmid-encoded 
Ptet::csrC (pKB47) expression construct. CsrC levels were low in Y. pseudotuberculosis grown 
in minimal media and CsrC was detectable in the hfq mutant. However, expression of csrC 
from the Ptet promoter resulted in similar CsrC concentrations in the wild type and the hfq 
mutant. This indicated that Hfq did not affect CsrC stability (Fig. 33B). 
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Fig. 33. Hfq does not affect CsrC stability. A. Ptet-lacZ activity was analyzed in Y. pseudotuberculosis YPIII  
and YP80 (hfq -) haboring pPtet::csrC (pKB47) after overnight cultivation in minimal medium MMA at 25°C. 
β-galactosidase activity is given in μmol/(min·mg). The data represent the mean ± standard deviation of three 
independent experiments, each performed in duplicate. B. CsrC was detected by Northern blot analysis with CsrC-
specific Dig-labeled probes using total RNA prepared YPIII and YP80 (hfq -) harboring the empty vector pV 
(pHSG575) or pPtet::csrC (pKB47). Strains were cultivated in MMA medium overnight at 25°C. 16S and 23S rRNA 
served as loading controls. 
Next, it was tested whether ymoA and hfq deletions could be complemented by ymoA or hfq 
overexpression to analyze whether the regulators act in a hierarchical manner. Therefore, 
pKB4 (ymoA+) or pAKH119 (hfq+) were transformed into YPIII (wild type), YP50 (ymoA-) 
and YP80 (hfq -). CsrC levels in the strains were determined by Northern blot analysis. In 
contrast to the wild type, very low amounts of CsrC were found in the ymoA and the hfq 
mutant. Overexpression of hfq or ymoA resulted in increased CsrC synthesis in the wild type, 
but neither overexpression of ymoA could restore CsrC production in the hfq mutant nor 
could Hfq overproduction induce an increase of CsrC in a ymoA mutant (Fig. 34). 
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Fig. 34. YmoA and Hfq act independently on CsrC. Y. pseudotuberculosis YPIII, YP50 (ymoA-) and YP80 
(hfq -) harboring the empty vector pV (pHSG575), pymoA+ (pKB4) or phfq+ (pAKH119) were cultivated overnight 
in LB medium at 25°C. Total RNA was prepared, separated and analyzed by Northern blotting using a CsrC-
specific Dig-labeled DNA probe. CsrC is marked by an arrow. 16S and 23S rRNA served as loading controls. 
This demonstrated that YmoA and Hfq cannot complement each other suggesting that both 
factors influence CsrC synthesis independently. In fact, YmoA was shown to act on the post-
transcriptional level (e.g. CsrC stability) whereas Hfq does not affect CsrC stability. To 
further address the mechanism how Hfq affects CsrC levels the csrC(+4)-lacZ (pAKH103) 
and a csrC(+81)-lacZ (pAKH76) fusion plasmids were introduced into YPIII (wild type) and 
YP80 (hfq -) to analyze the impact of Hfq on csrC transcription. In order to study the 
complementation and hfq overexpression on csrC transcription, activities of the fusions were 
also measured in the wild type and the hfq mutant harboring the hfq+ plasmid pAKH115. 
Expression of both csrC-lacZ fusions was significantly reduced (50%-75%) in an hfq-deficient 
strain, and overproduction of Hfq restored csrC transcription levels in an hfq mutant to wild 
type levels (Fig. 35). This strongly indicated that Hfq activates csrC transcription. 
 
Fig. 35. Hfq activates csrC gene expression. β-galactosidase activity of the plasmid-encoded csrC(+4)-lacZ 
(pAKH103) and csrC(+81)-lacZ (pAKH76) fusions was determined in Y. pseudotuberculosis strain YPIII and the 
YP80 (hfq -) carrying an empty vector pV (pAKH85) or an hfq+ plasmid (pAKH115) cultivated overnight in LB 
medium at 25°C. Enzyme activity is given in µmol/(min·mg). The data represent the mean ± standard deviation 
of three independent experiments, each performed in duplicate. 
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3.1.8 Analysis of the csrC promoter region  
To determine the promoter region of csrC, which might be important for Hfq-mediated 
activation, transcriptional reporter gene fusions with varying csrC promoter lengths were 
constructed (csrC(-355)-lacZ (pAKH103), csrC(-310)-lacZ (pAKH125), csrC(-283)-lacZ 
(pAKH126), csrC(-204)-lacZ (pAKH127) and csrC(-106)-lacZ (pAKH128) fusions) and their 
activity was tested in Y. pseudotuberculosis YPIII (wild type) grown overnight at 25°C. 
The csrC-lacZ fusions harboring promoter regions to positions -355, -310, -283 and -204 with 
respect to the transcription start of csrC showed no significant difference in their transcription 
rate. However, expression of a csrC-lacZ fusion encoding only 106 nucleotides of the 
5' upstream region was found to be significantly reduced to approx. 14% of the activity of the 
other fusion constructs (Fig. 36). 
 
Fig. 36. Promoter deletion studies of the csrC regulatory region. Analysis of the csrC promoter region was 
performed by introducing csrC(-355)-lacZ (pAKH103), csrC(-310)-lacZ (pAKH125), csrC(-283)-lacZ (pAKH126), 
csrC(-204)-lacZ (pAKH127) and csrC(-106)-lacZ (pAKH128) fusion plasmids into Y. pseudotuberculosis YPIII 
(wild type). Samples of overnight cultures grown in LB medium at 25°C were taken to measure the β-galactosidase 
activity. Enzyme activity is given in µmol/(min·mg). The data represent the mean ± standard deviation of three 
independent experiments, each performed in duplicate. 
According to these results, promoter regions of csrC transcription located upstream of 
position -106 relative to the transcription start are required for maximal csrC transcription. 
They might be targeted by activating regulators. This suggests that Hfq stimulates csrC 
transcription through a promoter element located upstream of position -204. Since Hfq is an 
RNA chaperone, it is most likely, that it stimulates csrC transcription indirectly, e.g. by 
controlling a regulatory RNA element influencing a csrC transcription factor. 
 89 
3.1.9 The nucleoid-associated protein H-NS activates CsrC synthesis 
H-NS regulates inv and rovA expression by binding to the promoter regions of these genes. 
Lawrenz and Miller (2007) described that, in Y. enterocolitica, H-NS binds to its homolog 
YmoA which in turn prevents repression of inv transcription under certain conditions. 
Furthermore, association of the YmoA homolog Hha and H-NS has been shown to regulate 
gene expression in Salmonella (Olekhnovich and Kadner 2007). This indicated that YmoA 
might influence CsrC RNA stability through or in association with H-NS.  
To address this question, influence of H-NS on csrC expression and RNA synthesis was 
evaluated in the presence and absence of YmoA. Expression of the csrC(+4)-lacZ (pKB45) 
and csrC(+81)-lacZ (pKB46) fusions were analyzed in Y. pseudotuberculosis YPIII and the 
isogenic ymoA mutant (YP50) expressing a dominant-negative variant of the hns gene 
encoded on the hns' plasmid pAKH31. To test the influence of hns overexpression activity, 
both csrC-lacZ fusions were also determined in YPIII (wild type) and YP50 (ymoA-) carrying 
the hns+ plasmid pAKH74.  
Expression of the csrC(+4)-lacZ fusion in the wild type strain and the ymoA mutant was not 
strongly affected by the production of unfunctional H-NS (H-NS') or H-NS overexpression. 
In consistency with previous results, expression of the csrC(+81)-lacZ fusion was strongly 
reduced to about 30% in a ymoA mutant (Fig. 20, Fig. 37A). Expression of the dominant-
negative hns' fragment had also no considerable effect on the csrC transcription of this fusion 
but hns overexpression restored transcription activity of the csrC(+81)-lacZ fusion to wild 
type levels (Fig. 37A). 
To confirm this result, Northern blot analysis was performed to determine CsrB and CsrC 
RNA concentrations in the different strains. As shown in Fig. 37B, CsrC RNA levels in 
Y. pseudotuberculosis wild type were significantly reduced when H-NS protein was inactivated 
by a non-functional H-NS' fragment. In contrast, overexpression of hns stimulated CsrC 
synthesis. The CsrC RNA was hardly detectable in a ymoA mutant carrying an empty vector 
and was even less expressed when the non-functional N-terminal H-NS' fragment was 
produced. However, high CsrC concentrations were found in a ymoA mutant overexpressing 
the hns gene, indicating that H-NS can complement a ymoA mutation when present in high 
concentrations.  
Synthesis of the CsrB RNA was regulated in the opposite manner. Inactive H-NS led to a mild 
increase of CsrB amounts in the wild type, and overexpression of hns' repressed CsrB 
synthesis. In a ymoA mutant CsrB concentrations were strongly elevated compared to the wild 
type. Further, increase of CsrB levels was detectable in the dominant-negative hns'/ymoA 
mutant. In contrast, hns overexpression reduced CsrB levels significantly, i.e. to amounts that 
are even lower than CsrB levels in the wild type (Fig. 37B). 
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Fig. 37. H-NS upregulates CsrC synthesis post-transcriptionally. A. Y. pseudotuberculosis YPIII and YP50 
(ymoA-) expressing the csrC(+4)-lacZ (pAKH103) or csrC(+81)-lacZ (pAKH76) fusion also carrying an empty 
vector pV (pAKH85), a hns' (pAKH31) or hns+ (pAKH74) overexpression plasmid were cultivated overnight in LB 
medium at 25°C. β-galactosidase activity was determined and normalized relative to YPIII with pV. The data 
represents the value ± standard deviation of three independent experiments, each performed in duplicate. B. Total 
RNA of the cultures was prepared, RNA was separated and analyzed by Northern blotting. CsrC and CsrB were 
detected by specific Dig-labeled DNA probes. 16S rRNA was visualized for loading controls. 
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In summary, H-NS does not seem to influence csrC promoter activity but seems to be 
important for post-transcriptional regulation of CsrC synthesis as shown for YmoA. Still, in 
the absence of YmoA, only hns overexpression led to an increase of csrC(+81)-lacZ expression 
to wild type levels and fully complemented the effect of YmoA on CsrC synthesis. CsrB levels 
are reversely affected by H-NS which might be due to negative regulation by the CsrC RNA in 
Y. pseudotuberculosis (Heroven, et al. 2008; Fig. 37B).  
Expression of truncated H-NS from E. coli strain EPEC activated ymoA transcription in 
Y. enterocolitica (Banos, et al. 2008). To test whether H-NS regulates CsrC synthesis by 
altering YmoA protein levels, the dominant-negative H-NS' protein was overproduced in 
Y. pseudotuberculosis wild type (YPIII phns') and YmoA protein levels in this strain were 
compared to the wildtype (YPIII) or an H-NS overexpressing strain (YPIII phns+). As shown 
in Fig. 38, YmoA protein levels were strongly increased in the presence of dominant-negative 
H-NS' protein whereas overexpression of hns completely abolished YmoA synthesis. These 
data suggest that YmoA protein levels are negatively regulated by H-NS. Therefore, this 
influence of H-NS on ymoA expression does not explain CsrC levels in a ymoA mutant when 
overexpressed (Fig. 38). 
 
Fig. 38. H-NS represses YmoA synthesis. Y. pseudotuberculosis YPIII and YP50 (ymoA-) harboring an empty 
vector pV (pAKH85), phns' (pAKH31) or phns+ (pAKH74) were cultivated overnight in LB medium at 25°C. 
Samples were withdrawn, the OD600nm was adjusted and whole cell extracts were prepared. Proteins were separated 
by 20% TRICINE gel electrophoresis and YmoA was visualized by immunoblotting using a specific polyclonal anti-
YmoA antibody. A molecular weight ladder was loaded on the left. The YmoA protein is marked by an arrow. 
H-NS has previously been shown to bind to the rpoS mRNA and the DsrA regulatory RNA in 
E. coli (Brescia, et al. 2004). In order to clarify whether a direct interaction of H-NS with the 
CsrC RNA is responsible for the activation of CsrC synthesis, purified CsrC RNA transcript 
was incubated with increasing concentrations of C-terminally His-tagged H-NS (pAKH11) 
purified from E. coli strain KB4 ∆hns∆stpA∆hha deficient of all E. coli H-NS and YmoA 
homologous proteins. 5S RNA was included in the binding assay as a negative control.  
Although high concentrations of H-NS were applied (8.4 to 33.2 μM) no CsrC-H-NS 
complexes could be detected. At 66.4 μM of His-tagged H-NS protein, CsrC as well as the 
control 5S RNA were shifted. This suggested, that H-NS binds unspecifically to CsrC and the 
5S RNA at high H-NS concentrations. No defined RNA-protein complexes could be observed 
because of H-NS oligomerization to the RNAs seemed to occur at different degrees resulting 
in multiple complexes of varying sizes in low concentrations. These cannot be easily detected 
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in the RNA band shift assay. As a result, H-NS action on CsrC in a ymoA mutant appears to 
be indirect (Fig. 39). 
 
Fig. 39. H-NS binds unspecifically to the CsrC RNA. In vitro transcribed CsrC RNA and 5S rRNA were 
incubated with purified C-terminal His-tagged H-NS protein in increasing concentrations of 8.4, 16.6, 33.2 and 
66.4 μM for 30 min at room temperature (lane 2 to 5). As a control, CsrC and 5S rRNA were incubated with 
1 x RNA-bandshift buffer (lane 1). Samples were separated by 8% non-denaturing polyacrylamide electrophoresis 
and visualized by SybrGreen staining under UV light. 
To summarize, the synthesis of the regulatory RNA CsrC in Y. pseudotuberculosis underlies 
transcriptional and post-transcriptional control by at least four regulators. The RNA 
chaperone Hfq upregulates csrC gene expression. By binding to the CsrC RNA, CsrA prevents 
its degradation and is further sequestered from stimulating RovM production. H-NS can 
indirectly activate CsrC synthesis. The nucleoid-associated protein YmoA is stable at 
moderate temperatures due to reduced degradation by ATP-dependent ClpP/Lon proteases. 
YmoA supports production of the major early virulence factor invasin by impairing 
degradation of CsrC via an unknown pathway. Thereby rovA expression is activated and 
expression of early virulence factors is established at low temperatures.  
Tight temperature and growth phase regulation of YmoA lead to the hypothesis that high 
YmoA levels during exponential growth phase in nutrient-rich medium at 25°C are also 
important to repress expression of later-stage virulence functions, which are not synthesized 
under these conditions, for example those expressed from the Yersinia virulence plasmid pYV. 
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3.2 Virulence factor expression during late phase of infection 
After penetration of the M-cells and attachment to the underlying Peyer’s patches, 
Y. pseudotuberculosis switches its virulence factor expression. The synthesis of invasin is 
turned off. Instead, the nonfimbrial Yersinia adhesin A, YadA, is produced to enable host cell 
adhesion. Furthermore, a type III secretion system and Yersinia outer proteins (Yops) are 
synthesized, secreted by this system and injected into professional phagocytes of the host. 
These factors enable the bacterium to circumvent the host immune system and ensure 
dissemination into other organs like liver, spleen and kidney. Expression of the virulence 
factors encoded by the Yersinia virulence plasmid pYV occurs under the control of the AraC-
like transcriptional activator LcrF (VirF) mainly during exponential growth in minimal medium 
and at higher temperatures when YmoA production is repressed. The following experiments 
were performed to address whether LcrF synthesis is controlled by YmoA in response to 
environmental signal. 
3.2.1 The nucleoid-associated protein YmoA represses lcrF expression 
from a promoter upstream of yscW  
In Y. enterocolitica, expression of the late virulence factors YadA, the Yersinia enterotoxin 
Yst, several Yops and their transcriptional activator LcrF were induced in a ymoA mutant 
(Cornelis, et al. 1991). In Y. pseudotuberculosis, yadA expression was shown to be activated 
during exponential growth, in minimal medium and at 37°C, conditions under which YmoA 
synthesis is repressed (Fig. 29). Gene transcription of yadA occurs only in the presence of 
LcrF (W. Opitz, unpublished data). To check, whether YmoA influences LcrF synthesis in 
Y. pseudotuberculosis at 25°C and 37°C, expression of a plasmid-encoded translational 
lcrF '-'lacZ fusion (pSF3), encoding 526 bp upstream of the lcrF gene and 74 bp of the lcrF 
coding sequence, was analyzed in Y. pseudotuberculosis wild type (YPIII) and the ymoA 
mutant strain (YP50). To overexpress ymoA and to complement the mutation in a ymoA-
deficient strain, the ymoA+ plasmid (pAKH71) was introduced into strains YPIII and YP50. 
β-galactosidase activity was measured from overnight cultures at 25°C and 37°C. 
Furthermore, whole cell extracts were prepared from Y. pseudotuberculosis YPIII (wild type) 
and YP50 (ymoA-)to detect LcrF protein levels. 
As shown in Fig. 40A, lcrF '-'lacZ was not expressed in the wild type and ymoA mutant 
strains at 25°C or 37°C. In contrast, the LcrF protein could be clearly detected in whole cell 
extracts of a ymoA mutant at 25°C while LcrF was absent in the wild type strain. At 37°C, 
LcrF production was significantly increased in the wild type and the ymoA mutant whereby 
overall levels of LcrF protein were higher in the ymoA-deficient strain (Fig. 40B). 
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Fig. 40. LcrF synthesis is repressed by YmoA. A. Y. pseudotuberculosis YPIII and YP50 (ymoA-) which express 
a translational lcrF '-'lacZ fusion (pSF3) and carry an empty vector pV (pAKH85) or pymoA+ (pAKH71) were 
grown overnight at 25°C and 37°C. β-galactosidase activity was measured and is given in µmol/(min·mg). The 
data represent the mean ± standard deviation of three independent experiments, each performed in duplicate. 
B. Whole cell extracts from overnight cultures at 25°C and 37°C of Y. pseudotuberculosis YPIII (wild type) and 
YP50 (ymoA-) and YP66 (lcrF -) were prepared and proteins were separated by 12% SDS gel electrophoresis. 
Immunoblotting was performed using a specific anti-LcrF polyclonal antibody. The LcrF protein is marked by an 
arrow. 
These data suggest that LcrF production is repressed in the presence of YmoA at 25°C. Due 
to rapid degradation of YmoA at 37°C, lcrF expression is increased at higher temperatures. 
Interestingly, a temperature-induced expression of lcrF also occurs in the absence of YmoA, 
indicating an additional mechanism of LcrF synthesis control. Low expression of a lcrF '-'lacZ 
fusion at both temperatures further indicates that the upstream fragment of lcrF used for the 
construction of the lcrF '-'lacZ fusion might miss the promoter region. Analysis of the 526 bp 
region upstream of the lcrF gene revealed an open reading frame starting at position -499 to 
position -124 relative to the lcrF start codon. The gene product of the upstream gene which 
has been described as yscW (virG) is implicated in the localization and oligomerization of the 
type III secretion component YscC in the outer membrane. The yscC gene is transcribed in 
the same direction as lcrF (Allaoui, et al. 1995a; Burghout, et al. 2004) indicating that both 
genes might form an operon. In fact, in P. aeruginosa, homologs of yscW and lcrF called exsB 
and exsA have shown to be expressed in an operon (Yahr and Frank 1994). For this reason, a 
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translational lacZ fusion was constructed encoding 573 bp upstream of the yscW gene, yscW, 
the intergenic region between yscW and lcrF as well as 74 bp of the lcrF 5' end to determine 
whether lcrF was transcribed under the control of the yscW promoter region (Fig. 41A). A 
plasmid-encoded copy of the yscWlcrF '-'lacZ fusion (pSF4) was introduced into the YPIII 
(wild type) and also into YP50 (ymoA-) in order to analyze the influence of YmoA on yscW 
expression. In addition, ymoA was expressed in trans (pAKH71) in both strains to test 
yscWlcrF '-'lacZ expression at high YmoA levels. At 25°C, yscWlcrF '-'lacZ expression was 
3fold induced in the ymoA mutant compared to the wild type whereas overexpression of 
ymoA led to a complete repression of the fusion construct. Furthermore, a ten times higher 
activity of the yscWlcrF '-'lacZ fusion was observed in the wild type at 37°C. Loss of ymoA 
stimulated activity additionally by about 2.5fold whereas overexpression of ymoA led to a 
strong reduction of the promoter activity down to about 5% in both (Fig. 41B). The overall 
activity of the yscWlcrF '-'lacZ fusion was significantly increased. 
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Fig. 41. YmoA represses transcription of the yscWlcrF operon. A. Translational lcrF '-'lacZ and 
yscWlcrF '-'lacZ fusions constructed to determine the influence of YmoA on lcrF expression. B. Plasmids encoding 
the lcrF '-'lacZ (pSF3) and yscWlcrF '-'lacZ (pSF4) were introduced into Y. pseudotuberculosis YPIII and YP50 
(ymoA-) carrying an empty vector pV (pAKH85) or pymoA+ (pAKH71). Samples were from overnight cultures at 
25°C and 37°C and β-galactosidase activity was measured. The enzyme activity is given in µmol/(min·mg). The 
data represent the mean ± standard deviation of three independent experiments, each performed in duplicate. 
 96 
This experiment demonstrated that expression of lcrF occurs from a promoter region 
upstream of the yscW gene, and YmoA represses the transcription of the putative yscWlcrF 
operon. 
To analyze in more detail how YmoA represses yscWlcrF transcription, yscWlcrF '-'lacZ 
fusions with varying promoter lengths were constructed and introduced into 
Y. pseudotuberculosis YPIII (wild type) and the YP50 (ymoA-). The reporter gene fusion 
contained inserts starting at position -573 (pKB34), -466 (pKB39), -368 (pKB40), -267 
(pKB41), -171 (pKB42), -73 (pKB43) and -8 (pKB38) relative to the start codon of the 
yscW gene, followed by the yscW gene, the intergenic region and 74 bp of the 5' end of lcrF. 
Strains were cultivated overnight at 25°C, and β-galactosidase activity was monitored. The 
activity of the yscW promoter was maximal when the promoter region encompasses 368 bp of 
the upstream region of the yscW gene (Fig. 42). In comparison, fusions harboring 573 bp or 
466 bp upstream of the yscW gene exhibited a lower activity of about 50% indicating that a 
negative regulator might interact upstream of position -368. This component does not seem 
to be YmoA as all fusions harboring regulatory sequences to position -368, -466 and -573 are 
2 to 3fold higher expressed in the ymoA mutant background. Thus, YmoA must repress 
yscWlcrF expression through a DNA segment located further upstream of position -573. 
Transcription of fusions with promoter fragments of only 267 bp or less were not or only very 
weakly expressed independent whether YmoA was present or not. This indicated that either 
the promoter is located upstream of position -267 or that a positive regulator is required to 
induce yscWlcrF expression (Fig. 42). 
 
Fig. 42. Expression of the yscWlcrF operon is regulated by YmoA. Y. pseudotuberculosis YPIII and ymoA 
mutant strain YP50 haboring yscW(-573)lcrF '-'lacZ (pKB34),  yscW(-466)lcrF '-'lacZ (pKB39), 
yscW(-368)lcrF '-'lacZ (pKB40), yscW(-267)lcrF '-'lacZ (pKB41), yscW(-171)lcrF '-'lacZ (pKB42), 
yscW(-73)lcrF '-'lacZ (pKB43) and yscW(-8)lcrF '-'lacZ (pKB38) fusion plasmids were cultivated overnight in LB 
medium at 25°C. β-galactosidase activity is given in µmol/(min·mg). The data represent the mean ± standard 
deviation of three independent experiments, each performed in duplicate. 
Taken together, expression studies indicated, that the 5' end of the yscWlcrF transcript is 
located relatively far, between 267 and 367 bp, upstream of the yscW start codon. The 
nucleoid-associated protein YmoA still represses transcription of yscWlcrF harboring 
regulatory sequences up to position -573 upstream of the yscW gene. This suggested that a 
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YmoA-responsible site is located upstream of position -573. Interestingly, deletion of a 
promoter region upstream of position -466 relative to the yscW start codon resulted in lower 
levels of yscWlcrF transcription, indicating the influence of an additional repressing factor.  
3.2.2 yscWlcrF transcription is influenced by a Yersinia-specific regulator 
To analyze whether yscWlcrF transcription is regulated by a Yersinia-specific factor, the 
yscW(-573)lcrF '-'lacZ fusion (pSF4) was introduced into E. coli K12 strain MC4100 and its 
expression was compared to Y. pseudotuberculosis YPIII (wild type) at 25°C and 37°C. 
The yscWlcrF '-'lacZ expression levels were strongly reduced in E. coli strain MC4100 relative 
to the expression in Y. pseudotuberculosis wild type at 25°C and 37°C, but a 2 to 3fold 
increase of the activity of the fusion was observed when the environmental temperature was 
increased (37°C)(Fig. 43). 
 
Fig. 43. Expression of yscWlcrF is strongly repressed in E. coli. Y. pseudotuberculosis YPIII and E. coli K12 
strain MC4100 harboring the plasmid-encoded yscWlcrF '-'lacZ fusion (pSF4) were cultivated overnight in LB 
medium at 25°C and 37°C. The β-galactosidase activity was determined and is given in µmol/(min·mg). The data 
represent the means ± standard deviation of three independent experiments, each performed in duplicate. 
Low expression of the yscWlcrF '-'lacZ fusion in E. coli indicates that a Yersinia-specific factor 
is essential for yscWlcrF transcription. As some temperature induction of yscWlcrF could still 
be detected in E. coli, a control mechanism might be present which is conserved in Yersinia 
and E. coli.  
Further, it was investigated, whether LcrF is autoregulated. AraC-type proteins were often 
found to negatively regulate their expression by binding to the RNA polymerase interaction 
site within their own promoter region (Lee, et al. 1981). An yscWlcrF '-'lacZ encoding plasmid 
(pSF4) was transformed into the Y. pseudotuberculosis YPIII (wild type) and YP66 (lcrF -). 
Expression of the yscWlcrF '-'lacZ fusion was identical in the wild type and the lcrF mutant, 
which indicates that LcrF does not autoregulate its transcription (Fig. 44A). 
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In the next step, influence of the Yersinia virulence plasmid pYV on yscWlcrF expression was 
tested, which might harbor regulatory components controlling the major transcriptional 
activator of virulence plasmid-encoded pathogenesis genes. Y. pseudotuberculosis YPIII (wild 
type) and the wild type strain YP12 cured of pYV were transformed with the yscWlcrF '-'lacZ 
fusion plasmid (pSF4) and expression of yscWlcrF '-'lacZ fusion was measured in overnight 
cultures grown at 37°C.  
In the absence of pYV, transcription levels of yscWlcrF '-'lacZ were reduced to about 
50% compared to YPIII harboring pYV. This suggests that a regulator is encoded by pYV 
which activates gene expression of yscWlcrF (Fig. 44B). 
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Fig. 44. lcrF expression is not autoregulated but activated by a factor encoded on the virulence plasmid.  
(A) Y. pseudotuberculosis YPIII and YP66 (lcrF -) or (B) YPIII and YP12 (YPIII pYV -) haboring an 
yscWlcrF '-'lacZ (pSF4) fusion were cultivated in LB medium overnight at 37°C. The β-galactosidase activity was 
determined and is given in µmol/(min·mg). The data represent the mean ± standard deviation of three 
independent experiments, each performed in duplicate. 
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3.2.3 LcrF translation is thermoregulated 
Thermoregulation of yscWlcrF expression was still observed in E. coli or in a ymoA mutant 
strain of Yersinia (Fig. 43, Fig. 41). This indicated that besides regulation by YmoA another 
temperature-dependent control mechanism must affect lcrF expression. To test whether this 
control system affects yscWlcrF on the transcriptional or post-transcriptional level, the 
promoter region upstream of yscW was exchanged by a thermo-independent PBAD promoter 
(Fig. 45A). The PBAD::yscWlcrF '-'lacZ fusion encoded on pED10 was transformed into 
Y. pseudotuberculosis YPIII (wild type) and the E. coli K12 strain MC4100 and 
β-galactosidase activity was determined from overnight cultures at 25°C and 37°C. 
Transcription from the PBAD promoter was induced with 0.2% arabinose. 
Expression of PBAD::yscWlcrF '-'lacZ in Y. pseudotuberculosis was induced 5fold at 37°C 
compared to 25°C. In E. coli, the overall expression level was reduced, but the activity of the 
fusion was also increased about 4fold at 37°C (Fig. 45B). 
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Fig. 45. lcrF expression is temperature-regulated independent of the yscW promoter. A. Schematic 
representation of pED10 harboring the yscWlcrF '-'lacZ expression under the control of the inducible 
PBAD promoter. B. To measure PBAD::yscWlcrF '-'lacZ expression, pED10 was introduced into Y. pseudotuberculosis 
YPIII and the E. coli K12 MC4100 and grown overnight in LB medium with 0.2% arabinose at 25°C and 37°C. 
The β-galactosidase activity was determined and is given in µmol/(min·mg). The data represent mean values ± 
standard deviation of three independent experiments, each performed in duplicate. 
 100 
Despite of the use of a different promoter, yscWlcrF '-'lacZ was still controlled by 
temperature, in Y. pseudotuberculosis and E. coli K12 (Fig. 45). This suggests that 
thermodependency is not controlled on the transcriptional level but is regulated post-
transcriptionally by a different unknown mechanism. To more elucidate the region which 
might be responsible for thermoregulation of yscWlcrF '-'lacZ expression, the intergenic region 
between yscW and lcrF with additional 74 nt of the lcrF 5' end was fused to the lacZ reporter 
gene and transcribed from the PBAD promoter (pKB14). Expression of the fusion was 
determined at 25°C and 37°C in LB medium supplemented with 0.2% arabinose to induce 
PBAD expression. Furthermore, a PBAD::gnd '-'lacZ fusion (pED05) encoding the 5' untranslated 
region (UTR) of the thermo-independently expressed gluconate-phosphate dehydrogenase was 
transformed to proof that the inducible promoter PBAD is independent of the growth 
temperature when used in wild type strain YPIII (Fig. 46A). Expression of PBAD::gnd '-'lacZ at 
25°C and at 37°C was identical, demonstrating that transcription from PBAD  is not affected by 
temperature. In contrast, expression of PBAD::lcrF(-123)'-'lacZ was about 5fold induced at 
37°C compared to 25°C (Fig. 46B).  
This strongly suggests that temperature-regulation of lcrF '-'lacZ is independent of the 
yscWlcrF promoter and occurs on the post-transcriptional level implicating elements of the 
intergenic region between yscW and lcrF or the lcrF 5' untranslated region (UTR). 
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Fig. 46. Thermoregulation of LcrF synthesis involves a mechanism located in the lcrF 5' untranslated region. 
A. pPBAD::lcrF(-123)'-'lacZ (pKB14) and pPBAD::gnd '-'lacZ (pED05) constructs used to determine the temperature-
dependent expression of the lcrF 5' UTR. B. Y. pseudotuberculosis YPIII was transformed with pKB14 and pED05 
and cultivated overnight in LB medium with 0.2% arabinose at 25°C and 37°C. The β-galactosidase activity was 
determined and is given in µmol/(min·mg). The data represent mean values ± standard deviation of three 
independent experiments, each performed in duplicate. 
3.2.4 Secondary structure analysis of the Y. pseudotuberculosis LcrF RNA 
reveals a FourU motif 
Hoe and Goguen (1993) hypothesized that LcrF translation in Y. pestis is controlled by a 
secondary structure formation in the 5' untranslated region (UTR) of the lcrF RNA. The 
secondary structure of the Y. pseudotuberculosis lcrF RNA transcribed from the 123 nt 
intergenic region between yscW and lcrF elongated by 10 nt of the lcrF coding sequence was 
analyzed by the RNA structure prediction tool Mfold (Zuker 2003; 
http://mfold.bioinfo.rpi.edu/). The most probable secondary structure revealed that the RNA 
of the intergenic region forms two major hairpins. The first hairpin comprises 57 nucleotides, 
which show three base pairing regions, interrupted by three single-stranded loop sections 
consisting of six to nine nucleotides and a bulged uracil 61 bases upstream of the start codon. 
From the first hairpin a long stretch of 11 unpaired nucleotides leads to hairpin II, which 
comprises nucleotides -44 to +2 relative to the lcrF start codon. This second hairpin contains 
AU-rich sequences, which undergo base pair formation in three sections. Base pairing regions 
are connected by single or double unpaired nucleotides forming only small loops in the 
predicted secondary structure. The start codon itself is partially involved in the formation of 
the stem. Cornelis (1989) proposed a putative Shine-Dalgarno sequence for the lcrF 
homologous gene virF in Y. enterocolitica where an AGGA motif is located 14 to 
17 nucleotides upstream of the virF start codon. A similar ribosomal binding site was also 
found in the lcrF RNA at the same distance. This AGGA motif was included in the stem 
formation of hairpin II and was predicted to interact with a sequence of four uracils (Fig. 47). 
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Fig. 47. The 123 nt lcrF 5' UTR is predicted to form two hairpin structures. The secondary structure of the 
lcrF 5' UTR was generated using Mfold which applies a free energy minimization algorithm to RNA sequences 
(Zuker et al., 1999; http://bioweb.pasteur.fr/seqanal/interfaces/mfold-simple.html). For the prediction, 
parameters were set to default. The most probable prediction with the lowest free energy is shown. Blue circles 
represent base pairing. START indicates the start codon of the lcrF coding region. The putative Shine-Dalgarno 
(SD) sequence is given in brown. The FourU motif (blue) comprises the AGGA motif of the SD sequence paired 
with four uracils. Numbers indicate nucleotides relative to the lcrF start codon.  
3.2.5 The FourU motif within the LcrF 5' UTR functions as an RNA 
thermometer 
Interaction of four uracils with Shine-Dalgarno sequences in a stem-loop-like RNA structure 
has been described as a so-called FourU thermometer and was found to regulate translation of 
the agsA RNA in response to temperature (Waldminghaus, et al. 2007). Formation of the 
secondary structure and thereby sequestration of the Shine-Dalgarno sequence through 
imperfect base pairing to the FourU motif at low temperatures impaired translation initiation. 
High temperatures eliminated the base pairing and, as a result, liberated the ribosomal binding 
site. This allows translation initiation by ribosome-RNA-interaction.  
To test whether elements of the lcrF 5' UTR are essential for the temperature regulation of 
LcrF synthesis, a sequence of hairpin II predicted to base pair with the start codon and the 
Shine-Dalgarno sequence (∆-44 to -25) was deleted from PBAD::lcrF(-123)'-'lacZ. In addition, 
a lcrF-lacZ fusion derivative was constructed in which sequences from -13 to -64 implicated in 
hairpin I formation were eliminated. The resulting fusion constructs 
(pPBAD::lcrF(-123)'-'lacZ(∆-44 to -25) (pKB13) and pPBAD::lcrF(-63)'-'lacZ (pKB18)) were 
introduced into E. coli K12 strain DH5αZ1 and cultivated overnight at 25°C and 37°C. The 
PBAD promoter was induced by 0.2% arabinose and β-galactosidase activity was measured. 
While expression of the intact lcrF 5' UTR was five times induced at 37°C compared to 25°C, 
deletion of the region from -44 to -25 upstream of the lcrF gene led to a significant change of 
lcrF expression. Expression of the fusion was strongly induced at 25°C whereas expression was 
slightly reduced by about 30% at 37°C. The activity of the lcrF-lacZ fusion missing the first 
hairpin was found to be 2fold upregulated at 25°C. At 37°C, lcrF-lacZ expression was still 
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increased compared to 25°C but the overall expression was somewhat lower in comparison to 
the intact lcrF-lacZ fusion construct (Fig. 48). 
 
Fig. 48. Deletions of hairpin I or II in the 5' UTR of lcrF cause changes in the thermoregulation. E. coli K12 
strain DH5αZ1 was transformed with pPBAD::lcrF(-123)'-'lacZ (pKB14),  pPBAD::lcrF(-123)'-'lacZ(∆-44 to -25) 
(pKB13) or pPBAD::lcrF(-63)'-'lacZ (pKB18). Strains were grown overnight at 25°C and 37°C in LB medium 
supplemented with 0.2% arabinose. The β-galactosidase activity was determined and is given in µmol/(min·mg). 
The data represent the mean ± standard deviation of three independent experiments, each performed in duplicate. 
A deletion of sequences implicated in the formation of the stem structure in hairpin II which 
undergoes base pair interaction with the start codon and the Shine-Dalgarno sequence 
resulted in derepression and a temperature-independent translation of lcrF. Ribosomes seem to 
have full access to their target site. Loss of hairpin I still allowed thermo-dependent lcrF 
expression, but expression levels were significantly increased at 25°C and the ratio between 
expression at 25°C and 37°C was reduced. This indicates that not only hairpin II containing 
the FourU motif but the entire secondary structure formed by the 123 nt lcrF 5' UTR is 
responsible for tight lcrF thermoregulation.  
To further analyze the importance of single and double-stranded RNA regions within the 
second stem-loop structure of the lcrF 5' UTR for thermoregulation, different nucleotide 
exchanges were introduced into the PBAD::lcrF(-123)'-'lacZ fusion construct. According to the 
secondary structure prediction, an exchange of GUU at position -30 to -28 to AAA (pED07) 
and of AUA at position -36 to -34 to CCC (pED13) should reduce complementarity and 
abolish stem formation. In contrast, perfect base pairs were introduced by changing AG to CC 
at position -46 and -45 (pED06) and UU to CC at position -28 and 27  (pED08) (Fig. 49A). 
These modified and an unmodified PBAD::lcrF(-123)'-'lacZ fusions were introduced into E. coli 
K12 DH5αZ1 and β-galactosidase activity was determined from overnight cultures induced 
with 0.2% arabinose at 25°C and 37°C. 
An exchange of GUU (-30 to -28) to AAA completely abolished temperature regulation and 
led to identical expression rates at 25°C and 37°C which were slightly lower than expression of 
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the intact lcrF-lacZ fusion at 37°C. The AUA to CCC substitution at 
positions -36 to -34 resulted in a high expression of lcrF-lacZ at 25°C. The overall expression 
was identical to the unmodified lcrF-lacZ fusion at inducing temperature of 37°C. AUA-GGG 
exchange led to a reduction of the expression at 37°C (Fig. 49B).  
In contrast, lcrF-lacZ expression was completely impaired at all temperatures when 
complementarity of the sequence of hairpin II was increased by exchanging AG (-46/-45) with 
CC and UU (-28/-27) with CC (Fig. 49C). 
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Fig. 49. Mutations within the 5' UTR of lcrF change thermoregulation of LcrF synthesis. (A) Base exchanges 
leading to increased complementarity are marked in red, whereas mutations impairing base pair formation are 
indicated in green. Blue circles represent base pairing. START indicates the start codon of the lcrF coding region. 
The putative Shine-Dalgarno sequence is marked in brown. The FourU motif is labeled in blue. Numbers indicate 
nucleotides relative to the lcrF start codon. (B) PBAD::lcrF(-123; GUU -30/-28 AAA)'-'lacZ (pED07) and 
PBAD::lcrF(-123; AUA -36/-24 CCC)'-'lacZ (pED13)  or (C) PBAD::lcrF(-123; AG -46/-45 CC)'-'lacZ (pED06) and 
PBAD::lcrF(-123; UU -28/-27 CC)'-'lacZ (pED08) fusion plasmids were transformed into E. coli K12 strain 
DH5αZ1. Strains were cultivated overnight in LB medium with 0.2% arabinose at 25°C and 37°C. β-galactosidase 
activity was determined and is given in µmol/(min·mg). The data represents the mean ± standard deviation of 
three independent experiments, each performed in duplicate. 
As a conclusion, mutations which were introduced to destabilize the secondary structure 
formation of hairpin II of the lcrF 5' UTR showed a significant loss of temperature-dependent 
expression of lcrF. Base pair substitutions at these positions seem to resolve the stem 
formation of hairpin II at or close to the ribosomal binding site which induce lcrF expression 
at low temperatures. On the other hand, nucleotide substitutions in predicted single-stranded 
regions designed to allow perfect base pairing abolished lcrF expression. This indicates that a 
stable double-stranded RNA structure is formed even at 37°C. Thus, perfect complementarity 
within the FourU motif towards perfect base pairing with the Shine-Dalgarno sequence 
completely prevented lcrF expression. This suggests that imperfect UG base pairs formed by 
the FourU motif are essential for proper temperature regulation. These results needs to be 
further studied by in vitro assays.  
3.2.6 In vitro analysis of the lcrF 5' UTR  
To proof the predicted secondary structure of the lcrF 5' UTR, RNA structure probing was 
performed. To do so, the 123 bp 5' UTR plus ten nucleotides of the lcrF coding region were 
transcribed in vitro, radioactively labeled and incubated at 25°C and 37°C. RNA samples were 
probed using RNase V1, which cleaves double-stranded RNA regions, and RNase T1 cleaving 
RNA at the 5' end of single-stranded guanines (G). 
The 5' UTR of lcrF revealed many cleavage sites of RNase V1. Sites of about one to three 
nucleotides protected against RNase V1 digestion are located at positions -109, -102 
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to -100, -93 to -92, -73 to -72, -57 to -56 and -46 to -45 relative to the lcrF start codon. 
Larger sites of about nine to ten nucleotides not influenced by this RNase were found at 
about -86 to -78 and -19 to -9. These double-stranded regions were not affected by 
temperature changes, since a temperature shift from 25°C to 37°C did not significantly 
change the cutting pattern of RNase V1. RNase T1 cut single-stranded Gs at 
positions -102, -101, -85, -82, -45, -24 and -11. RNase T1 cleavage at other positions was due 
to unspecific digestion with preference for adjacent single-stranded adenines (A). At 25°C, 
accessibility of single-stranded Gs was significantly reduced compared to 37°C resulting in 
lower amounts of RNase T1 cleavage products. In particular, G-16 and G-15 showed partial 
protection to RNase T1 cleavage at 25°C, whereas they were greatly accessible at 37°C 
(Fig. 50). 
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Fig. 50. The 5' UTR of lcrF in vitro exhibits minor structural changes upon temperature shift from 25°C to 
37°C. A. The lcrF 5' UTR (-123 to +10 relative to the lcrF start codon) was enzymatically probed at 25°C and 
37°C using RNase T1 (ss G, 0.001 U/μl) and RNase V1 (ds RNA, 0.0002 U/μl). RNA fragments were separated by 
8% polyacrylamide gel electrophoresis. Lane C contains the incubation control without RNase. The alkaline 
reference ladder is loaded in Lane L. Selected nucleotides represent RNase T1 cleavage sites and are marked with 
arrows. Grey bars label RNase V1 cleavage sites. On the right, the 3' end is magnified. The ribosomal binding site 
is indicated by “rbs”. B. Secondary structure of the lcrF 5' UTR predicted by Mfold. Arrows indicate 5' ends of 
guanines cleaved by RNase T1. Blue circles represent base pairing. START indicates the start codon of the lcrF 
coding region. The putative Shine-Dalgarno sequence is marked in brown. The FourU motif is labeled in blue. 
Numbers indicate nucleotides relative to the lcrF start codon. 
Long stretches of RNase V1 cleavage products indicate that large parts of the 5' UTR 
represent base paired regions, interrupted by only small bulges and loops. Interestingly, RNA 
structure probing of the lcrF 5' UTR exhibited only small structural rearrangements within a 
very limited region during the temperature shift from 25°C to 37°C (Fig. 50). These mainly 
occur within the Shine-Dalgarno sequence. At 37°C, the two Gs of the ribosomal binding site 
were found to be single-stranded to a higher degree than at moderate temperatures which 
indicates an opening of the region and better accessibility for ribosomes. 
3.2.7 Translation initiation at the lcrF 5' UTR is thermo-dependent in 
vitro 
RNA structure probing revealed only minor rearrangements in the lcrF 5' UTR structure upon 
a temperatures increase from 25°C to 37°C. In order to determine whether these are sufficient 
for ribosomal binding and translation initiation, toe printing experiments were performed. An 
RNA sequence comprising the lcrF 5' UTR and 63 nucleotides of the coding region was 
synthesized in vitro and a primer complementary to the 3' end was annealed. The subsequent 
primer extension inhibition reaction, using initiator tRNAfMet in the presence or absence of 30S 
ribosomal subunits isolated from E. coli, was carried out at 25°C and 37°C.  
At 25°C, full length transcript of the lcrF 5' UTR was observed at high concentrations in the 
presence or absence of 30S ribosomal subunits. In addition, some termination products were 
generated during the primer extension when no ribosomes were added at 25°C, suggesting 
that the reverse transcriptase might have fallen of the RNA because of a strong RNA 
secondary structure. In contrast to 25°C, the amount of full length transcript was considerably 
reduced at 37°C. Addition of ribosomes at 37°C led to an even stronger decrease, but instead 
additional transcripts were detected at positions corresponding to +18 to +14, representing a 
typical toe print (Fig. 51). 
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Fig. 51. 30S ribosomal subunits bind to the 5' UTR of lcrF at 37°C. In vitro transcribed RNA including the 
5' UTR of lcrF (-123 to +63 relative to the lcrF start codon) was incubated with or without 30S ribosomal 
subunits (indicated above the gel) at 25°C and 37°C. Full length product, termination products and the “toe print” 
(encircled) of the primer extension inhibition experiment are indicated. The sequencing reaction (ACGT) was 
carried out with the same labeled primer used for the toe print experiment. The lcrF start codon AUG, the 
ribosomal binding site (rbs) and the FourU motif in the corresponding RNA sequence are marked. Numbers 
correspond to nucleotides relative to the start codon of lcrF. 
In summary, addition of 30S ribosomal subunits to the lcrF 5' UTR resulted in the formation 
of an mRNA-ribosome-tRNAfMet ternary complex which inhibited the primer extension at 37°C. 
At 25°C, only full length transcript was observed indicating that the binding site for the 
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ribosomes along the RNA was not accessible. In conclusion, access of the ribosomal binding 
site and so lcrF translation initiation is temperature-controlled. Even small temperature-
induced changes within the secondary structure are sufficient to allow ribosome access and 
interaction with the Shine-Dalgarno sequence in the 5' UTR of Y. pseudotuberculosis lcrF. 
3.2.8 Mutations in the FourU motif alter temperature-controlled 
accessibility of the Shine-Dalgarno sequence 
The FourU motif and adjacent bases in the lcrF 5' UTR were mutated to determine whether 
the binding of ribosomes to the Shine-Dalgarno sequence at 25°C and 37°C was altered by 
nucleotide exchanges. Complementarity of the base pairing between the ribosomal binding site 
and the FourU region was increased by exchanging UU at positions -28 to -27 into CC 
(UU-28/-27CC). Furthermore, destabilizing mutations were introduced at positions -30 to -28, 
changing GUU into AAA (GUU-30/-28AAA). RNA structure probing with RNases V1 and T1 
were performed at 25°C and 37°C with these variants which comprised the 5' UTR of lcrF 
and the following first ten bases of the 5' coding region (Fig. 49A). 
Enzymatic probing within the region from +10 to -34 of the UU-28/-27CC RNA with 
improved base pairing displayed similar cleavage patterns at 25°C and 37°C. Strikingly, 
cleavage products of the RNase T1 at G-15 and G-16 were barely detectable and no 
differences were observed in the intensity of the products at 25°C and 37°C. RNase V1 
cleavage in the region adjacent to the Shine-Dalgarno region was observed approx. at 
positions -34 to -33,  -29 to -22, -20 to -19, -8 to -6 and upstream of +1 (Fig. 52A). In 
summary, strongly improving the complementarity of the FourU motif to the Shine-Dalgarno 
sequence reduced the ability of the two Gs within in the ribosomal binding site to become 
single-stranded at both, low and higher temperatures. In fact, melting and cleavage of the 
RNA at these two nucleotides was still strongly reduced at 37°C, suggesting that the 
complete secondary structure remained stable with increasing temperatures. 
RNase V1 digestion of the lcrF 5' UTR with mutations GUU-30/-28AAA revealed many 
cleavage sites over longer regions but the concentration of the cleavage products due to the 
cleavage at positions -37 to -27, -18 to -17 and -13 to -10 was significantly reduced compared 
to the wild type. Positions -21 and -20 as well as position -6 to -1 exhibited a stronger 
accessibility to RNase V1 at 37°C than at 25°C. Cleavage of RNase T1 at single-stranded Gs 
or As was also observed in regions from -37 to -34, -18 to -15 and -12 to -7. Furthermore, 
position G-15 and G-16 displayed reduced protection against the digest by RNase T1 at 37°C 
as the intensity increased strongly compared to 25°C. Defined signals of the GUU-30/-28AAA 
RNA under control conditions were also detected at positions -37 to -34, -18 to -17 and -13 
to -12 in the absence of RNases indicating that the secondary structure is generally less stable 
(Fig. 52B).  
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Fig. 52. Mutations within the FourU motif alter temperature-dependent structural rearrangements of the 
lcrF 5' UTR. RNA structure probing of the lcrF 5' UTR with nucleotide exchanges either at (A) UU-28/-27CC or 
(B) GUU-30/-28AAA were applied to enzymatic cleavage at 25°C and 37°C using RNase T1 (cuts ss G, 
0.001 U/μl) and RNase V1 (cuts ds RNA, 0.0002 U/μl). RNA fragments were separated by 8% polyacrylamide gel 
electrophoresis. Cleavage products of the 3' end are shown. Lane C contains the RNA without addition of RNases. 
The alkaline reference ladder is loaded in lane L. Selected nucleotides represent RNaseT1 cleavage sites and are 
marked with arrows. Numbers indicate nucleotides relative to the lcrF start codon. The ribosomal binding site is 
indicated by “rbs” and partial sequences were applied to the gel. 
Although the 5' UTR of lcrF with an exchange at GUU-30/-28AAA seems less stable, a 
different cleavage pattern with a shorter double-stranded region adjacent to the Shine-
Dalgarno sequence was observed in the mutant compared to the wild type RNA. Reduced 
complementarity resulted in decreased stem structure formation within this region. This is 
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supported by the detection of single-stranded Gs in the ribosomal binding site, which occur at 
low and even more intense at 37°C. In contrast, two small regions upstream of the AGGA 
motif and a second further downstream towards the start codon revealed increased formation 
of double strands at 37°C which implies strong tension and topological rearrangements within 
the RNA molecule (Fig. 51).  
In order to monitor the effect of structural changes of the lcrF 5' UTR caused by the 
stabilizing or destabilizing mutations on the formation of ribosome-RNA complexes, toe 
printing experiments were performed. To do so, primers were annealed to an in vitro 
transcript including the lcrF 5' UTR plus 63 nucleotides of the coding region with 
UU-28/-27CC or GUU-30/-28AAA mutations. 30S ribosomal subunits from E. coli and 
tRNAfMet were added and the primer extensions were carried out at 25°C or 37°C. Primer 
extension of the UU-28/-27CC RNA at 25°C resulted in full length transcript as well as 
termination signals corresponding to positions from -12 to -14 and -50 to -51. This indicates 
the formation of a stable double-stranded region, which interferes with the primer extension 
reaction. Addition of ribosomes to the reaction reduced the amount of termination product 
but increased the concentration of full length transcript in comparison to the reaction without 
ribosomal subunits. At 37°C, mainly full length product was synthesized in the absence of 
ribosomes, although the overall amount of the transcript was generally low. Primer extension 
of UU-28/-27CC RNA at 37°C with ribosomes led to high concentrations of full length 
product, with similar termination products observed at 25°C. A very light toe print was only 
observed from incubation at 37°C with ribosomes, indicating that the Shine-Dalgarno 
sequence is weakly accessible to the ribosomes (Fig. 53). 
Exchange of GUU (-30/-28) against AAA within the lcrF 5' UTR led to full length transcripts 
in the presence or absence of ribosomal subunits at 25°C. Primer extension of 
GUU-30/-28AAA RNA without ribosomes produced some transcripts terminating at 
positions -50 to -51 relative to the start codon. Strikingly, a weak toe print result was already 
observed at 25°C when the reaction was supplemented with ribosomes. The amount of toe 
print transcript increased strongly when primer extension was performed at 37°C in the 
presence of ribosomes. In this reaction, levels of full length transcript were reduced compared 
to that at 37°C without ribosomal subunits (Fig. 53). 
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Fig. 53. Mutations within the 5' UTR of LcrF alter access of ribosomes to the Shine-Dalgarno sequence. In 
vitro transcribed 5' UTR of lcrF (-123 to +63 relative to the lcrF start codon) with mutations UU-28/-27CC (red) 
or GUU-30/-28AAA (green) were incubated with or without 30S ribosomal subunits (indicated above the gel) at 
25°C and 37°C. Full length product, termination products and toe print signals of the primer inhibition experiment 
are indicated. The sequencing reaction (ACGT) was performed with the same labeled primer as for the toe print 
experiment. The lcrF start codon AUG, the ribosomal binding site (rbs) and the FourU motif in the corresponding 
RNA sequence are marked. Numbers correspond to nucleotides relative to the start codon of lcrF. 
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Introducing perfect base pairing between the FourU motif and the Shine-Dalgarno sequence in 
the lcrF 5' UTR led to a significant inhibition of primer extension at elevated temperatures. 
Formation of the mRNA-ribosome-tRNAfMet ternary complex is impaired by the higher 
complementarity. The high amount of early termination transcripts further indicated a tight 
secondary RNA structure which interferes with the activity of the reverse transcriptase.  
In contrast, imperfect base pairing by mutating GUU (-30/-28) to AAA within the FourU 
motif improved toe print formation. RNA-ribosome interaction and blockage of the extension 
reaction occurred already at moderate temperature and was considerably increased at 37°C. 
Ribosomes showed to have elevated access to the Shine-Dalgarno sequence, which is exposed 
due to inefficient base pairing already at 25°C. 
In conclusion, in vivo expression as well as structural and mutational analysis of the yscW-lcrF 
intergenic region demonstrated that LcrF synthesis is temperature-regulated at two levels. 
YmoA controls transcription of the yscWlcrF operon in response to temperature changes. In 
addition, LcrF production is controlled by temperature on the post-transcriptional level by a 
FourU thermometer. At low temperatures, ribosomal access to the Shine-Dalgarno sequence is 
blocked by base pairing to a FourU motif. Increasing the temperature induces liberation of the 
ribosomal binding site by conformational alterations mainly within this region and allows 
access of the ribosomes. These small changes are sufficient to enable translation initiation for 
protein synthesis, although the entire structure is essential to allow optimal control of the lcrF 
5' UTR. 
3.2.9 The RNA chaperone Hfq activates LcrF synthesis in 
Y. pseudotuberculosis 
In Y. pestis, the RNA chaperone Hfq was found to repress the expression of components of 
the type III secretion system, the Yop effector genes and their activator LcrF (Geng, et al. 
2009). In contrast to Y. pestis, Hfq of Y. pseudotuberculosis strain IP32953 was shown to 
stimulate gene expression of these virulence factors (Schiano, et al. 2010). In order to 
determine the influence of Hfq on LcrF synthesis in Y. pseudotuberculosis YPIII, an 
yscW '-'lacZ fusion (pKB35) was introduced into wild type strain and the hfq mutant strain 
YP80 to monitor the Hfq effect on transcription of the yscWlcrF operon. For overexpression 
and complementation of hfq, an hfq+ plasmid (pAKH115) was transformed into both strains 
and expression of the yscWlcrF fusion was determined in overnight cultures of the strains 
grown at 25°C and 37°C. Furthermore, whole cell extracts were prepared to determine LcrF 
protein production. At 25°C, yscW-lacZ expression in an hfq mutant was about 50% reduced 
compared to wild type, whereas hfq overexpression resulted in 1.3fold increase of 
transcription. Activity of the yscW '-'lacZ construct was slightly increased at 37°C independent 
of the amount of Hfq, indicating that Hfq has no major effect on the yscW promoter at this 
temperature (Fig. 54A). In contrast, LcrF protein synthesis was strongly activated in the 
absence of hfq, whereas overproduction of Hfq completely abolished LcrF synthesis 
(Fig. 54B). 
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Fig. 54. Hfq activates expression of yscW at 25°C, but represses LcrF synthesis at 37°C. A. Y. pseudo-
tuberculosis YPIII and YP80 (hfq -) harboring an yscW '-'lacZ fusion (pKB35) and an empty vector pV (pAKH85) 
or the hfq+ plasmid (pAKH115) were cultivated overnight in LB medium at 25°C and 37°C. β-galactosidase 
activity was measured and is given in µmol/(min·mg). The data represent the mean ± standard deviation of three 
independent experiments, each performed in duplicate. B. LcrF protein levels were monitored in 
Y. pseudotuberculosis YPIII and YP80 (hfq -) carrying an empty vector pV (pAKH85) or the hfq+ plasmid 
(pAKH115) grown overnight in LB medium at 37°C. Whole cell extracts were prepared and separated by 12% SDS 
gel electrophoresis. LcrF was detected by immunoblotting using a specific polyclonal antibody. A molecular weight 
marker was loaded and LcrF protein is labeled by an arrow.  
Hfq seems to control LcrF production in Y. pseudotuberculosis YPIII at both, transcriptional 
and post-transcriptional level, in response to temperature. At 25°C, Hfq activates transcription 
of the yscWlcrF operon whereas no major influence of Hfq was observed at 37°C. In contrast, 
LcrF protein synthesis was strongly repressed by Hfq. This suggested a post-transcriptional 
mechanism of Hfq-mediated inactivation of LcrF synthesis. To further analyze this hypothesis, 
expression of a translational yscWlcrF '-'lacZ fusion (pKB34) including the 5' UTR of lcrF was 
studied in Y. pseudotuberculosis YPIII and YP80 (hfq -). To complement the hfq deletion, hfq 
was overexpressed from a plasmid (pAKH115). β-galactosidase activity was measured from 
overnight cultures at 25°C and 37°C. Transcription of the yscWlcrF '-'lacZ fusion was slightly 
reduced in an hfq mutant strain and somewhat higher expressed upon Hfq overexpression at 
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25°C very similar to the yscW '-'lacZ fusion at the same temperature (Fig. 54). Additional hfq 
expression enhanced yscWlcrF '-'lacZ expression approx. 1.7fold relative to wild type activity. 
However, this yscWlcrF '-'lacZ expression pattern was significantly different at 37°C. Loss of 
hfq led to a 2.5fold increase of yscWlcrF '-'lacZ expression and this phenotype could be 
complemented by overexpression of hfq (Fig. 55). 
 
Fig. 55. Hfq represses LcrF synthesis at 37°C. Expression of an yscWlcrF '-'lacZ fusion (pKB34) in 
Y. pseudotuberculosis YPIII and YP80 (hfq -) carrying an empty vector pV (pAKH85) or the hfq+ plasmid 
(pAKH115) grown overnight in LB medium at 25°C and 37°C was determined by analysis of the β-galactosidase 
activity. Enzyme activity is given in µmol/(min·mg). The data represent the mean ± standard deviation of three 
independent experiments, each performed in duplicate. 
In summary, Hfq seems to activate transcription of the yscWlcrF operon at moderate 
temperatures. At 37°C, however, Hfq was found to repress LcrF production on the post-
transcriptional level. In particular, the region upstream of the lcrF coding region appears to be 
implicated in this control process. 
LcrF synthesis in Y. pseudotuberculosis and activation of LcrF-controlled late virulence factors 
underlies a complex regulation in response to temperature. The nucleoid-structuring protein 
YmoA represses transcription of the yscWlcrF operon. Furthermore, a thermoswitch structure 
controls LcrF protein synthesis post-transcriptionally in response to temperature and the RNA 
chaperone Hfq affects LcrF production on both levels. This chromosomal factor upregulates 
lcrF gene transcription at 25°C but reversely represses LcrF synthesis, most probably by 
affecting the 5' untranslated region of lcrF at 37°C. 
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4 Discussion 
4.1 YmoA activates rovA expression by stabilizing the CsrC 
RNA 
An infection with Y. pseudotuberculosis depends on the efficient transition of the bacterium 
from the gut lumen through the epithelial cell layer to the underlying lymphatic tissues. To 
attach and invade into the M-cells within the gut epithelium, the pathogen expresses the 
outer membrane protein invasin (Inv) (Dersch and Isberg 1999; Dersch and Isberg 2000). Its 
production is activated by the global transcriptional activator RovA which is synthesized 
during growth in nutrient rich medium when the amount of the LysR-like repressor RovM is 
reduced (Heroven and Dersch 2006; Heroven, et al. 2004; Nagel, et al. 2003; Revell and Miller 
2000). Under these conditions the regulatory RNA CsrC of the carbon storage regulator 
system is highly expressed and binds the RNA-binding protein CsrA, resulting in an 
inactivation of RovM synthesis (Heroven, et al. 2008). In a gene bank screen for additional 
rovA regulators, the nucleoid-associated protein YmoA, a member of the Hha-family, was also 
found to control rovA expression. 
This study showed that YmoA in Y. pseudotuberculosis activates rovA indirectly and leads to 
upregulation of the RovA-dependent inv gene. Downregulation of rovA expression occured by 
stimulating the production of the LysR-type regulator RovM (Fig. 14 and Fig. 15). However, 
a previous study reported that YmoA represses inv expression in Y. enterocolitica, whereas 
rovA remained unaffected (Ellison and Miller 2006; Ellison, et al. 2003). In this study, a 
different strategy was used to eliminate YmoA function. An insertion was introduced into the 
open reading frame upstream of ymoA, designated “ymoB” in order to cause a polar effect on 
ymoA expression. Furthermore, a negative effect of YmoA on Y. enterocolitica inv expression 
was only observed when ymoA was overexpressed from a plasmid. In an earlier study, we 
could also show that overexpression of ymoA from a plasmid downregulated transcription 
from the Y. pseudotuberculosis inv promoter but not rovA expression (K. Böhme, unpublished 
data). These results are explained by unspecific effect accompanying overexpression of 
members of this protein family. For instance, in an hha mutant, YmoA was also able to 
repress transcription of hlyCABD when expressed from a midi-copy vector but not from a low-
copy vector (Balsalobre, et al. 1996). This and other observations in our group indicate that 
multiple copies of the ymoA gene alter regulation patterns of multiple genes unspecifically. 
High YmoA concentrations were found to result in unspecific binding of YmoA to normally 
non-regulated promoters. Thus, balanced YmoA protein levels seem to be crucial for proper 
gene regulation in Yersinia.  
Experiments in this work clearly demonstrated that YmoA-mediated activation of rovA 
expression is the result of YmoA-mediated repression of RovM production by upregulation of 
CsrC RNA levels (Fig. 17). Experimental data in this work demonstrated that YmoA stabilizes 
the CsrC RNA by an indirect mechanism, since direct RNA-protein interaction was not 
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observed (Fig. 26 and Fig. 28). Turnover of regulatory RNAs such as CsrC is usually subject 
to degradation by RNases, stabilization by RNA-binding proteins and chaperones or base 
pairing with other regulatory RNAs. In P. aeruginoasa, levels of the Csr-like RNAs RsmY and 
RsmZ are preferentially degraded by RNase G, which itself is controlled by a two-component 
system (Petrova and Sauer 2010). In fact, microarray analysis of an ymoA mutant versus 
Y. pseudotuberculosis wild type indicated that ymoA represses transcription of components of 
several RNases such as endoribonuclease L-PSP or RNase P (A. K. Heroven, K. Böhme, 
unpublished data). Little is known about the function of endoribonuclease L-PSP, also 
referred to as rat liver perchloric acid-soluble protein. L-PSP was found to cleave RNA 
molecules primarily at single-stranded regions producing 3' monophosphate ends (Morishita, 
et al. 1999). RNase P is a highly conserved ribonuclease found in all eu- and prokaryotes 
where it was first described to mainly cleave 5' ends of pre-tRNAs (Guerrier-Takada, et al. 
1983). More recently, RNase P was shown to be implicated in the regulation of metabolic 
processes. RNase P in E. coli was found to cleave intergenic regions within mRNA operons, 
including that of tna (tryptophane biosynthesis), his (histidine synthesis), rbs (ribose 
transport) and sec operons (protein secretion system) (Li and Altman 2003). Furthermore, 
ribonuclease P is responsible for the cleavage of some metabolite-binding regulatory RNAs so-
called riboswitches. For instance, RNase P affects the stability of coenzyme B12 riboswitch of 
E. coli as well as of Bacillus subtilis (Altman, et al. 2005). Seif and Altman (2008) 
demonstrated an RNase P-dependent cleavage of an adenine riboswitch of the pbuE gene, 
encoding a purine efflux pump in B. subtilis. Thus, RNase P seems to preferentially cleave 
RNAs with secondary structures, and might be a likely candidate implicating the control of 
CsrC RNA stability. 
In fact, a ymoA deletion of Y. pseudotuberculosis only affected expression of a csrC-lacZ 
fusion when sequences forming such a secondary structure were present in the fusion 
construct (Fig. 20). The stem-loop structure could serve as a potential RNase target site. 
Whether the RNases such as RNase P or L-PSP affect CsrC levels in Y. pseudotuberculosis 
still needs to be determined.   
It was also shown that, in the absence of ymoA, transcription of the second Csr RNA gene, 
csrB, was slightly induced. This might be due to counterregulation of the Csr RNAs in 
Y. pseudotuberculosis, by which downregulation of one Csr RNA induces the expression of the 
other (Heroven, et al. 2008). Overexpression of the response regulator UvrY has been shown 
to be the only known stimulating signal for CsrB production, and YmoA was found to induce 
the transcription of the uvrY gene (Fig. 18). Interestingly, other members of the YmoA family 
were also shown to control two component systems. For instance, Hha in Salmonella affects 
intracellular growth of the pathogen during host infection by blocking the transcription of ssrB 
and ssrA (Silphaduang, et al. 2007), essential for the expression of type III secretion system 
genes from SPI-2 (Cirillo, et al. 1998; Tomljenovic-Berube, et al. 2010). However, YmoA-
mediated activation of uvrY was rather small and indirect, and does not explain strong 
YmoA-mediated increase of CsrC levels. In fact, elimination of csrB did not abolish YmoA 
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influence on CsrC levels (Fig. 19). This indicates that the influence on CsrC stability is much 
more dominant than the YmoA effect on UvrY and CsrB which reduce CsrC expression. 
Interestingly, it was found that YmoA does not only regulate rovA expression by activating 
the synthesis of CsrC but might influence RovA synthesis by a different mechanism. A ymoA 
deletion in Y. pseudotuberculosis revealed a stronger impact on RovA protein levels than a 
csrC deletion mutant investigated by Heroven et al. (2008). Furthermore, in a rovM mutant, 
YmoA did not significantly alter gene expression of rovA but protein production (Fig. 14). 
Herbst and coworkers (2009) analyzed that RovA represents a substrate for the ATP-
dependent Lon protease. Microarray analysis in our laboratory revealed increased lon 
transcription in a ymoA mutant (A. K. Heroven, K. Böhme, unpublished data). This indicates 
that YmoA might not only control rovA expression but also RovA protein degradation to 
ensure a tightly regulated invasin synthesis. The presence of the nucleoid-associated protein is 
essential for early virulence factor expression. 
4.1.1 CsrA acts as a chaperone for CsrC stabilization 
Besides YmoA, also the RNA-binding protein CsrA was shown to strongly influence CsrC 
stability. Interestingly, CsrA in Y. pseudotuberculosis did not influence expression of csrC-lacZ 
fusions with varying 3' portions of the csrC gene (Fig. 23). This indicated that CsrA mediates 
stabilization of CsrC and/or proper folding of the regulatory RNA. CsrA interaction with a Csr 
RNA to prevent degradation of the non-coding RNA has also been shown for other Csr-like 
systems. In E. carotovora subsp. carotovora the CsrA homolog RsmA increases the half-life of 
the non-coding RNA RsmB (Chatterjee, et al. 2002). Similarly, RsmA and its homolog RsmE 
in P. fluorescens stabilize the RsmY and RsmZ (Reimmann, et al. 2005). CsrB in E. coli, 
however, showed no dependency on CsrA (Gudapaty, et al. 2001).  
One reason why CsrA-binding to Csr-type RNAs such as CsrC might lead to stabilization of 
the RNA could be the protection of RNase recognition sites. Csr RNAs have been observed to 
be degraded by RNase E, for example CsrC and CsrB in Salmonella (Viegas, et al. 2007). In 
P. aeruginosa, RsmY is subject to degradation by RNase E. RsmA covers one cleavage site of 
RNase E within RsmY which might contribute to the stabilization of the RNA (Sorger-
Domenigg, et al. 2007). Similarly, Suzuki et al. (2006) found that CsrC as well as CsrB were 
stabilized in an RNase E mutant in E. coli. RNase E is a single-strand specific endo-
ribonuclease which recognizes AU-rich regions whose substrate binding is enhanced by the 
interaction with monophosphorylate 5' ends (Mackie 1998). Moreover structural analysis 
revealed that RNase E might interact with structured RNA substrates, which was observed for 
interaction with its own 5' untranslated region forming a stem-loop (Koslover, et al. 2008; 
Schuck, et al. 2009). In E. coli, a fourth component of the Csr system was found to influence 
stability of the Csr RNAs CsrC and CsrB. The specificity factor CsrD was found to bind to 
CsrB and CsrC, which targeted these RNAs for RNase E degradation (Suzuki, et al. 2006). 
CsrD in Y. pseudotuberculosis was not found to influence RovA synthesis and thereby unlikely 
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encounters a significant role in the regulation of RovA production mediated by CsrC 
(A. K. Heroven, unpublished results).  
This work demonstrated, that deletion of csrA results in a more rapid degradation of the CsrC 
RNA than a deletion of ymoA. Moreover, overexpression of CsrA stabilizes the CsrC RNA also 
in the absence of YmoA, whereas YmoA overexpression could not restore CsrC levels in a 
csrA mutant (Fig. 26 and Fig. 27). This suggests that CsrA-binding to CsrC is essential for 
the abundance of the RNA within Y. pseudotuberculosis. YmoA might promote interaction of 
CsrA and CsrC or might be involved in the regulation of an RNase that controls CsrC 
stability. 
4.1.2 Environmental control of CsrC levels by YmoA and CsrA 
Experimental data in this study revealed that YmoA protein synthesis is strongly regulated by 
environmental parameters such as temperature, growth and medium components. High YmoA 
protein concentrations occur mainly during the exponential phase in complex medium at 25°C. 
YmoA was observed throughout the entire growth of Yersinia with low protein levels during 
the stationary phase at moderate temperatures but the nucleoid-associated protein was 
completely absent during exponential growth in minimal medium at 37°C (Fig. 29, Fig. 30 
and Fig. 56). 
YmoA concentrations decreased rapidly at 37°C due to the activity of ATP-dependent 
ClpP/Lon proteases (Fig. 31). This is in full agreement with data obtained for YmoA stability 
in Y. pestis at higher growth temperatures (Jackson, et al. 2004). Ellison et al. (2006), 
however, reported that YmoA in Y. enterocolitica was found to be synthesized at 26°C as well 
as 37°C.  
The RovA protein represents another regulatory factor of Y. pseudotuberculosis within the 
invasin expression cascade that is rapidly degraded at higher temperatures by the Lon 
protease (Herbst, et al. 2009). YmoA is most prominent during the exponential growth, 
whereas RovA is predominantly proteolysed during log phase at 37°C, perhaps due to the 
absence of a stabilizing cofactor. This indicates that degradation of YmoA by Clp and Lon 
proteases is controlled by a different mechanism. Enhanced degradation of YmoA might be 
the result of an upregulated lon expression during stationary phase (Herbst, et al. 2009). 
Interestingly, lon expression was also found to be stimulated in the absence of ymoA, 
indicating a negative autoregulatory circuit for YmoA (A. K. Heroven, K. Böhme unpublished 
results). Decreasing YmoA levels induce the expression of the lon gene which in turn leads to 
further proteolysis of the regulator. This shows that controlled proteolysis of the crucial 
virulence regulators such as YmoA is very important for pathogenesis in Y. pseudo-
tuberculosis. In fact, Clp/Lon proteases have shown to be implicated in virulence in other 
pathogens. Expression of virulence factors from SPI-1 in S. Typhimurium was induced in 
clpXP mutants causing enhanced macrophage apoptosis. Transcription of the activatory 
factors hilC and hilD was elevated under these conditions (Kage, et al. 2008). Moreover, Lon 
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protease activity was found to decrease survival of Salmonella in HEp-2 cell cultures 
(Boddicker and Jones 2004). In Campylobacter, inactivation of protease encoding genes lon, 
clpP and clpX resulted in less viability of the bacterium at 42°C due to accumulation of 
misfolded proteins within the cell (Cohn, et al. 2007). The ClpXP protease was also observed 
to regulate virulence in Streptococcus mutans by cleaving the global regulator Spx (Kajfasz, 
et al. 2009). 
Thermodependent proteolysis and regulation of gene transcription is known also for other 
YmoA homologous members of the related H-NS family. Deletion of the hns and hha genes in 
E. coli leads to transcription of the hlyCABD operon at moderate temperatures (Nieto, et al. 
2000). An hha hns double mutant also allowed synthesis of virulence factors from SPI-1 of 
S. Typhimurium at low temperature (Olekhnovich and Kadner 2006; Olekhnovich and Kadner 
2007). In E. coli, the nucleoid-associated protein StpA, homologous to H-NS is as well subject 
to proteolysis by Lon. Johannson and Uhlin (1999) described that StpA is degraded in the 
absence of H-NS, which stabilizes the protein in heteromeric H-NS-StpA dimers (Johansson, 
et al. 2001). 
In contrast to YmoA, CsrA synthesis increased continuously during the growth of 
Y. pseudotuberculosis with a maximum in late stationary phase in complex medium. In 
general, expression of csrA was lower at 37°C compared to growth at moderate temperatures 
(Fig. 29, Fig. 30 and Fig. 56). This is different to other CsrA-type proteins such as RsmA of 
Erwinia, which was upregulated in minimal medium at 37°C (Hasegawa, et al. 2005) or CsrA 
in E. coli which was found to be synthesized predominantly in minimal medium though at low 
levels (Jonas and Melefors 2009). 
 
Fig. 56. Levels of YmoA, CsrA and CsrC during growth at 25°C and 37°C in nutrient-rich medium. Model of 
protein (YmoA and CsrA) or RNA (CsrC) levels at 25°C (blue) and 37°C (red). Qualitative amounts are displayed 
during the exponential, early stationary and stationary growth. Increasing levels are marked by an arrow. 
Both, YmoA and CsrA determine the stability and intracellular concentrations of CsrC which 
increased during stationary growth at 25°C. At 37°C, CsrC level reached a maximum during 
the late exponential growth but decreased again during stationary phase, most likely due to 
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YmoA degradation (Fig. 30 and Fig. 56) (Heroven, et al. 2008). A similar temperature 
regulation was observed for the expression of the Csr-like RNAs RsmX, RsmY and RsmZ in 
P. fluorescens where transcription of the RNAs' encoding genes was more induced at 30°C 
than at 35°C (Humair, et al. 2009).  
In summary, CsrC is mainly present during stationary growth, complex medium and moderate 
temperatures, i.e. rovA inducing conditions (Nagel, et al. 2001). This strongly suggests that 
CsrA, which is maximally expressed under these environmental signals, contributes dominantly 
to the stability of the CsrC RNA. On the other hand, Yersinia produces low amounts of 
YmoA under these conditions and this concentration is still sufficient and important to 
promote CsrC stability. High YmoA protein concentrations during the exponential phase 
indicate that the nucleoid-associated protein might be involved in the regulation of additional 
genes important for growth and survival. 
4.1.3 Hfq activates csrC gene expression 
Besides YmoA, the RNA chaperone Hfq was shown to be important for csrC expression and 
CsrC-dependent rovA transcription. Hfq activates the transcription of the csrC gene, whereas 
no influence of Hfq was observed on CsrC RNA stability (Fig. 32 and Fig. 33). In contrast to 
Y. pseudotuberculosis, it was found that loss of hfq in Y. pestis led to 6.5fold increased 
transcript expression of rovA (Geng, et al. 2009). However, this was shown in microarray 
analysis, with RNA of bacteria grown at 37°C, conditions under which RovA is rapidly 
degraded (Herbst, et al. 2009). As RovA of Y. pestis is not required to activate inv expression 
because this gene is not expressed due to a transposon insertion, it is also possible that the 
RovA protein encounters a different role in Y. pestis and is differently regulated (Simonet, et 
al. 1996). In fact, RovA regulons were observed to be distinct between Y. enterocolitica and 
Y. pestis suggesting that RovA-regulated genes have evolved in Y. pestis more recently 
(Cathelyn, et al. 2007). Deletion of hfq in Y. pestis did not significantly change cell adhesion 
of bacteria to macrophages but phagocytosis by macrophages was increased (Geng, et al. 
2009). This indicates that Hfq is important for Y. pestis defense against the host immune 
response. In agreement with these results, virulence of an hfq-deficient Y. pestis strain was 
strongly reduced in mouse experiments, indicating that Hfq is responsible for the regulation of 
other important virulence determinants (Geng, et al. 2009).  
Virulence of other pathogens has also been shown to be dependent on the RNA chaperone 
Hfq. In enterohemorrhagic E. coli, EHEC, regulation of factors expressed from the locus of 
enterocyte effacement (LEE) is affected by the RNA chaperone. Hfq influences the mRNAs of 
these virulence determinants controlling the formation of attaching and effacing lesions 
especially during the exponential phase of growth (Hansen and Kaper 2009). Additionally, Hfq 
is involved in quorum sensing regulation in V. cholerae, where it destabilizes the mRNA of the 
master regulator HapR, which activates expression of tcpA encoding a main part of the toxin-
coregulated pilus (Lenz, et al. 2004). On the other hand, Hfq is reported to repress ompT 
synthesis in this pathogen (Song, et al. 2010). Deletion of hfq reduced virulence of 
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N. meningitidis (Fantappie, et al. 2009). Virulence of an hfq mutant in S. Typhimurium was 
attenuated in mice infection experiments (Sittka et al., 2007). Loss of the RNA chaperone 
induced drastic effects on the invasiveness of Salmonella into epithelial cells. Survival of the 
bacteria in epithelial cells and macrophages was also reduced. InvR, a non-coding RNA 
expressed from SPI-1 was found to downregulate the synthesis of the outer membrane 
protein D (OmpD) in presence of Hfq. Further, the chaperone is essential for the production 
of the sigma factor RpoS, which implicated control of SPI-1 through the regulation of HilA 
(Pfeiffer, et al. 2007; Sittka, et al. 2007).  
In Y. pseudotuberculosis, Hfq positively affects both Csr RNAs CsrC and CsrB (Fig. 32). 
However, Hfq stimulates csrC on the transcriptional level (Fig. 35), whereas the second 
known RNA of the Csr system, CsrB, was influenced on the post-transcriptional level 
(A. K. Heroven, J. Viereck, unpublished data). CsrB was found to be degraded more rapidly in 
an hfq mutant than in the wild type strain. Hfq in P. aeruginosa is also responsible for 
stabilization of the Csr-like RNA RsmY. The RNA chaperone binds to RsmY at single-
stranded RNA regions adjacent to stem-loop formations. The Hfq-binding sites overlap with 
recognitions sites of RNase E and might stabilize the Csr-like RNA post-transcriptionally by 
preventing RNase activity (Sorger-Domenigg, et al. 2007). In contrast to Y. pseudo-
tuberculosis, CsrC and CsrB in Salmonella, which induce expression of genes from SPI-1, were 
not influenced by Hfq (Viegas, et al. 2007). Stability of CsrC and CsrB from E. coli was also 
independent of the RNA chaperone, since half-life of the RNAs did not change significantly in 
comparison to the wild type. 
Promoter deletion analysis performed in this study to characterize csrC transcription 
demonstrated that 200 nucleotides upstream of the csrC transcription start are essential for 
csrC expression. Furthermore, a Yersinia-specific positive regulator is required for maximal 
csrC expression (Fig. 36). As Hfq acts mainly as an RNA chaperone, it is unlikely that Hfq 
activates csrC directly. Up to now, only expression of rpsO in E. coli, which encodes for the 
ribosomal protein S15, was observed to underlie transcriptional activation by Hfq. The 
chaperone protein induced the transcription of rpsO in vivo and in vitro. 
Le Derout et al. (2010) hypothesized that Hfq prevents the arrest of the transcription 
complex within a secondary structure by unfolding the nascent mRNA. In Y. pseudo-
tuberculosis, interaction of an activatory component with the csrC promoter region occurs in 
position -204 and -106 upstream of the transcriptional start site (Fig. 36), but for an rpsO-
like activation mechanism Hfq might need to interact more closely to the RNA polymerase 
binding site. Alternatively, Hfq might influence synthesis of a csrC activator protein through 
the control of other regulatory RNAs. 
Up to date, little is known about how csrC gene expression is regulated in Y. pseudo-
tuberculosis. Latest results in our laboratory showed that csrC promoter activity depends on 
the access to iron. Further, the cyclic AMP receptor protein was found to be essential for 
csrC transcription activation in Y. pseudotuberculosis. However, both positive regulation 
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mechanisms seem to be independent of Hfq function (A. K. Heroven, S. Nordlohne, M. Scheb-
Wetzel, unpublished results).  
In summary, the Hfq protein is essential for the expression of rovA and RovA-dependent 
invasin expression in Y. pseudotuberculosis, although its effect on virulence still needs to be 
investigated in strain YPIII. Its differential influence on CsrC and CsrB points out, that these 
RNAs might not only represent redundant RNA molecules to induce rovA expression but 
encounter distinct functions within the pathogen. 
4.1.4 H-NS stimulates CsrC synthesis 
The H-NS protein of Y. pseudotuberculosis, another related member of the nucleoid-
structuring protein family, was also shown to positively influence CsrC synthesis post-
transcriptionally in this study (Fig. 37). It seemed possible that H-NS exerts its influence on 
CsrC stability by binding to the RNA. Interaction of H-NS with RNAs has previously been 
shown. For instance, Park et al. (2010) analyzed that H-NS stimulates translation of the 
mRNA into the transcriptional activator MalT of the maltose regulon in E. coli. In this case, 
H-NS interacts with the mRNA, which repositions the 30S ribosomal subunit within the 
pre-initiation complex and facilitates its binding to suboptimal Shine-Dalgarno sequences. 
Furthermore, H-NS binds to the mRNA of the sigma factor RpoS (Brescia, et al. 2004). 
Interaction with the nucleoid-associated protein at single-stranded regions destabilized the 
RNA. In contrast, rpoS mRNA of V. cholerae is destabilized in the absence of hns and allows 
synthesis of the cholera toxin under non-permissive conditions (Silva, et al. 2008). 
Brescia et al. (2004) as well elucidated that H-NS binds to the non-coding RNA DsrA in 
E. coli, which enhanced RNA decay. However, RNA binding assays in this study did not reveal 
preferential binding of H-NS to the CsrC transcript (Fig. 39). Moreover, another protein of 
the nucleoid-associated protein family, StpA was also found to act as a RNA chaperone. This 
regulator is able to facilitate the loosening of the td pre-mRNA three-dimensional structure 
which leads to a refolding of the RNA (Mayer, et al. 2002).	 StpA preferentially binds to 
unstructured RNA induced by electrostatic interactions resulting from the negatively charged 
backbone of the RNA molecule. Strikingly, when StpA-binding affinity to RNA was reduced 
by mutations in its RNA-binding domain, its RNA chaperone activity is enhanced. One reason 
for the RNA-binding and chaperone properties of StpA is its disordered protein structure 
(Mayer, et al. 2007). Since StpA and H-NS share structural features, it is also possible that 
H-NS has an RNA chaperone function. This facilitates CsrC loop formation and CsrA-binding 
which needs to be further analyzed.  
H-NS influence on CsrC through a post-transcriptional mechanism is rather unusual as H-NS 
has been mainly found to reduce expression of virulence factors in Yersinia by inhibiting 
transcription. For instance, H-NS was identified to downregulate rovA and inv transcription, 
whereby RovM levels remain unaffected in Y. pseudotuberculosis (Heroven, et al. 2008; 
Heroven and Dersch 2006). A similar mechanism is described for the H-NS-mediated 
regulation of invasin synthesis in Y. enterocolitica (Ellison and Miller 2006). In pathogenic 
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E. coli, H-NS is responsible for the downregulation of virulence factor synthesis such as 
fimbriae or capsular polysaccharides (Muller, et al. 2010). Deletion of hns derepressed the 
transcription of the long polar fimbriae (lpf) leading to enhanced adherence of E. coli 
O157:H7 to tissue-cultured cells (Torres, et al. 2007; Torres, et al. 2008). Rogers and 
coworkers (2009) analyzed that H-NS downregulates the expression of the ehx operon located 
in the LEE pathogenicity island. This operon encodes the enterohemolysin EhxA. An hns-
deficient strain was impaired to bind to human colonic epithelial cells. H-NS also reduces the 
expression of acrEF, mdtEF and emrKY, operons harboring drug transporter systems (Nishino 
and Yamaguchi 2004) and H-NS-dependency was shown for multidrug resistance in 
S. Typhimurium (Nishino, et al. 2009). Due to its dominant influence on gene transcription it 
is most likely that H-NS controls transcription of a regulatory component that affects CsrC 
stability. 
Several studies demonstrated that H-NS is also able form heteromers with YmoA (Nieto, et 
al. 2002). YmoA from Y. enterocolitica was found to associate with H-NS protein purified 
from Yersinia as well as from E. coli. H-NS heteromerization with the YmoA homolog Hha 
modified the DNA-binding affinity of the complex, whereas Hha homomers interacted with 
promoter regions unspecifically (Nieto, et al. 2000). In Salmonella, Hha-mediated suppression 
of gene expression from SPI-1 and the type III secretion system encoded by SPI-2 occurs also 
in cooperation with H-NS (Duong, et al. 2007; Olekhnovich and Kadner 2007). Interaction of 
H-NS with StpA in uropathogenic E. coli causes the reduction of S fimbriae synthesis because 
expression of the major subunit expressing gene sfaA is abolished (Morschhauser, et al. 1993).  
Based on these results it seems also possible that YmoA and H-NS act on CsrC stability in a 
cooperative manner. For example, YmoA-binding to H-NS might enhance the RNA 
chaperone-like function. In fact, H-NS was able to restore CsrC synthesis in the absence of 
YmoA, which indicates an independent mechanism of regulation by H-NS. However, very high 
concentrations were necessary to complement YmoA function. Moreover, findings in this work 
show that H-NS represses YmoA protein levels (Fig. 38). H-NS-dependent ymoA regulation in 
Y. enterocolitica confirms this observation (Banos, et al. 2008). Thus, the influence of H-NS 
on CsrC can occur by different molecular mechanisms which will be addressed in future 
experiments.  
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4.2 The complex control of LcrF synthesis – Activator of late 
stage virulence factors 
For survival and dissemination in the deeper tissues like mesenteric lymph nodes, liver, spleen 
or kidney, Y. pseudotuberculosis produces the outer membrane adhesin YadA and a type III 
secretion system which translocates effector molecules, the Yersinia outer proteins (Yops), 
into host cells (Allaoui, et al. 1995b; Eitel and Dersch 2002; Heise and Dersch 2006; Rosqvist, 
et al. 1995). These virulence determinants are encoded on the Yersinia virulence plasmid pYV 
and their expression is induced by the AraC-like activator LcrF (VirF in Y. enterocolitica) in 
response to higher temperature (37°C) (Cornelis, et al. 1987; Lambert de Rouvroit, et al. 
1992; Simonet, et al. 1990; Skurnik and Toivanen 1992). 
4.2.1 The nucleoid-associated protein YmoA represses expression of the 
yscWlcrF operon  
Analysis of reporter gene fusions in Y. pseudotuberculosis revealed that lcrF forms an operon 
with yscW and that the transcription start site of the lcrF gene is located about 260 bp 
upstream of yscW (Fig. 41 and Fig. 42). Indication supporting an expression of lcrF from an 
operon with yscW was also obtained in Y. pestis. Hoe and coworkers (1992) showed that lcrF 
transcription is only temperature-regulated when two kb of the 5' region of lcrF was present 
in Y. pestis strains KIM5 and KIM6.   
Homologs of the yscWlcrF operon were also found in P. aeruginosa and Vibrio harveyi. The 
activator gene exsA of the type III secretion system in P. aeruginosa is encoded downstream 
of exsB. Alike LcrF, ExsA is a member of the AraC family and is expressed in response to the 
Ca2+ concentration (Hovey and Frank 1995; Vallis, et al. 1999). The function of ExsB is still 
unknown and an exsB transcription product could not yet be detected (Goranson, et al. 
1997). Interestingly, expression analysis revealed an antisense product called exsB ', with 
unknown function. Recent experiments in our group showed also the production of an YscW' 
antisense RNA which stabilized the yscWlcrF transcript when overexpressed (R. Steinmann, 
unpublished data). ExsB exhibits 26% identity to the amino acid sequence of YscW whereas 
ExsA and LcrF of Y. enterocolitica share 56% identity (Allaoui, et al. 1995a). In V. harveyi, 
exsBA expression results in activation of type III secretion genes dependent on quorum sensing 
signals (Waters, et al. 2010). The transcriptional start site of this operon is located 38 nt 
upstream of the exsB start codon. Despite of the homology of the operons, they seem to 
show very distinct properties. In contrast to exsB, the yscW gene in Yersinia was found to 
encode a lipoprotein, which assists a component of the type III secretion system, YscC, to 
localize within the outer membrane (Allaoui, et al. 1995a; Koster, et al. 1997). Furthermore, 
the transcript of yscWlcrF in Y. pseudotuberculosis harbors a long 5' untranslated region 
upstream of the yscW start codon that is subject to intensive processing (K. Böhme, 
R. Steinmann, unpublished data).  
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In this study, it was demonstrated that the nucleoid-structuring protein YmoA affects lcrF 
transcription negatively at moderate temperatures and that a region comprising 360 bp 
upstream of the yscW start codon is important for the YmoA-mediated repression of the 
yscWlcrF operon (Fig. 42). Also in E. coli, the homolog of YmoA, Hha, was shown to repress 
expression of genes encoded by the virulence plasmid pCD1 (homolog of pYV) of Y. pestis 
(Bartra, et al. 2006). Besides control by low calcium concentrations, LcrF (VirF) production 
in Y. enterocolitica has been described to be regulated by temperature-dependent alterations 
in the DNA supercoiling of the promoter region. With increasing temperature the regulatory 
region of lcrF (virF) was found to partially linearize and so induce lcrF (virF) expression. The 
nucleoid-associated protein YmoA was observed to assist structural rearrangements at 
moderate temperatures (Cornelis, et al. 1991; Rohde, et al. 1994; Rohde, et al. 1999). 
However, up to date, YmoA has not been found to bind to DNA by itself, only in association 
with H-NS but reduction of the H-NS function did not influence yscWlcrF expression 
(K. Böhme, S. Sievers, unpublished data). YmoA might regulate expression of the yscWlcrF 
operon by interaction with another regulatory protein. 
In Y. pestis, regulation of lcrF expression in response to temperature occurs due to the 
thermoregulated proteolysis of YmoA by ATP-dependent Clp/Lon proteases. Activity of ClpP 
and Lon proteases was found to stimulate expression of several yop genes and ysc genes 
encoding the type III secretion system by degrading YmoA at 37°C (Jackson, et al. 2004). 
Similar protease-dependent degradation of YmoA was also observed in Y. pseudotuberculosis 
in this study (Fig. 31). Considering, that YmoA upregulates expression of the early invasion 
factor invasin at moderate temperatures but represses transcription of the main regulator of 
late virulence factors lcrF, this nucleoid-associated protein seems to function as a molecular 
switch controlling virulence gene expression during different stages of the infection. 
Immediately after oral uptake from the environment with moderate temperatures, YmoA is 
present and induces expression of invasin through the CsrC-CsrA-RovM-RovA regulatory 
cascade which enables the bacteria to invade into M-cells. Higher temperature within the host 
environment leads to a rapid degradation of the YmoA protein, resulting in LcrF production 
and synthesis of YadA, the Yop effector proteins and the type III secretion system.  
Besides YmoA, other regulatory factors seem to influence transcription of the yscWlcrF 
operon. Promoter deletion experiments indicated that a Yersinia-specific factor stimulates 
yscW transcription through a regulatory segment located about 570 bp upstream of the yscW 
start codon. Data in this study further suggests that this activator might be encoded on pYV 
in Y. pseudotuberculosis (Fig. 42 to Fig. 44). Furthermore, host cell contact was found to 
activate expression of a yscWlcrF '-'gfp fusion (W. Opitz, S. Fehse, unpublished results), 
indicating that a regulatory component might sense the attachment of the bacterium to 
mammalian cells and transduce this signal to activate the yscWlcrF gene. Whether the 
virulence-encoded activator of yscWlcrF expression is also implicated in host cell contact is 
unclear and will be subject of further studies. 
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Induction of virulence factors by host cell contact of the pathogenic bacteria has also been 
observed in Shigella, Salmonella and P. aeruginosa (Ginocchio, et al. 1994; Vallis, et al. 1999; 
Watarai, et al. 1995). P. aeruginosa expresses components of the type III secretion system in 
the presence of the LcrF homolog ExsA, and Urbanowski et al. (2007) found that attachment 
of Pseudomonas to mammalian cells induced ExsA-mediated gene expression of the type III 
secretion machinery or effector proteins. PsrA, a regulator of the fatty acid degradation 
operon, was found to activate the expression of the exsCEBA operon in P. aeruginosa. (Kang, 
et al. 2009).  
4.2.2 A FourU thermometer regulates LcrF translation  
LcrF protein synthesis in Y. pseudotuberculosis is also subject to post-transcriptional 
temperature regulation by formation of a secondary structure in the 5' untranslated region 
(UTR) of the lcrF mRNA (Fig. 46). Such a mechanism was first suggested for the thermo-
dependent LcrF production in Y. pestis (Hoe and Goguen 1993). Recently, Waldminghaus 
et al. (2007) predicted a FourU thermometer in the 5' UTR lcrF which might be responsible 
for translation regulation at moderate or elevated temperatures. Structural mapping, 
computational and toe print analysis in this study demonstrate that within this secondary 
structure the Shine-Dalgarno sequence interacts with a FourU motif at 25°C which masks the 
ribosomal recognition site for translation initiation. At 37°C, conformational changes liberate 
the Shine-Dalgarno sequence and allow access to binding of 30S ribosomal subunits which 
induces LcrF synthesis. Mutagenesis at the FourU sequence, leading to an increased or 
reduced complementarity of the FourU motif to the ribosomal binding site, validated these 
results (sec. 3.2.6 to sec. 3.2.8).  
RNA thermometers are often involved in the synthesis of chaperones essential for the bacteria 
to adapt to higher temperatures. The sigma factor RpoH acts on transcription of target genes 
under various stress conditions. Its translation occurs at elevated temperatures due to 
conformational changes of in the 5' UTR of the rpoH mRNA in E. coli (Morita, et al. 1999a; 
Morita, et al. 1999b). RpoH induces the transcription of another heat shock protein, the 
inclusion body binding protein IbpA. The translation of this protein is activated by increasing 
temperatures which depends on the structure of its 5' UTR comprising three different 
hairpins. In this case, the Shine-Dalgarno site forms base pair interactions with a sequence 
with high complementarity containing a bulged G. Only the third stem-loop of this so-called 
ROSE (repression of heat shock gene expression) element is instabilized (e.g. melted) by 
elevated temperatures, whereas the first two do not change their conformation. They might 
facilitate and stabilize an optimal folding of the ibpA RNA structure (Waldminghaus, et al. 
2009). This is similar to structural alteration of the lcrF RNA thermometer. In Y. pseudo-
tuberculosis, secondary structure changes in response to temperature were only observed 
within hairpin II (Fig. 50 and Fig. 57), whereas the first hairpin remained unchanged. In 
contrast, deletion of hairpin I resulted in efficient translation of a lcrF '-'lacZ fusion and 
significantly higher LcrF production at 25°C which is confirmed by LcrF protein levels 
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(R. Steinmann, unpublished results). RNA structure mapping of the hairpin I deletion mutant 
also showed that it is an unstable RNA molecule (K. Böhme, data not shown). Thus, 
functionality of the LcrF RNA thermometer is not only dependent on the FourU motif itself 
but also requires a correct overall conformation of the complete 5' UTR. 
 
Fig. 57. Small temperature-induced changes of the lcrF 5' UTR secondary structure. RNA secondary structure 
examples predicted by RNAshapes for the lcrF 5' UTR (Steffen, et al. 2006, http://bibiserv.techfak.uni-
bielefeld.de/rnashapes/) at 25°C and 37°C. RBS marks the ribosomal binding site. The FourU motif is indicated. 
5' UTR structure probing of lcrF further demonstrated that an increase in temperature leads 
to relatively small changes of the second hairpin conformation. Only the FourU motif, the 
ribosomal binding site and some adjacent nucleotides underwent conformational changes upon 
a temperature shift from 25°C to 37°C. However, these small changes at 37°C were sufficient 
to allow in vitro binding of the small ribosomal subunit to the ribosomal binding site and 
promote efficient translation initiation of a lcrF-lacZ fusion in vivo. Other RNAs sensing 
environmental cues have shown to induce more global alterations within their secondary 
structure. For example, Kulshina and coworkers (2009) observed massive structural 
rearrangements of the tfoX 5' UTR in response to c-di-GMP ligand binding in V. cholerae. In 
the 5' UTR of a putative virulence gene in Clostridium difficile, C-di-GMP-binding leads to 
conformational changes resulting in the formation of alternative splicing sites. Depending on 
the secondary structure of the RNA, processing occurs either upstream or downstream of the 
Shine-Dalgarno sequence which regulates translation of the putative virulence determinant 
(Lee, et al. 2010).  
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A FourU thermometer was also identified in S. enterica where it influences synthesis of the 
small heat shock protein AgsA. Similar to lcrF, the Shine-Dalgarno sequence of the agsA 
mRNA interacts with four Uracils within a RNA stem-loop structure (Waldminghaus, et al. 
2007). NMR spectroscopic analysis revealed that the secondary structure of the agsA 5' UTR 
is unfolded in a zipper-type mechanism which shows high cooperativity. This cooperative 
behavior was based on the small number of mismatches and bulges within the FourU 
thermometer in Salmonella (Rinnenthal, et al. 2010). In contrast to agsA, computational 
analysis and RNA structure probing of the lcrF 5' UTR demonstrated that the adjacent region 
to the FourU/ribosomal binding site contains several mismatches and especially bulges which 
may lead to the only limited structural alterations in response to higher temperatures 
(Fig. 57). Interestingly, even more distanced mutations such as AUA -36 to -34 CCC or 
AG -46/-45 CC within the lcrF 5' UTR have a strong impact on the activity of a translational 
lcrF '-'lacZ fusion (Fig. 49). In general, Rinnenthal and coworkers (2010) explained such 
influences by remote effects on the hydration shell surrounding the RNA molecule. 
Besides riboswitches, other thermosensory mRNA structures of regulatory genes also undergo 
conformational alterations upon temperature changes. For instance, synthesis of the cold 
shock protein CspA in E. coli is affected due to the formation of different secondary structures 
of the cspA mRNA at 10°C and 37°C. At low temperatures, the conformation of the mRNA 
leads to a single-stranded Shine-Dalgarno sequence and AUG start codon. The cspA mRNA 
refolds at higher temperatures. This leads to incooperation of the translation initiation site 
and the first codon into double-stranded regions, which inhibits translation of the cold shock 
protein (Giuliodori, et al. 2010) 
Only few thermosensors have been found to regulate virulence of a pathogen. Besides LcrF, 
the 5' region of prfA mRNA in Listeria monocytogenes was shown to be important for 
pathogenesis. The prfA gene encodes a crucial transcriptional activator (PrfA) which 
stimulates expression of virulence factors for host cell invasion. Its 5' UTR forms a secondary 
structure at 30 °C which resolves at 35°C and enables access of the ribosomes to the Shine-
Dalgarno sequence (Johansson, et al. 2002). Interestingly, prfA translation is not only 
temperature-dependent but underlies a more complex regulation. PrfA production is also 
influenced by the presence of a trans-acting riboswitch, called SreA (Loh, et al. 2009) which 
strongly depends on the nutrient availability. Also LcrF synthesis of Yersinia is subject to 
multiple control systems, e.g. the transcriptional regulation by YmoA and the post-
transcriptional control by the FourU thermometer and Hfq. This complex regulatory network 
ensures that important virulence regulators are only expressed under specific of environmental 
conditions, e.g. during certain stages during host infection.  
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4.2.3 Hfq ambivalently regulates yscWlcrF expression dependent on the 
temperature 
Studies of this work further revealed that LcrF production is strongly affected by the RNA 
chaperone Hfq. At 25°C, Hfq of Y. pseudotuberculosis YPIII activates transcription of 
yscWlcrF operon, while LcrF production was strongly repressed at 37°C (Fig. 54 and Fig. 55). 
In Y. pestis, loss of hfq also induced transcript synthesis of many genes encoded by pCD1. For 
instance, expression of lcrF, yscW (virG), several yop and ysc genes were strongly stimulated 
(Geng, et al. 2009). Virulence of an hfq mutant in Y. pestis was strongly attenuated. The 
authors explained this by the higher sensitivity of an hfq mutant to stress signals from the 
environment. Furthermore, in vitro studies also showed that a Y. pestis hfq-deficient strain 
exhibits a strong growth defect, which may also explain why Y. pestis is less virulent when hfq 
was deleted. Results obtained in this study with Y. pseudotuberculosis YPIII, however, are 
different from what has been described for an hfq mutant in Y. pseudotuberculosis strain 
IP32953. Loss of hfq in this strain led to decreased expression of the type III secretion genes 
and reduced virulence, although lcrF expression levels were significantly induced in an hfq 
mutant (Schiano, et al. 2010). Ysc and Yop synthesis and secretion might still be reduced to 
a contrary Hfq-dependent effect on type III secretion. However, it is more likely that 
decreased ysc-yop expression is the result of loss of the virulence plasmid in the bacterial 
population. In fact, high overexpression of the LcrF production in a Y. pseudotuberculosis 
YPIII strain deficient in hfq or ymoA frequently results in the loss of pYV in the culture, due 
to massive deleterious yop/ysc overexpression (K. Böhme, A. K. Heroven, unpublished 
results). Alternatively, it is possible that the pYV-encoded genes are differentially regulated in 
different Y. pseudotuberculosis strains that might be due to differences in the genetic 
information. This has already been shown for the formation of biofilms on Caenorhabditis 
elegans by Sun and coworkers (2009). In contrast to Y. pseudotuberculosis strain IP2666c, 
strain YPIII carries insertions in the phoP gene, encoding the response regulator of the 
PhoP/Q two component system. This mutation inactivates the expression of phoP and 
induces biofilm formation similar to Y. pestis, but does not allow colonization of C. elegans in 
form of biofilms by the phoP+ Y. pseudotuberculosis strain IP2666c. Furthermore, hfq 
deletions lead to different growth behavior in Y. pseudotuberculosis strain YPIII and IP32953. 
Schiano et al. (2010) demonstrated that an hfq mutant in strain IP32953 was not or slightly 
attenuated during growth in BHI medium at 37°C. We observed that loss of hfq reduced the 
growth rates of Y. pseudotuberculosis strain YPIII significantly under these growth conditions 
and curing an hfq mutant of the virulence plasmid pYV restored wild type growth at this 
temperature (K. Böhme, unpublished results). This indicates that, during growth of 
Y. pseudotuberculosis strain YPIII in BHI medium at 37°C, Hfq-induced LcrF synthesis and 
thereby stimulated expression of yop genes might lead to toxic effects on Yersinia cells and 
growth arrest. At 25°C, hfq deletions in Y. pestis KIM6+ and Y. pseudotuberculosis strain 
YPIII also attenuated growth of both strains, but to a lower extent than at 37°C (Bai, et al. 
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2010, Böhme unpublished data). These results suggest a different role of the RNA chaperone 
in different Yersinia species and strain variants.  
Involvement of Hfq in the regulation of type III secretion systems and their effectors has also 
been found in several pathogens. For instance, invE in Shigella sonnei is upregulated in an 
hfq-deficient strain at low osmolarity, which in turn activates a type III secretion system 
(Mitobe, et al. 2009). Hfq of EHEC represses expression of genes from the pathogenicity 
island LEE and non-LEE-dependent effectors such as espFu, espJ or espK. The chaperone 
downregulates synthesis of the major regulator Ler (Shakhnovich, et al. 2009).  
Hfq implication in the environmental control of different crucial virulence genes expressed 
during different phases of the infection underlines the importance of this global regulator for 
pathogenesis. Variation of Hfq function between related species and strain isolates requires a 
more detailed analysis of the effects in future studies to fully understand its role in virulence. 
4.3 Working model for regulation of virulence factor expression 
in Y. pseudotuberculosis 
Analysis of environmental control of early and later stage virulence factors of 
Y. pseudotuberculosis in this study revealed a complex regulatory network coregulating and 
adapting virulence gene expression in Y. pseudotuberculosis in response to different 
environmental conditions. At moderate temperatures, during stationary growth and in complex 
medium, conditions resembling an environment outside of the host or in contaminated food, 
the nucleoid-associated protein YmoA and the RNA-binding protein CsrA are present. Hfq 
activates transcription of the regulatory RNA csrC gene indirectly, which is stabilized by an 
interaction with CsrA. The YmoA protein also reduces the degradation of CsrC, most likely by 
downregulation of the expression of RNases. Binding of CsrA to the regulatory RNA prevents 
synthesis of the LysR-type regulator RovM. RovM no longer represses production of RovA in 
association with H-NS, which leads to invasin expression. Furthermore, YmoA-mediated 
repression of proteases production reduces rapid degradation of RovA and supports 
upregulation of RovA and RovA-dependent virulence genes under these conditions. In parallel, 
YmoA abolishes the expression of the yscWlcrF operon, encoding the major activator of late 
virulence factors, LcrF. Moreover, translation initiation of lcrF mRNA is inhibited by the 
formation of a FourU RNA thermoswitch in the 5' UTR. During the early phase of infection, 
Y. pseudotuberculosis thereby ensures an efficient uptake by the M-cells and translocation 
through the gut epithelium shortly after ingestion. 
After attachment to the gut and colonization of the Peyer’s patches, the RovA and YmoA 
proteins are degraded by ATP-dependent Clp and Lon proteases due to increased temperature 
and a reduced growth rate. Reduced or changing nutrient availability also influences 
expression of rovA and ymoA negatively. Furthermore, lower amounts of CsrA and the YmoA 
proteins lead to a strong degradation of the CsrC RNA under these conditions. Liberated 
unbound CsrA molecules lead to enhanced RovM synthesis and prevent rovA expression in 
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cooperation with H-NS. Additionally, RovA proteolysis is even further increased due to a 
higher production of Clp and Lon proteases caused by the loss of YmoA. Invasin synthesis is 
prevented because RovA no longer antagonizes the binding of H-NS to the inv promoter. 
Moreover, degradation of the nucleoid-associated protein YmoA and activity of an unknown 
Yersinia-specific regulator induces transcription of the yscWlcrF operon. Increased 
temperatures also lead to structural alterations and melting of the FourU RNA thermometer 
which results in a higher accessibility and binding of the Shine-Dalgarno sequence by 
ribosomal subunits. LcrF protein synthesis activates gene expression of several yops, the 
type III secretion system genes and yadA. These virulence determinants mediate the defense 
of Y. pseudotuberculosis against immune system attacks, allow proliferation in the mesenteric 
lymph nodes and dissemination to kidney, spleen or liver (Fig. 58).  
In this regulatory network, the nucleoid-associated protein YmoA has a crucial function as it 
acts as a temperature-sensitive switch controlling the overall change of virulence factor 
expression in Y. pseudotuberculosis from early to ongoing phases of infection. Temperature-
dependent proteolysis of RovA, the main regulator of early virulence genes and the FourU 
thermoswitch affecting lcrF translation act as a second gateway of control to limit expression 
of the virulence factors to the right time and place during infection. 
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Fig. 58. Regulatory factors YmoA and Hfq as well as a FourU thermometer in the lcrF 5' UTR are essential 
for tight control of virulence factor expression in Y. pseudotuberculosis. Model of virulence factor expression 
derived from experimental data of this work. Arrows indicate direct activation of the gene expression or protein 
synthesis, whereas dashed arrows suggest indirect regulation. T represents repression or inactivation. 
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5 Outlook 
This work defined the nucleoid-associated protein YmoA as an activator of early phase 
virulence factor expression where it stabilizes the CsrC RNA. The mechanism of stabilization 
needs to be further analyzed, in particular the role of YmoA to regulate the expression of 
RNases. In general, it is still unclear how YmoA affects gene expression or protein synthesis, 
since DNA-binding ability could only be observed in association with H-NS (K. Böhme, 
S. Sievers, unpublished data). Additional gene expression and EMSA studies with or without 
H-NS will help to elucidate this question.  
Furthermore, it needs to be analyzed how and which RNases degrade the CsrC or CsrB RNA 
in yersiniae. Major influence of YmoA on the control of the carbon storage regulatory system 
and severe growth defects of a ymoA mutant indicate a major role of YmoA in the control of 
the bacterial metabolism. Influence of the nucleoid-associated protein on the Yersinia 
metabolism is currently studied using microarray, metabolomics and Biolog analysis. Interplay 
of the regulatory components of Yersinia virulence regulators YmoA, CsrA and CsrC were 
examined in vitro but nothing is known about expression of these important regulators in the 
mouse model during different stages of the infection as invasin expression in 
Y. pseudotubrculosis occurs only in the ileum and in the beginning of the infection (J. Eitel, 
unpublished data). This would be accomplished, for example, by in vivo imaging or 
histological experiments using reporter gene fusions encoding  flourescent proteins. 
The RNA chaperone protein Hfq was shown to influence csrC transcription, but this seems to 
occur indirectly by another regulatory protein. In future experiments, it needs to be analyzed 
whether Hfq controls other regulatory RNA that affect csrC expression directly or through 
other regulatory components. 
Interestingly, Hfq was not only observed to activate invasin expression but also represses LcrF 
synthesis in Y. pseudotuberculosis strain YPIII. This influence occurs mainly on the post-
transcriptional level, but the mechanism is not yet clear. Future experiments will address 
implications of Hfq on the RNA thermometer formation. Therefore, transcription-independent 
fusion containing the 5' UTR of lcrF in the presence and absence of Hfq will be monitored. 
Furthermore, other regulatory factors and influence of host cell contact on the function of the 
RNA thermometer will be tested. The importance of the FourU RNA thermometer on LcrF 
protein production and virulence of Y. pseudotuberculosis in the mouse model will be analyzed 
in more detail. Mouse survival experiments and organ burden of mice infected with mutants 
harboring mutations to stabilize or destabilize the FourU secondary structure will confirm the 
significance of such a thermoelement in virulence factor expression of enterobacteria.  
Furthermore, involvement of an untranslated antisense RNA in Hfq/YmoA-mediated 
regulation of LcrF production within similar to exsB' in Pseudomonas aeruginosa will be 
addressed. 
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Expression data in this study showed that lcrF is organized in an operon with yscW. The 
existence of the polycistronic RNA will be verified by primer extension analysis, 5' RACE 
(rapid amplification of cDNA-ends) or Northern blotting. These experiments would also 
elucidate the transcription start of the yscWlcrF operon which seems to be located at least 
260 nt upstream of the yscW gene. Transcription of the yscWlcrF operon was also found to 
be regulated by other regulatory proteins, e.g. a Yersinia specific activator which appears to 
be encoded by the Yersinia virulence plasmid pYV. Genetic screening and mutational analysis 
will help to identify this regulator and address its role in host cell contact-dependent 
expression of lcrF (W. Opitz, S. Fehse, unpublished data). 
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6 Summary 
The enteric pathogen Y. pseudotuberculosis causes gut-associated diseases by ingestion of 
contaminated food. The bacterium passes the intestinal tract until it reaches the ileum at the 
end of the small intestine. During the infection process, the bacterium uses two primary 
invasion factors, invasin and YadA. Invasin synthesis occurs only in the beginning of the 
infection process, whereas YadA expressed during later stages of the infection helps 
Y. pseudotuberculosis to colonize and disseminate in the host. Expression of invasin is tightly 
regulated in response to environmental parameters by the MarR-type regulator RovA, which is 
negatively controlled by the nucleoid-associated protein H-NS and the LysR regulator RovM. 
The carbon storage regulator system influences rovA expression by regulating the synthesis of 
RovM. Under conditions which suppress expression of invasin, e.g. during later infection 
phases, production of YadA is induced by the AraC-like regulator LcrF. During genetic 
screenings, the nucleoid-associated protein YmoA and the RNA chaperone Hfq were found to 
influence expression of invasin or YadA. 
Early phase of infection 
Expression studies in this work revealed that YmoA activates the expression of rovA in 
Y. pseudotuberculosis by inhibiting the synthesis of the rovA repressor RovM. Deletion of 
ymoA in a rovM mutant also showed, that the YmoA protein activates RovA synthesis in a 
post-transcriptional manner most likely by repression of the Lon protease which was previously 
shown to degrade RovA at 37°C. More importantly, Northern blot analysis demonstrated that 
YmoA stimulates the synthesis of the rovA activating regulatory RNA CsrC, independent of 
the expression of the second regulatory RNA CsrB known to suppress CsrC synthesis. 
Regulatory studies and stability assays revealed that YmoA influences the CsrC RNA on the 
post-transcriptional level by preventing CsrC degradation. Similar experiments using a csrA-
deficient strain demonstrated that also the RNA-binding protein CsrA inhibits CsrC decay. 
CsrA-mediated stabilization of CsrC seems to be independent of YmoA and was much more 
pronounced than YmoA-promoted stability. RNA-binding studies using purified YmoA protein 
and in vitro transcribed CsrC RNA demonstrated that YmoA influence on CsrC stability seems 
to be indirect and appears to involve additional regulatory components such as H-NS and 
RNases.  
Expression analysis of CsrA and YmoA further showed that synthesis of both regulators is 
downregulated in minimal medium and at 37°C, which results in reduced CsrC levels under 
these growth conditions. At 37°C, the YmoA protein is rapidly degraded by ATP-dependent 
ClpP/Lon proteases. Surprisingly, although high levels of YmoA were produced during the 
exponential growth in complex medium, CsrC levels were still reduced due to low amounts of 
CsrA. As presence of CsrA was more important for CsrC than the presence of YmoA, CsrC 
levels were maximal at high levels of CsrA and moderate YmoA concentrations. 
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In the present work it was also shown that Hfq influences rovA expression through the Csr 
system. Reporter gene fusion studies revealed that Hfq affects transcription of the csrC gene. 
Promoter deletion analysis further indicated that csrC expression is controlled by an additional 
positive regulator which seems to interact with sequences located 200 to 350 nucleotides 
upstream of the csrC transcription start.  
Finally, the nucleoid-associated protein H-NS was found to be implicated in the regulation of 
CsrC. H-NS was shown to upregulates CsrC levels post-transcriptionally. Induction of CsrC by 
H-NS was also observed in the absence of ymoA indicating that H-NS can partially 
complement the YmoA function when it is overexpressed. YmoA-mediated activation of H-NS 
expression was excluded but in this context it was also shown that H-NS is able to repress 
YmoA protein synthesis in Y. pseudotuberculosis. 
Later phases of infection 
YmoA was also found to inhibit the synthesis of the activator of late stage virulence factors 
LcrF at moderate temperatures. The lcrF gene was shown to be organized in an operon with 
the yscW gene which was regulated by YmoA from a region 300 bp upstream of the yscW 
gene. Promoter deletion studies of yscWlcrF-lacZ fusions as well as expression of an yscWlcrF 
fusion in E. coli revealed that an additional Yersinia-specific activator influences expression of 
the operon. This regulator seems to be encoded by the Yersinia virulence plasmid (pYV), 
since promoter activities were reduced in a strain cured of pYV. Autoregulation of lcrF 
expression could be excluded. Expression of the operon from a thermo-independent promoter 
showed that translation of the lcrF mRNA is still regulated in response to temperature. 
Studies using a translational lcrF '-'lacZ fusion under the control of a thermo-independent 
promoter demonstrated that an element located within the intergenic region between yscW 
and lcrF is responsible for this phenomenon. 
Computational predictions indicated that this 5' untranslated region of lcrF forms a secondary 
structure containing two hairpins forming a FourU thermometer. Partial deletions of these 
hairpins confirmed that the entire structure is essential for a precise thermocontrol of lcrF 
translation. Mutational studies demonstrated that altering the complementarity of the base 
pairing at the FourU motif changed temperature-dependence of LcrF production drastically. 
Destabilizing mutations allow LcrF synthesis already at 25°C, whereas stabilizing exchanges 
abolished LcrF synthesis at 25°C and 37°C. RNA structure mapping of in vitro synthesized 
RNA of the lcrF 5' UTR at 25°C and 37°C confirmed structural predictions and revealed 
enhanced single-stranded regions at the Shine-Dalgarno sequence at 37°C compared to 
moderate temperatures. Toe print analysis confirmed that these structural rearrangements at 
high temperatures allow the binding of ribosomal subunits to their recognition site. 
Experiments using RNAs mutated at the FourU motif confirmed these observations.  
In addition, the RNA chaperone Hfq was shown to be implicated in the control of LcrF 
protein synthesis. Deletion of hfq elevates LcrF protein production at 37°C; and expression 
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analysis showed that Hfq-mediated expression seems to occur on the post-transcriptional level, 
e.g. via an RNA that affects the stability of the lcrF mRNA.  
All these results point out that both, the RNA chaperone Hfq and the nucleoid-associated 
protein YmoA, represent crucial regulators of early and late phase virulence genes in 
Y. pseudotuberculosis (virulence). In particular, YmoA seems to function as a molecular 
switch which activates expression of virulence genes needed in the initial part of the infection 
in response to low temperature, whereas factors produced for the survival in the deeper tissues 
are repressed. At body temperature of 37°C, YmoA is rapidly degraded and allows 
transcription of the yscWlcrF operon. Furthermore, formation of the inhibitory secondary 
structure of the FourU RNA thermometer is prevented at 37°C and permits efficient 
translation of the RNA. This sophisticated control system of the Yersinia virulence genes 
demonstrates how synthesis of virulence regulators is finely adjusted in pathogenic bacteria to 
trigger virulence factor production in response to environmental signals throughout the 
different stages of an infection. 
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Supplementary Material 
1. Plasmid constructions 
1.1 Construction of plasmid pKB4 
To complement gene deletions, the coding sequence of ymoA was introduced into the low 
copy vector pHSG575. The insert was amplified using primer 1 and 2. Vector pHSG575 and 
the PCR product were digested with SalI and BamHI and ligated, generating pKB4.  
 
Fig. S1. Plasmid map of pKB4. The coding sequence of ymoA was inserted into the BamHI/SalI restriction sites 
of pHSG575 multiple cloning site, interrupting the lacA gene. In black, restriction sites preceded by nucleotide 
number of the cleavage site with respect to the plasmid origin, ( ) indicates number of restriction sites.  
1.2 Construction of plasmids pKB13, pKB14 and pKB18 
pKB13, pKB14 and pKB18 were constructed to measure the transcription-independent lcrF 
translation of the PBAD promoter followed by the intergenic region between yscW and lcrF 
with different sequence deletions. Primers 3 and 6 were used to synthesize the insert for 
pKB14. The pKB18 insert was amplified with primers 6 and 7. For pKB13, the insert was 
generated by a three-step-PCR to delete nucleotides -41 to 30 in relation to the lcrF start 
codon. Therefore, an upstream fragment was generated with primers 3 and 4. The 
downstream fragment was synthesized using primers 5 and 6. In the last step, the resulting 
insert was amplified in reaction containing up- and downstream fragment with primers 3 and 
6. All inserts were digested with EcoRI and NheI and ligated into the pBAD18-lacZ (481) 
linearized with the same restriction enzymes. 
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Fig. S2. Plasmid maps of pKB14, pKB18 and pKB13. A. The 5' UTR of lcrF from (A) nucleotide -123 to +74 
(B) -63 to + 74 and (C) -123 to +74 with a deletion from position -41 to -30 relative to the lcrF start codon was 
introduced into the EcoRI-NheI sites of pBAD18-lacZ (481). In black, restriction sites preceded by nucleotide 
number of the cleavage site with respect to the plasmid origin. ( ) indicates number of restriction sites. 
1.3 Construction of plasmid pKB20 
To determine the csrC expression of construct harboring the first 71 nucleotides after the 
transcription start, a fragment was synthesized using primers 8 and 9. The insert was digested 
with EcoRI and SalI and introduced into the similar linearized lacZ reporter gene vector 
pHT124. 
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Fig. S3. Plasmid map of pKB20. The promoter region of csrC from positions -355 to +71 nt relative to the 
transcription start was inserted into vector pHT124 using restriction sites EcoRI and SalI. In black, restriction sites 
preceded by nucleotide number of the cleavage site with respect to the plasmid origin, ( ) indicates number of 
restriction sites. 
1.4 Construction of plasmid pKB17 
For the expression of csrC with a deletion at nucleotides +24 to +57 relative the transcription 
start, a fragment was generated with primers 10 and 9 and digested with EcoRI and SalI. The 
insert was introduced into the lacZ reporter gene vector pHT124 linearized with the same 
restriction enzymes. 
 
Fig. S4. Plasmid map of pKB17. The promoter region of csrC from positions -355 to +81 nt relative to the 
transcription start with a deletion at positions +24 to +57 nt was inserted into vector pHT124 using restriction 
sites EcoRI and SalI. In black, restriction sites preceded by nucleotide number of the cleavage site with respect to 
the plasmid origin, ( ) indicates number of restriction sites. 
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1.5 Construction of plasmids pKB34 and pKB38 to pKB43 
To measure the influence of YmoA on the yscW promoter region translational promoter 
deletion fusions were constructed. Therefore, fragments comprising the yscW promoter region, 
the yscW gene, 5' region of lcrF and lcrF gene were generated producing an yscW upstream 
region to position -573 (pKB34), -466 (pKB39), -368 (pKB40), -267 (pKB41), -171 (pKB42), 
-73 (pKB43) and -8 (pKB38) with primer pairs 11/12, 15/12, 16/12, 17/12, 18/12, 19/12 
and 14/12, respectively.   The inserts were digested with PstI and ligated into the similarly 
linearized and dephosphorylated vector pTS02, which fuses the fragment in frame to a lacZ 
reporter gene.                                                                                                                                
 
Fig. S5. Plasmid maps of pKB34, pKB39 to pKB43 and pKB38. Promoter deletion fusion with yscWlcrF 
regions from positions -573 (pKB34), -466 (pKB39), -368 (pKB40), -267 (pKB41), -171 (pKB42), -73 (pKB43) 
and -8 (pKB38) upstream of the yscW gene were fused to the lacZ gene of vector pTS02 at the PstI restriction 
site. In black, restriction sites preceded by nucleotide number of the cleavage site with respect to the plasmid 
origin, ( ) indicates number of restriction sites. 
1.6 Construction of plasmid pKB35 
To determine the impact of Hfq on the yscW gene expression, the promoter region of yscW 
and the following five codons of the yscW gene were fused to the reporter gene lacZ in vector 
pTS02. Therefore an insert was amplified with primers 11 and 13. After digestion with PstI, it 
was ligated into the corresponding restriction site of the linearized and dephosporylated 
vector. 
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Fig. S6. Plasmid map of pKB35. The promoter region of yscW and five codons of the yscW gene were 
introduced into pTS02 at the PstI site for translational fusion to a lacZ reporter gene. In black, restriction sites 
preceded by nucleotide number of the cleavage site with respect to the plasmid origin, ( ) indicates number of 
restriction sites. 
1.7 Construction of plasmids pKB45 and pKB46 
Plasmids pKB45 and pKB46 were constructed to examine the effect of H-NS on csrC 
expression. For this purpose, the regulatory region of csrC and 4 nt (pKB45) or 81 nt 
(pKB46) downstream of the transcription start were amplified with primer pairs 20/21 or 
20/22, respectively. Generated fragments were digested with PstI and inserted into the 
corresponding restriction site of the linearized and dephosphorylated vector pTS03.  
 
Fig. S7. Plasmid maps of pKB45 and pKB46. The promoter region of csrC and 4 nt or 81 nt of the sequence 3' 
of the transcriptional start site was introduced into pTS03 at the PstI site, generating pKB45 and pKB46, 
respectively. In black, restriction sites preceded by nucleotide number of the cleavage site with respect to the 
plasmid origin, ( ) indicates number of restriction sites. 
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1.8 Construction of plasmid pKB47 
To express csrC independently from transcription, a Ptet promoter was fused to the csrC gene 
by PCR using primers 23 and 24. The insert was digested by SalI and BamHI and ligated into 
the linearized vector pHSG575 cleaved with the same restriction enzymes. 
 
Fig. S8. Plasmid map of pKB47. A fragment carrying the sequence of Ptet and the csrC gene was introduced into 
the PstI site of pHSG575. In black, restriction sites preceded by nucleotide number of the cleavage site with 
respect to the plasmid origin, ( ) indicates number of restriction sites. 
1.9 Construction of plasmids pKB49 and pKB59 
To compare the synthesis of RNA from a csrC wild type gene and csrC harboring a deletion 
from position +24 to +57 relative to the transcription start. An insert carrying the csrC gene 
and its regulatory region was synthesized by primers 27 and 28, digested with BamHI and SalI 
and ligated into pHSG576, generating pKB59. Deletion of the region deletion from position 
+24 to +57 within the csrC gene was accomplished by three-step-PCR. First, the upstream 
region was amplified by primers 25 and 27, where primer contained the mutated region. In the 
following, primers 26 and 28 were used to generate a downstream fragment, in which primer 
26 missed the nucleotides to be deleted. In a third step, up- and downstream fragment were 
mixed with primers 25 and 28 to generate the entire insert. This was digested with SalI and 
BamHI and introduced into pHSG576 resulting in pKB49. 
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Fig. S9. Plasmid maps of pKB59 and pKB49. Fragments harboring the regulatory region of csrC and (A) the 
wild type csrC gene or (B) csrC missing the region from position +24 to +57 relative to the transcription start 
were inserted into vector pHSG576 generating pKB59 and pKB49, respectively. In black, restriction sites preceded 
by nucleotide number of the cleavage site with respect to the plasmid origin, ( ) indicates number of restriction 
sites. 
1.10 Construction of plasmid pKB60 
Expression of csrA from a low copy vector was essential to prevent toxic effects of the CsrA 
protein. The coding region of csrA was amplified using primers 29 and 30. The insert was 
digested with SalI and BamHI and ligated into the linearized vector pHSG576.  
 
Fig. S10. Plasmid maps of pKB60. The coding sequence of csrA was ligated into the BamHI and SalI sites of 
pHSG576. In black, restriction sites preceded by nucleotide number of the cleavage site with respect to the plasmid 
origin, ( ) indicates number of restriction sites. 
1.11 Construction of plasmid pKB63 
To monitor the transcription activity of the csrA regulatory region, the promoter sequence of 
csrA and five codons of csrA was amplified using primers 31 and 32. The insert was digested 
 168 
with PstI and ligated into the linearized, dephosphorylated vector pTS02. This fuses the csrA 
coding region in frame to a lacZ reporter gene generating pKB63. 
 
Fig. S11. Plasmid maps of pKB63. An insert harboring the promoter sequence of csrA and the first 5 codons of 
csrA was fused to lacZ reporter gene of vector pTS02 at the PstI site. In black, restriction sites preceded by 
nucleotide number of the cleavage site with respect to the plasmid origin, ( ) indicates number of restriction sites. 
 
